FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
Lastest Publications
2025HPV vaccine and HPV-related diseases: A communication guide to support pharmacists to start conversations with consumers
2024The FIP Global Competency Framework: A validated adaptation for the South East Asia Region
2024FIP knowledge and skills reference guide for pharmacists supporting self-care
Every year, December 12th marks Universal Health Coverage (UHC) Day, raising awareness, celebrating progress, and urging action to ensure access to quality health services without financial burden. Self-care is vital to well-being across all life stages, and its integration into UHC can enhance health outcomes and ease pressure on healthcare systems. Pharmacists, as self-care champions, play a key role in this evolving health landscape. This event will highlight the importance of self-care in UHC, its integration into national health policies, and the critical role of pharmacy collaborations.
The academic section concluded with a strategic plan, and advocacy and global influence were identified as critical priorities for the section. Panelists representing key stakeholders worldwide will be invited to address the following questions related to advocacy and change management. 1.) What has worked well in your region to shape education policy? 2) What challenges did you face? 3) How can the FIP academic section influence education policy in your region? 4) What advice do you have for individuals entering this area of advocacy and policy in pharmacy education? Live participants will be encouraged to provide additional perspectives.
Series coordinators:
- Nadia Al Mazrouei, Associate Professor, University of Sharjah UAE, Expert Advisory Board Panel at the WHO, United Arab Emirates
- Barry Bleidt, Adjunct Professor - Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, United States
Panellists:
- Osama Ibrahim, Vice Dean for Graduate Studies and Scientific Research, School of Pharmacy, New Giza University, Egypt
- Moureq Alotaibi, Associate Professor, King Saud University, President, Saudi Pharmaceutical Society, KSA, Saudi Arabia
- Diana Malaeb, Assistant Professor, Gulf Medical University, United Arab Emirates
- Sara Ramadan, CEO & Founder, Catalyst, United Arab Emirates
- Rana Ibrahim, Doctor in Pharmacy, Lecturer in Pharmacy Practice, and Clinical Pharmacy, University of Sharjah, United Arab Emirates
This webinar will explore the evolving role of pharmacists in the dispensing of medicinal cannabis and address the increasing demand for pharmacist involvement in this emerging therapeutic area. The importance of this topic lies in the unique responsibilities pharmacists have in patient education, dispensing, monitoring and ensuring ethical standards. By addressing the pharmacological effects of cannabinoids, global regulatory frameworks and challenges for pharmacists, this event will equip pharmacists with the tools to navigate the complexities of medical cannabis use, while highlighting the need for ongoing education and training in this evolving field.
The webinar will explain how disrupting technologies and novel concepts impact the way clinical trials are designed and executed. This new age of clinical trial advancements means that Sponsors and all trial stakeholders, including the sites and technology partners must evolve to meet the demands of this new paradigm. In this talk, Dr Kubassova will talk about the fundamentals of a digital strategy, which is needed to leverage novel technologies within clinical trials. She will also speak about data-driven approach to drug development and cover how integrating AI into drug development process affects cost, speed and success of pharmaceutical drug development. You can bring these fundamentals with you into development of drugs in a particular indication or conducting a real-world evidence study.
Chair:
- Mathew Cherian, VP of Operations & Development, ReVive Biotechnology, United States
Webinar video • 5 December 2024, 13:00 - 14:30 CET
Use of doxycycline for the prevention of bacterial sexually transmitted infections (STIs) (DoxyPEP): Supporting evidence and the challenge of antimicrobial resistance (AMR)
The increasing incidence of bacterial sexually transmitted infections (STIs), particularly among men having sex with men has encouraged the wide preventative use of doxycycline as Post-Exposure Prophylaxis (DoxyPEP), although experts think the strategy could benefit patients outside this group. There are also concerns associated with antimicrobial resistance and the frequent (and potentially incorrect) use of antibiotics by individuals who use this intervention. This event will inform pharmacists of the evidence supporting the rational use of this intervention and explore the potential impacts of widespread use from a public health perspective
COVID exposed worldwide health inequalities and security challenges. Consequently WHO, WTO and other entities are calling for regional diversification of vaccines and drug manufacturing. For this to be sustainable there has to be strong demand from countries and multilateral procurement agencies.
Chair: - Mathew Cherian, VP of Operations and R&D, ReVive Biotechnology, USA
El webinar abordará la sostenibilidad de la fuerza laboral en la farmacia comunitaria, un tema de vital importancia dada la creciente presión sobre los farmacéuticos, especialmente tras la pandemia de COVID-19. La carga de trabajo excesiva, el agotamiento y los desafíos económicos afectan negativamente tanto a los profesionales como a la atención al paciente. Este webinar destacará la necesidad de políticas que apoyen la salud mental y el bienestar de los farmacéuticos. A través de un enfoque integral, se ofrecerán recomendaciones para crear entornos de trabajo positivos y sostenibles que mejoren tanto el entorno laboral como la atención comunitaria.
Moderador:
- Mario Alberto Ramírez Camacho, Profesor Investigador - Farmacéutico Responsable del Centro de Información de Medicamentos y Farmacia Clínica, Universidad Autónoma de Yucatán - Facultad de Química, México
Ponente:
- Jaime Acosta, Farmacéutico Comunitario, Farmacia Acosta, España
- Leticia Caligaris, Farmacéutica Comunitaria, Ministerio de Defensa Uruguay, Secretaria de la Sección de Farmacia Comunitaria de la FIP, Uruguay
- Jorge Schlottke, Miembro de la Sección de Farmacia Comunitaria de la FIP, Argentina
Worldwide, around 2.6 million deaths were caused by alcohol consumption in 2019, with 1.6 million of these resulting from non-communicable diseases (NCDs), according to the WHO. This webinar explores the burden of alcohol consumption and the complex relationship between alcohol addiction and various diseases, including NCDs, emphasising the importance of early intervention, support, and effective management strategies. Attendees will learn about the WHO SAFER initiative and how pharmacists can play a crucial role in prevention, support, and management efforts, collaborating with healthcare teams to improve patient outcomes and reduce alcohol-related health risks.
A sore throat is a common symptom, typically resulting from an upper respiratory tract infection, the majority of which are viral in origin. As a self-limiting condition, it frequently leads to consultations with community pharmacists. However, it is also one of the most frequent reasons for unnecessary antibiotic use. A sore throat can be associated with various conditions such as strep throat, the common cold, allergies, or other upper respiratory illnesses. Strep throat, a less common bacterial infection caused by Streptococcus, necessitates antibiotic treatment to prevent potential complications. Pharmacists play a critical role in symptom identification and management through both pharmacological and non-pharmacological interventions. They are also essential in referring patients for appropriate prescriptions and educating them about the risks of inappropriate antibiotic use.
Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease that requires comprehensive care. Community pharmacists and their teams are ideally placed to raise COPD awareness, identify those at risk and be the driving force behind earlier detection and referral to primary care partners for screening, diagnosis and intervention. At this event, the “COPD Pharmacy Toolkit” to support pharmacists in providing a range of COPD pharmacy services will be presented. Participants will also learn about the new Speak Up for COPD Coalition publication "The Global State of COPD: Driving Change to Tackle a Lung Health Crisis". Join this event to mark World COPD Day.
Moderator:
- Luís Lourenço, Professional secretary FIP, Portugal
Panellists:
- Tonya Winders,President & acting CEO of the Global Allergy & Airways Patient Platform (GAAPP); Chair of Speak Up for COPD, USA
- Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands - Ema Paulino, President National Pharmacy Association (ANF), Portugal
This webinar is hosted by FIP on behalf of the World Health Professions Alliance (WHPA), which brings together the global organizations representing the world’s dentists, nurses, pharmacists, physiotherapists and physicians: www.whpa.org. Antimicrobial resistance is not only one of the top ten global health threats, but it is also exacerbated by climate change, making it a major challenge to global health security and achieving the SDGs. Given this heightened global relevance, it was the subject of the recent High-Level Meeting (HLM) at the 2024 UN General Assembly.
In this webinar, WHPA’s expert speakers will take stock of the meetings’ outcomes and discuss how they contribute to ongoing efforts to tackle AMR. Will they result in higher levels of political commitment, and funding? What are the key financial and operational challenges? How does AMR play out differently in low-, middle- and high-income countries? How should public health messaging evolve? And what are best practice examples of interprofessional collaboration on AMR?
Moderator:
- Catherine Duggan, Chair of WHPA and CEO of FIP WHPA/FIP, The Netherlands
Panellists:
- Caline Mattar, Associate Professor of Medicine, and Director of Global Health Education and Partnerships Washington University at St. Louis, USA
- Enrique Castro-Sanchez, Senior Lecturer in Global Challenges Brunel University, UK
- Wendy Thompson, Clinical Senior Lecturer in Primary Dental Care and practicing dentist,University of Manchester and mydentist (dental practice), UK
On 14 August 2024, the World Health Organization determined that the new upsurge of mpox (formerly known as monkeypox) constitutes a public health emergency of international concern. As healthcare professionals, and to be prepared to face any questions from the community, it is important that pharmacists are up to date about this disease, its symptoms and global distribution, modes of transmission and prevention, treatment options and available vaccines. Particularly for pharmacists practising in countries with confirmed cases, but for all pharmacists around the world, this event will help mobilise pharmacists to promote awareness and prevent disease progression.
Moderator:
- Jocelyn Chaibva, Pharmacist Nu Fife Avenue Pharmacy, Harare, Zimbabwe
Panellists:
- Wolfgang Preiser, Head: Division of Medical Virology Stellenbosch University and National Health Laboratory Service Tygerberg, South Africa
- Philippe Mukumbayi, Research Assistant Faculty of Pharmaceutical Sciences, University of Kinshasa, Democratic republic of Congo
The original Nanjing Statements, launched in 2016, continue to guide global direction for pharmacy and pharmaceutical sciences education. On November 7, 2024, FIP will host a digital event to launch the updated publication titled “FIP Nanjing Statements - Shaping pharmacy and pharmaceutical sciences education to 2030 – Guidance Document”. This revised edition addresses shifts in global healthcare, especially in light of COVID-19, and the evolving competency needs of the pharmaceutical workforce. The webinar will explore the updated eight domains, discussing how they reflect these changes and affirm their relevance to both current and future healthcare demands.
Moderator:
- Dalia Bajis, FIP Senior Programme Lead FIP, Netherlands
Facilitator:
- Ozge Ozer, FIP Education and Professional Development Manager FIP, Netherlands
Guests:
- Toyin Tofade, Albany College of Pharmacy and Health Sciences, USA
- Ralph Altiere, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
- Ian Bates, University College London, United Kingdom
- Pascale Salameh, Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie
- Liban (INSPECT-LB) & Faculty of Pharmacy, Lebanese University, Lebanon
- Nadia Al Mazrouei, Associate professor University of Sharjah, Pharmacy practice and Pharmacotherapeutics Department, Clinical pharmacist and Chairman of Experiential Training Committee, UAE
- Silvana Leite, Federal University of Santa Catarina, Brazil
- Yahya Choonara, University of Witwatersrand, South Africa - Anisha Sandhu, School of Pharmacy, Monash University, Malaysia
- Jack Yu-Chieh Chen, Taiwan Society of Health-System Pharmacists (TSHP), China Taiwan - Wanda Maldonado Davila, University of Puerto Rico, School of Pharmacy, Puerto Rico
- Lilian M. Azzopardi, Department of Pharmacy at the Faculty of Medicine and Surgery of the University of Malta, Malta
FIP is proud to announce a special digital event on 24 October 2024, in recognition of World Mental Health Day. This webinar will focus on the current state of mental health policy and practice globally, with particular emphasis on Türkiye, UAE, Saudi Arabia, and India. Pharmacists and policymakers will come together to discuss approaches to mental health care, addressing key challenges and opportunities for improvement. The event will highlight how pharmacists can be better supported in their role and how policies can be adapted to improve access to mental health resources, promoting a holistic, patient-centred approach across these regions.
Moderator:
- Sherif Guorgui,President, FIP Community Pharmacy Section, Canada
- Dalia Bajis, FIP Senior Programme Lead FIP, Netherlands
Facilitator: - Ozge Ozer, FIP Education and Professional Development Manager, Netherlands
Chronic non-communicable diseases (NCDs), such as cancer, chronic respiratory diseases, cardiovascular diseases and diabetes represent a worldwide health challenge. According to the WHO 41 million people die each year from NCDs, accounting for 74% of all deaths globally. Prevention and management of chronic diseases is dependent on reducing underlying risk factors. Community pharmacists and their teams are ideally placed to raise chronic diseases awareness, identify those at risk and be the driving force behind earlier detection and referral to primary care partners for screening, diagnosis and intervention. At this event, the “Chronic Disease Service Framework” to support pharmacists in providing a range of NCD pharmacy services will be presented.
Moderator:
- Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
Panellists:
- Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands
- António Teixeira Rodrigues, Director, Evidence & Health Solutions National Association of Pharmacies, Portugal
- Jack Shen Lim, General Secretary Malaysian Pharmacists Society (MPS), Malaysia
This webinar aims to raise awareness of technologies in use within the pharmaceutical sector, with a focus on the African perspective. The event is targeted at members and non-members of the FIP (International Pharmaceutical Federation) worldwide. The goal is to highlight technological innovations from developing countries that can be embraced and utilized in developing regions to optimize patient care, enhance public wellness & safety and streamline pharmaceutical operations in general. The webinar will explore how these technological solutions were birthed and can be implemented in the pharmacy sector across Africa to enhance service delivery, improve health outcomes, and address the unique challenges faced by the pharmacy sector in the developing world. This knowledge-sharing session promises to be insightful for pharmacists seeking to leverage technology to transform their practice.
Moderator: - Jaime Acosta Gomez, Community Pharmacist FIP (TAG), Spain
Panellists: - Takunda Mukumba, Director Ehealth Afro Private Limited, Zimbabwe - Nabembezi Ziada Zalwango, Consultant Dumaic Global Health, Uganda - Samuel Akuffo, Africa Fulfilment Lead Zipline International, Ghana
Although perimenopause and menopause are inevitable parts of a woman's life, each experience is unique, influenced by culture, health beliefs, and general well-being, impacting physical, emotional, mental, and social aspects. This event will explore how pharmacists can expand their roles to support women during this transition. Participants will gain insights into recognising symptoms, understanding ethnic and cultural differences, and providing patient-centred care. In line with World Menopause Day 2024, which focuses on menopause hormone therapy, the webinar will empower pharmacists to enhance patient support and contribute meaningfully to menopause care.
Moderator: - Dalia Bajis, FIP Senior Programme Lead FIP, The Netherlands
- Catherine Duggan, FIP CEO FIP, The Netherlands
Panellists: - Sally Arnison, Lead Clinical Pharmacist Ascot Menopause Solutions, UK
- Rawan Bajis, Obstetrics and Gynaecology Registrar Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Australia
- Nasreen Hasan, Founder LaYas Life, United Arab Emirates
Musculoskeletal (MSK) pain is a common condition affecting millions of people, resulting in reduced quality of life and increased healthcare costs. Community pharmacists play a vital role as the first point of contact for patients seeking relief from MSK pain. In recognition of the Global Day Against Pain, this event will launch a new FIP guidance focused on enhancing the management of MSK pain in pharmacies. The guidance highlights the use of heat therapy, both as a stand-alone treatment and in combination with other therapies. Attendees will learn about types and symptoms of MSK pain, the mechanism of heat therapy, and effective patient assessment and management strategies in the pharmacy setting.
Moderator: - Sherif Guorgui, President, FIP Community Pharmacy Section, Canada
Panellists: - Nisa Masyitah, FIP Project and Data Support Coordinator International Pharmaceutical Federation (FIP), Indonesia
- Philip Conaghan, Director, NIHR Leeds Biomedical Research Centre University of Leeds, United Kingdom
- Zanoli Gustavo, Orthopaedic Surgeon Casa Di Cura Santa Maria Maddalena, Occhiobello, Italy
- Opeyemi Babatunde, Senior Lecturer: Evidence Synthesis and Applied Health Research School of Medicine, Primary Care Centre Versus Arthritis Keele University, Keele, Staffordshire, United Kingdom
- Ema Paulino, President National Pharmacy Association (ANF), Portugal
The FIP Pharmacy Technician Advisory Committee (PTAC) invites you to attend the 2024 Pharmacy Technicians’ Symposium that will take place on 15 and 16 October to celebrate World Pharmacy Technician Day (15 October).
Session 1 - Building relationships within the pharmacy team
1. Welcome and introduction by the moderator– Ryan Burke, Pharmacy Technician Certification Board, United States
2. Presenter 1 – Kenneth Hohmeier, The University of Tennessee Health Science Center, United States
3. Presenter 2 – Juny Sebastian, Program Director - Diploma in Pharmacy Technician Program; Assistant Professor & Acting Chair, Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University, UAE
4. Presenter 3 – Luís Lourenço, FIP Professional secretary, Portugal
5. Q&A 6. Wrap up and conclusion of the session
Session 2 – Pharmacy Technicians: To immunisation and beyond
1. Welcome and introduction by the moderator – Michael Mung’oma, Pharmaceutical Society of Kenya, Kenya
2. Presenter 1 – Mathew DeMarco, University of Waterloo School of Pharmacy, Canada
3. Presenter 2 – Alison Hemsworth, University of Huddersfield, England
4. Presenter 3 – Kimberly McKeirnan, Washington State University College of Pharmacy and Pharmaceutical Sciences, United States
The FIP Pharmacy Technician Advisory Committee (PTAC) invites you to attend the 2024 Pharmacy Technicians’ Symposium that will take place on 15 and 16 October to celebrate World Pharmacy Technician Day (15 October).
Opening remarks:
1. Catherine Duggan, CEO, FIP, Netherlands
2. Susan James, Chair, FIP Pharmacy Technician Advisory Committee; Ontario College of Pharmacists, Canada
Session1 - Pharmacy Workforce Across the World: Global Perspectives and the Role of Artificial Intelligence
1. Welcome and introduction by the moderator – Ryan Burke, Pharmacy Technician Certification Board, United States
2. Presenter 1 – Sherly Meilianti, FIP, United Kingdom
This webinar aims to raise awareness of technologies in use within the pharmaceutical sector, with a focus on the African perspective. The event is targeted at members and non-members of the FIP (International Pharmaceutical Federation) worldwide. The goal is to highlight technological innovations from developing countries that can be embraced and utilized in developing regions to optimize patient care, enhance public wellness & safety and streamline pharmaceutical operations in general. The webinar will explore how these technological solutions were birthed and can be implemented in the pharmacy sector across Africa to enhance service delivery, improve health outcomes, and address the unique challenges faced by the pharmacy sector in the developing world. This knowledge-sharing session promises to be insightful for pharmacists seeking to leverage technology to transform their practice.
Moderator:
- Jaime Acosta Gomez, Community Pharmacist, FIP (TAG), Spain
Work-related stress elicits a variety of physiological, emotional, cognitive and behavioural responses resulting from the demands of job content, organisation and environment. Pharmacy professionals often experience tension, distress, and feelings of being overwhelmed as a result of such stressors. Given the negative impact of stress on health, safety and productivity, proactive stress management is essential for pharmacy teams. At this event, we will explore tailored stress management techniques, enhancing professionals' well-being and capacity to deliver optimal patient care. By prioritising mental health, pharmacy teams can foster resilience and a thriving work environment. Join this webinar to equip yourself and your team with essential tools to meet the challenges of modern pharmacy practice.
Self-care for sore throat and mouth inflammation are common conditions that affect millions of individuals worldwide, especially during the colder months. Self-care options include non-prescription medicines and non-pharmacological measures for symptomatic relief. Pharmacists play a crucial role in managing these conditions by offering advice on effective treatments, ensuring proper use of non-prescription medicines, and identifying when it is necessary to seek medical attention.
One of the most dramatic shortages experienced worldwide has been the supply of anti-diabetic injectable medication Ozempic® (semaglutide). Introduced in 2017, short supply started early 2022, mainly due to a surge in off-label prescribing for weight-loss and the role of social media. Some have likened it to a ‘tsunami’. Documentaries portray desperate efforts made to attain the product. In response to the high demand, some pharmacists have surprisingly attempted to compound the product in-house. This phenomenon has raised several concerns relating to professional ethics in pharmacy and patient safety. In this session we will discuss ethical concerns about the provision of extemporaneous compounding, off-label prescribing and patient safety.
Moderator: - Maria Allinson, Senior Lecturer Sheffield University, UK
Panellists: - Betty Chaar, Associate Professor The University of Sydney, Australia
- Sanya Ram, Senior Lecturer University of Auckland, New Zealand
- Roche, Cicely, Associate Professor in Practice of Pharmacy & Trinity College Dublin Fellow in Education for Sustainable Development School of Pharmacy & Pharmaceutical Sciences, Faculty of Health Sciences, Panoz Institute, Trinity College Dublin. Centre for Academic Practice, Trinity Teaching and Learning, Trinity College Dublin, Ireland
- Jessica Pace, Associate Lecturer Sydney Pharmacy School, University of Sydney, Australia
Effective anticoagulation therapy requires careful monitoring and management to ensure safety, efficacy and optimal clinical outcomes while preventing complications. Pharmacists play a key role in the management of anticoagulation therapy through their extensive knowledge of medicines. Their responsibilities include educating patients, identifying medicine interactions, ensuring appropriate dosing and monitoring for adverse effects. This webinar will examine the different roles pharmacists play in anticoagulation management and how they can help improve patient care and outcomes. Join us to explore best practice, current research and practical examples of pharmacist-led anticoagulation services.
Moderator: - Robert Moss, FIP Vice president, Hospital Pharmacist Dutch National Medication Coordination Centre, The Netherlands
Panellists:
- José Ramón González Juanatey, Head of the Cardiology; Professor of Cardiology, Hospital Clínico Universitario de Santiago de Compostela University of Santiago de Compostela, Spain
- Allison E. Burnett, Inpatient Antithrombosis Stewardship Pharmacist University of New Mexico Hospital, USA
- Hadley Bortz, Senior Pharmacist - Anticoagulation Stewardship, Haemostasis Thrombosis Haemophilia, Alfred Health, Melbourne, Australia
Heart failure (HF) is often interconnected with other chronic diseases (including ischaemic heart disease, hypertension, diabetes, chronic kidney disease, atrial fibrillation, and obesity), creating a complex web of health considerations. The interconnectivity manifests in various ways, influencing identification, diagnosis, and treatment of these conditions.Community pharmacists are in a unique position to raise awareness, identify those at risk, educate and facilitate early detection and referral for screening, diagnosis, and intervention. At this event, the “Heart Failure Pharmacy Toolkit” to support pharmacists in providing a range of HF pharmacy services will be presented.
Digital health has revolutionized clinical practice, necessitating that pharmacists become adept at leveraging, developing, and benefiting from emerging technologies. Highlighting this need, the 2021 FIP report underscored the importance of integrating digital skills training into pharmacy education through well-designed courses, materials, and hands-on experiences. In response, the Academic Pharmacy Section, alongside the FIP Provision and Partnerships programme and several other FIP groups, initiated a ONEFIP project to overhaul the original digital health in pharmacy online course. This revamped, comprehensive course is specifically designed for educators and practitioners. At this event, we will review the advancements achieved so far, introduce the enhanced digital health in pharmacy course, and explore how this initiative aligns with FIP competency frameworks and recommendations.
Moderator: - Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK
Facilitator: - Genuine Desireh, FIP Educational partnerships and projects manager FIP, The Netherlands
Panellists: - Jaime Acosta, Community Pharmacist Farmacia Acosta, Spain
Catherine Duggan FIP CEO FIP, The Netherlands
Ardalan Mirzae - Barry A. Bleidt, Professor Barry and Judy Silverman College of Pharmacy Nova Southeastern University, USA
Michael Katz, Professor and Director of International Programs University of Arizona R. Ken Coit College of Pharmacy, USA
Dalia Bajis, FIP Senior programme lead FIP
Aukje Mantel-Teeuwisse, Professor of Pharmacy and Global Health, Utrecht University
To address the need for efficient RNA delivery beyond the liver, my lab designs inhalable, biocompatible nanocarriers for siRNA delivery to the lung. While siRNA drugs typically target the liver, the lung presents undruggable targets that RNA therapeutics could address. Nebulizable nanocarriers for pulmonary RNA administration can extend delivery beyond the liver. siRNA therapeutics are encapsulated in lipid nanoparticles (LNPs) or administered as GalNac-conjugates to protect RNA and facilitate membrane delivery. However, approved LNPs pose immunogenic risks, primarily target the liver, and offer low drug loading. Additionally, lipid-based carriers lack stability in lung surfactant and under nebulization stresses. To overcome these issues, we design polymer-based siRNA formulations.
The International Day for Clean Blue Skies emphasizes the critical importance of clean air and its impact on health and the environment. This day serves as a reminder of the urgent need to reduce air pollution, which is a major contributor to multiple health conditions. Healthcare professionals can help mitigate the adverse health effects of air pollution and support our global collective efforts to help the environment. Participants will learn about the latest research on the impact of air quality on respiratory health, explore the innovative #Care4EveryBreath programme, and discover actionable strategies for pharmacists to support climate change efforts. Join us to understand how healthcare professionals can lead the way in promoting a healthier, sustainable future.
The academic section concluded with a strategic plan, and advocacy and global influence were identified as critical priorities for the section. Panelists representing key stakeholders worldwide will be invited to address the following questions related to advocacy and change management. 1.) What has worked well in your region to shape education policy? 2) What challenges did you face? 3) How can the FIP academic section influence education policy in your region? 4) What advice do you have for individuals entering this area of advocacy and policy in pharmacy education? Live participants will be encouraged to provide additional perspectives.
Moderator: - Angela Caro Rojas, Pharmacy Career Director Pontificia Universidad Javeriana,Colombia
Panellist: - Sonia Mayra Pérez Tapia, PhD Chief Executive Officer UDIBI National School of Biological Sciences of the National Polytechnic Institute (IPN), Mexico - Wber Orlando Rios Ortiz, Dean The University of Antioquia, Colombia - David Ramirez, Assistant Professor at the Faculty of Biological Sciences, Pharmacology Department – Head of the Pharmacoinformatics and Systems Pharmacology Lab Universidad de Concepción, Chile - Aldo Alvarez, Managing Director / Professor and Researcher South American Network of Pharmaceutical Care (REDSAF), Peru
On 11/12/2008, the United Nations General Assembly set the 19th of August as the Humanitarian World Day, to remember the humanitarians, who risk their lives every day in the most critical crisis of the world. Pharmacists from diverse sectors and countries, ranging from academic settings to fieldwork, and from ongoing crises to those in the past, will share their experiences and stories of working and serving patients and the public in humanitarian and emergency settings. In this session, we will explore common transitional phases pharmacists and pharmacy team may encounter during crises, including: • The pharmacist professional journey • Transitioning from normality to emergency • Crisis recovery • Global initiatives
In the evolving landscape of Artificial Intelligence, Large Language Models (LLMs) like ChatGPT are at the forefront of innovation, transforming how we interact with technology daily. This webinar aims to provide a comprehensive understanding of these models, exploring their inner workings, training processes, and potential limitations. We propose an engaging session where learning meets practical application in a dynamic environment. Our goal is to show how these models can help us enhance and be more productive in our jobs, by helping us do the routinary tasks quicker leaving us more time to focus on the creative and challenging tasks.
Moderator: - Whitley Yi, Member Services Sr Manager of Delivery and Analytics, Adjunct Lecturer Well Digital, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, AI Collective, USA
Panellists: - Florencia Ojeda, Machine Learning Engineer, Professor Tryolabs ORT University, Uruguay
This webinar will focus on how expanding primary health care services provision to the pharmaceutical private sector can be achieved using the experience of a pilot programme implemented in Nigeria as a veritable template for the region. The integration of the pharmaceutical private sector into the nation’s health care delivery system is a key to meet universal health coverage (UHC) in most countries in the Afro Region of FIP because of their easy availability, access and non-payment of consultation fees. It will highlight the required policy changes, system strengthening tools and training will prepare pharmacists to position themselves critically. A panel discussion on current practice in selected countries and how the new learnings can be domiciled will also take place.
Moderator:
- Arinola Joda, Associate Professor Department of Clinical Pharmacy and Biopharmacy, Faculty of Pharmacy, University of Lagos, Nigeria
Self-care spans the wellness spectrum, from disease prevention to managing symptoms and common ailments, and the use of non-prescription medicines and medical devices. Globally, people are taking greater responsibility for their physical and mental health and are actively seeking reliable information to make informed decisions. Promoting self-care means empowering individuals to responsibly engage in managing their own health in an informed manner, rather than leaving them with no care. As pharmacists increasingly enable patients to make better health decisions, they must assure them that they may always count on their professional advice. To learn about this increasingly important role, join us on this event on International Self-care Day, 24 July 2024.
Moderator: - Luís Lourenço, Professional Secretary, FIP, The Netherlands
Panellists: - Austen El-Osta, Director, Self-Care Academic Research Unit (SCARU), UK - Charlie Benrimoj, Emeritus Professor, University of Sydney, Australia - Jurate Svarcaite, Director General, Association of the European Self-Care Industry, Belgium - Bisi Bright, CEO/ Board Member, Live well Initiative/ International Alliance of Patients’ Organizations (IAPO), Nigeria - Kai Zhen Yap, Lecturer, National University of Singapore, Department of Pharmacy and Pharmaceutical Sciences, Singapore
Global healthcare and pharmaceutical supply chains during humanitarian crises have become increasingly critical issues, requiring urgent attention to ensure the timely and safe delivery of medications and pharmaceutical products to patients in need. The importance of this issue is underscored by the consequences of supply chain disruptions, particularly during times of crisis. All stakeholders in the health and humanitarian supply chain, including pharmacists, play a key role in ensuring that safe and high-quality medicines are dispensed to patients during these critical situations. FIP is hosting a digital event to explore challenges and opportunities in maintaining a resilient supply chain, focusing on how to better equip the global healthcare system, particularly pharmacists, to respond to emergencies and crises, saving lives and improving patient outcomes.
Moderator: - Ruben Viegas, FIP Humanitarian and Sustainability Programme Manger FIP, The Netherland
Panellists: - Wilson Chandomba, Consultant CMCOMMS, Zimbabwe - Ronald Guse, International Digital Health Consultant National Association of Boards of Pharmacy (United States), Canada - Eiko Kobayashi, Chief Pharmacist Japanese Red Cross Medical Center, Pharmacy / International Medical Relief Department, Japan - Lucas Ercolin, Area Manager IDA Foundation, Brazil (Currently living in Netherlands)
Inhalable therapies provide a unique advantage by offering both targeted, localized treatment and systemic therapy. Despite the many benefits of inhalable drug administration, current treatment for pulmonary disorders often rely on other delivery routes, resulting in suboptimal therapeutic effects and off-target toxicities. This preference is influenced, in part, by the presence of defense mechanisms in the lungs that are actively involved in clearing foreign materials including drugs entering the lungs. Inhalable nanoparticle-based drug delivery carriers, when optimized, have shown promise in delivering therapies in a targeted and sustained manner to the deep lung tissue for the treatment of several lung disorders including cancer, inflammation and fibrosis. This webinar will explore current strategies in the development and surface modification of inhalable nanoparticles to overcome barriers and deliver therapies effectively to the lungs. Specifically, we will discuss our recent efforts in developing polymer- and lipid-based nanoparticles designed to evade macrophage recognition and uptake in the lungs.
Moderator: - Mathew Cherian PhD, VP of Operations & Development ReVive Biotechnology, United States - Nikolina Biskic, Manager Regulatory Affairs, Switzerland
Panellist: - Jyothi Menon PhD, Associate Professor, Biomedical, Pharmaceutical Sciences and Chemical Engineering University of Rhode Island, USA
En la Región de las Américas, el 16,6% de las personas mayores de 15 años son consumidores de tabaco. Dada la prevalencia y carga global y regional del consumo de tabaco, particularmente como factor de riesgo de enfermedades no transmisibles, es importante que se amplíe y consolide el papel de los farmacéuticos en la prevención y la deshabituación del consumo de tabaco. La FIP y su Foro Farmacéutico de las Américas le invitan a participar en este evento para conocer la carga del consumo de tabaco en la región de las Américas y el papel que pueden desempeñar los farmacéuticos en la deshabituación tabáquica. El evento incluirá reflexiones de la OPS, ejemplos de servicios farmacéuticos en los países y la presentación de los recursos de la FIP para avanzar en la deshabituación tabáquica a través de los farmacéuticos.
Moderadora - Gladys Beatriz Lugo Rodriguez, Directora de Educación Farmacéutica Foro Farmacéutico de las Americas, Paraguay
Ponente - Adriana Bacelar Gomes, Especialista de Vigilancia de Tabaco Departamento de Enfermedades no Transmisibles y Salud Mental de la Organización Panamericana de la Salud (OPS/OMS), Washington DC - Angie León Salas, Directora del Departamento de Atención Farmacéutica y Farmacia Clínica, Facultad de Farmacia, Universidad de Costa Rica, Costa Rica - Cinthia Caldas Rios, Consultora técnica del Consejo Federal de Farmacia Consultora técnica del Ministerio de Sanidad, Brasil - Pablo Alejandro Mujica Di Stasio, Presidente Asociación de Química y Farmacia de Uruguay, Uruguay - Inés Nunes da Cunha, Gestora de Proyectos de Desarrollo y Transformación de la Práctica FIP, Países Bajos
This digital event explores strategies for improving communication and collaboration between pharmacists, pharmacy technicians and other healthcare professionals. Participants will learn best practices for inter-professional interactions and improving intra-professional relationships to optimise patient care. We will also highlight the FIP's efforts to promote interprofessional collaborative practice, defined by the WHO as multiple health care professionals from different backgrounds working together with patients and communities to provide the highest quality of care. This webinar will provide valuable tools for improving teamwork and fostering a more cohesive health care environment.
Moderator: - Cathy Schuster, Coordinator, Pharmacy Technician Programs Canadian Council for Accreditation of Pharmacy Programs Canada
Panellists: - Nikki Rogers, Registered Pharmacy Technician Alberta Health Services – Provincial Pharmacy Operations, Canada - Jill Martin Boone, Clinical Professor and Interim Chair, Div of Pharmacy Practice & Administrative Sciences, Director of Interprofessional Education Univ of Cincinnati James L Winkle College of Pharmacy, USA - Luís Lourenço, Professional secretary FIP, Portugal
This event is jointly organised by FIP, the World Health Organization and the UNDP/UNFPA/UNICEF/WHO/World Bank Special Research Programme in Research, Development and Research Training in Human Reproduction (HRP).
Every year, the 24th of June to 24th of July marks Self-Care Month, with a focus on increasing awareness of this subject and available interventions, celebrating current benefits/ achievements, and calling for renewed commitments and action to expand health systems to include self-care interventions. Self-care is at the basis of healthier lives and populations, and therefore it is a pillar of more sustainable health systems and universal health coverage. As people around the world take greater responsibility for their physical, mental, and emotional health, they are actively seeking comprehensive and reliable information to make informed decisions, with or without the assistance of healthcare professionals, including pharmacists. This event will explore global self-care initiatives and highlight how pharmacists can utilise these in their practice and empower the public to promote self-care practices.
Moderators: - Dalia Bajis, Senior Programme Lead International Pharmaceutical Federation (FIP), The Netherlands - Gonçalo Sousa Pinto, Lead for Practice Transformation International Pharmaceutical Federation (FIP), The Netherlands
Facilitator: - Mfonobong Ekpoh, Practice Development and Transformation Projects Coordinator International Pharmaceutical Federation (FIP), Netherlands
Panellists: - Manjulaa Narasimhan, Lead, Self-care for health and well-being WHO Department of Sexual and Reproductive Health and Research, including the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training (HRP), Switzerland - Judy Stenmark, Director General Global Self-Care Federation (GSCF), Switzerland - Hussain Jafri, Executive Director World Patients Alliance, Pakistan - R (Sham) Moodley, Pharmacist Pharmaceutical Society of South Africa (PSSA) /Independent Community Pharmacy Assoc (ICPA), South Africa
In the European Region, 25.3% of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated. FIP you to join this event to learn more about the burden of tobacco use in Europe and the role that pharmacists can play in tobacco cessation. The event will include insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
Panellists: - Dongbo Fu, Medical Officer for Tobacco Cessation World Health Organization, Switzerland - Mónica Condinho, Pharmacist, AcF – Acompanhamento Farmacoterapêutico, Lda.; Invited Assistant Professor, Department of Chemistry and Pharmacy, Faculty of Sciences and Technology, University of Algarve Acompanhamento Farmacoterapêutico, Lda.; Department of Chemistry and Pharmacy, Faculty of Sciences and Technology, University of Algarve, Portugal - Fiona McIntyre, Policy & Practice Lead, Scotland Royal Pharmaceutical Society, Scotland - Björn Wagner, Industry Pharmacist (Dir Government Affairs & Access) Chamber of Pharmacists of the State of Berlin (Apothekerkammer Berlin), Germany - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, FIP, The Netherlands
The FIP Pharmacy Practice Research Special Interest Group (PPR SIG) is hosting another international event — “Pharmacy practice research summer meeting for PhD students, postdoctoral fellows and supervisors” — on 4 and 5 July 2024. This time the event will be online and the attendance will be free of charge.
The main scope of the PPR SIG is to increase pharmacy practice contributions to global health by providing greater access to the latest high-quality international pharmacy practice research. During this meeting both starting-out and experienced researchers will be given an opportunity to present their PPR research to an international audience.
PhD students, postdoctoral researchers, academics, and practitioners involved in research are welcome to join this virtual meeting to present their research and disseminate their findings in a specialised forum .
The FIP Pharmacy Practice Research Special Interest Group (PPR SIG) is hosting another international event — “Pharmacy practice research summer meeting for PhD students, postdoctoral fellows and supervisors” — on 4 and 5 July 2024. This time the event will be online and the attendance will be free of charge.
The main scope of the PPR SIG is to increase pharmacy practice contributions to global health by providing greater access to the latest high-quality international pharmacy practice research. During this meeting both starting-out and experienced researchers will be given an opportunity to present their PPR research to an international audience.
PhD students, postdoctoral researchers, academics, and practitioners involved in research are welcome to join this virtual meeting to present their research and disseminate their findings in a specialised forum .
In the African Region, 9.5% of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated. FIP and the African Pharmaceutical Forum invite you to join this event to learn more about the burden of tobacco use in the African region and the role that pharmacists can play in tobacco cessation.
Moderator: - Jocelyn Chaibva, President African Pharmaceutical Forum, Zimbabwe
Panellists: - Jacqueline Maimin, CEO Independent Community Pharmacy Association NPC, South Africa - Chima Amadi, Public health pharmacist Clemac Digital Health, Nigeria - Nicholas Muparadzi, Pharmacist Drug and Toxicology Information Services (DaTIS), Zimbabwe - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands
In the Eastern Mediterranean Region, 17.9 % of people aged 15 years and over are tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in tobacco use prevention and cessation is expanded and consolidated. FIP and the Eastern Mediterranean Regional Pharmaceutical Forum invite you to join this event to learn more about the burden of tobacco use in the Eastern Mediterranean region and the role that pharmacists can play in tobacco cessation. The event will include insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Moderator: - Nadia Al Mazrouei, President EMRPharm Forum, UAE
Panellists: - Fatimah El-Awa, Regional Adviser, Tobacco Free Initiative WHO Regional Office for the Eastern Mediterranean (WHO EMRO), Egypt - Wael Ali, - President of Egyptian organization of pharmacy (EOP), - Vice president of Eastern Mediterranean Pharmaceutical (EMRPharm) Forum, Egyptian organization of pharmacy, Egypt - Pascale Salameh, PharmD, MPH, PhD, HDR - Professor of Epidemiology INSPECT-LB & Lebanese University, Lebanon - Husam ALSalamat, Chairperson of Continuous Professional Development CPD committee, Jordan Pharmacists Association, Jordan - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP. The Netherlands
Most common skin diseases are rarely life-threatening; however, they have a negative impact on the quality of life of individuals and require care and treatment. They affect patients’ physical and mental well-being, their ability to function, and their social interactions. Leveraging on their accessibility and convenience, pharmacists are well-positioned to manage these conditions and offer accurate and reliable self-care information and products to empower individuals to manage such health problems. This event will explore some common skin ailments pharmacists encounter and their role in managing these ailments to promote good health and general well-being.
Moderator: - Jack Shen Lim, General Secretary Malaysian Pharmacists Society (MPS), Malaysia
Panellists: - Ana Zovko, Owner and director Chamber of Masters of Pharmacy of the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina - Adaeze Aroh, Chief Superintendent Pharmacist Curascare Pharmacy Ltd, Nigeria - Tomás Muret Ramón, National Lead for Dermopharmacy General Pharmaceutical Council of Spain, Spain - Santhy Shetty, Specialist Dermatology Prescribing Pharmacist/Locum Pharmacist Vita Health/Narie Holistic/Boots & Independent Pharmacies, United Kingdom
Pharmacists play a crucial role in supporting behaviour change, significantly impacting medication adherence. By offering personalised counselling, education, and motivational interviewing, pharmacists help patients understand the importance of their medication, address barriers to adherence, and foster healthier habits. This proactive engagement can lead to better health outcomes by ensuring patients take their medications as prescribed, reducing the risk of complications, and enhancing overall treatment efficacy. Furthermore, pharmacists' accessibility and frequent interactions with patients position them uniquely to reinforce adherence strategies and provide continuous support, ultimately improving patient health and reducing healthcare costs.
In the South-East Asia Region, 26.5% of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated. FIP and the SEARPharm Forum invite you to join this event to learn more about the burden of tobacco use in the South-East Asia region and the role that pharmacists can play in tobacco cessation. The event will include insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Moderator: - Venkata Narayana Tanniru, President Indian Pharmaceutical Association, FIP South-East Asian Pharmaceutical Forum (SEARPharm Forum), India
Panellists: - Jagdish Kaur, Regional Adviser, Tobacco Free initiative, Southeast Asia Regional Office of the World Health Organization (WHO SEARO), India - Vindya Pathiraja, Head of the Department and Senior Lecturer University of Ruhuna and Pharmaceutical Society of Sri Lanka, Sri Lanka - Audrey Clarissa, Vice Secretary General, Ikatan Apoteker, Indonesia - Wirat Tongrod, Lecturer, Faculty of Pharmaceutical Sciences, Huachiew Chalermprakiet University, Thailand - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands
In the Western Pacific Region, 22.5 % of people aged 15 years and over were current tobacco users. Given the global and regional prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the role of pharmacists in this area is expanded and consolidated. FIP and the Western Pacific Pharmaceutical Forum invite you to join this event to learn more about the burden of tobacco use in the Western Pacific region and the role that pharmacists can play in tobacco cessation. The event will include insights from the WHO Regional Office, country examples of pharmacist services and the presentation of FIP resources to advance tobacco cessation through pharmacists.
Moderator: - John Jackson, President, FIP Western Pacific Pharmaceutical Forum, Australia
Panellists: - Mina Kashiwabara, Technical Lead, Tobacco Free Initiative World Health Organization Regional Office for the Western Pacific, Philippines - Peter Guthrey, Senior pharmacist – strategic policy , Pharmaceutical Society of Australia, Australia - Andree Pei-wen Yu, Certified Tobacco Cessation Pharmacist, ART Pharmacy, China Taiwan - Atsushi Toyomi, Executive Director, Japan Pharmaceutical Association, Japan - Mohamad Haniki Nik Mohamed, Lecturer and tobacco cessation researcher and expert, International Islamic University Malaysia, Malaysia - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands
Dr. Stevenson presentation This presentation describes a study we conducted (it has been published in AJHP) in US health systems that examined the degree of digital inventory visibility and where gaps exist. It also discusses why digital inventory visibility is important to achieving better outcomes and steps that we can take to improve the degree of visibility.
Ms. Tan presentation: This presentation will describe the Inpatient Pharmacy Automation System (IPAS) at Sengkang General Hospital. It will discuss unit-dose medication systems and the workflow and safety benefits of automated dispensing in the inpatient pharmacy and on patient care wards
Moderator: - Rob Moss, Netherlands
Panellists: - James Stevenson, Professor Emeritus University of Michigan College of Pharmacy, USA - Angelina Tan, Deputy Director and Head of Pharmacy, Sengkang General Hospital, Singapore
Ms. Tan presentation:
This presentation will describe the Inpatient Pharmacy Automation System (IPAS) at Sengkang General Hospital. It will discuss unit-dose medication systems and the workflow and safety benefits of automated dispensing in the inpatient pharmacy and on patient care wards
The global landscape of generic drug development and regulation is undergoing significant harmonization efforts led by the Office of Generic Drugs (OGD, US FDA) and other international organizations to facilitate global access to high quality generic drugs. The sessions explore the key objectives and outcomes of these collaborative endeavors, with a focus on enhancing patient access to affordable and high-quality generic medicines. Three learning objectives emerge from this discussion.
Moderator: - Mathew Cherian PhD, VP of Operations & Development ReVive Biotechnolohy, United States
World Environment Day is celebrated annually on 5 June to raise awareness and take action on critical issues to make a positive impact on the environment. In recognition of World Environment Day 2024, themed 'Land restoration, desertification and drought resilience', FIP will host an event to delve deeper into the pharmacists’ role in addressing the global pressing environmental challenges. The event will feature discussions on the environmental impact of the pharmaceutical sector, sustainable practices in pharmacy operations, and the role of pharmacists in promoting environmental health and well-being.
Event objectives:
1 Highlight the role of pharmacists on the mitigation and reduction of the environmental impact of the pharmaceutical sector globally; 2 Explore the impact of environmental policies on sustainable pharmacy practice; 3 Understand how to promote sustainability on the pharmaceutical sector.
Moderator: - Ruben Viegas, FIP Humanitarian and Sustainability Programme Manger, The Netherland - Hanadi Alolimi, FIP Equity, Humanitarian and Sustainability Projects Coordinator, The Netherland
Panellists: - Shellyza Sajwani, Co-Chair, Canadian Association of Pharmacy for the Environment (CAPhE), Canada - Chima Amadi, Public health pharmacist, Public health Division, Birmingham City Council, United Kingdom; Clemac Digital Health, Nigeria. - Min Na Eii, Chief Sustainability Officer’s Clinical Fellow, South East London Integrated Care Board, United Kingdom - Naoko Arakawa, Associate Professor, University of Nottingham, UK - Angelina Lim, Lecturer, Monash University, Australia
There are 1.25 billion adult tobacco users around the world, and 60% of them want to quit, but only around 35% of the world’s population have access to comprehensive tobacco cessation services. Given the global prevalence and burden of tobacco use, particularly as a risk factor for noncommunicable diseases, it is important that the services provided by pharmacists in this area are expanded and consolidated. At this event, FIP will launch a global intelligence report on pharmacist-led tobacco cessation services. A joint WHO-FIP statement and call to action on the role of pharmacists in tobacco cessation and examples of successful pharmacist interventions/services in tobacco cessation will also be presented, along with findings from a survey and a systematic literature review.
Moderator: - Lars-Åke Söderlund, Vice President, FIP, Sweden - Long Chiau Ming, Professor and Associate Dean for Research and Postgraduate Studies, School of Medical and Life Sciences, Sunway University, Malaysia
Panellists:
- Paul Sinclair, President, FIP, Australia - Vinayak M Prasad, Unit Head, WHO No Tobacco Unit(TFI), World Health Organization, Switzerland - Inês Nunes da Cunha, Practice Development and Transformation Projects Manager, FIP, The Netherlands - Sherly Meilianti, Data and Intelligence Specialist, FIP, The Netherlands - Farah Aqqad, Data Integration Specialist , FIP, The Netherlands - Raj Vaidya, Ex-Chairperson & Vice President, Community Pharmacy Division, Indian Pharmaceutical Association, India - Husam ALSalamat, Chairperson of Continuous Professional Development CPD committee, Jordan Pharmacists Association, Jordan - António Teixeira Rodrigues, Director, Evidence & Health Solutions, National Association of Pharmacies, Portugal
Pregnant women and mothers often encounter bias by being viewed as inconveniences or liabilities by their employers. Their ability to perform quality work is also presumed to be compromised due to their pregnancy or motherhood responsibilities. Insufficient support and workplace policies exacerbate these challenges, including the absence of flexible work arrangements and adequate accommodations like maternity leave. These inequities impact women across various sectors; however, they are particularly evident within the health and pharmacy workforce since women represent over 70% of the workforce in the health and social sectors1. To address these issues and inequities, it is crucial to challenge and dismantle the gender biases and stereotypes that perpetuate discrimination against pregnant women and mothers. EquityRx and FIPWiSE (Women in Science and Education) are hosting a digital event to highlight and address some of these issues, particularly those related to maternity leave policies.
Pharmaceutical education is undergoing a dynamic transformation, driven by the evolving healthcare landscape, technological advancements, and the need for highly skilled professionals. To support pharmaceutical education reform in WPR, FIP through the UNITWIN Network on Global Pharmacy Education Development, in collaboration with UNESCO and University College London (UCL), is establishing the FIP-UNESCO UNITWIN Centre for Excellence in Western pacific region.
Moderator - Dalia Bajis , FIP Senior programme lead , FIP , The Netherlands Co-Moderator - Genuine Desireh , FIP Educational partnerships and projects manager ,FIP , The Netherlands Panellists - Catherine Duggan ,FIP CEO , FIP , The Netherlands - Ralph J. Altiere , FIPEd Chair , FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA - Paul Gallagher, Deputy Head-Clinical, Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore - John Jackson, President , Western Pacific Pharmaceutical Forum , Australia - Nisa Masyitah, FIP Project and Data Support Coordinator, FIP Netherlands - Lilian M. Azzopardi , Head, Department of Pharmacy , University of Malta , Malta
The expanding population in East Africa is putting immense pressure on the health sectors of Kenya, Uganda, Tanzania, and Rwanda, both financially and organizationally. Over 90% of drugs in the region are imported, leading to frequent stock-outs of essential medications and medical supplies, exacerbating health issues. Diagnostic equipment is often out of use due to lack of repair, further straining the healthcare system.
Moderator: - Genuine Desireh, Educational partnerships and projects manager, FIP, The Netherlands Facilitator: - Ruben Viegas, Humanitarian and Sustainability Programme Manager, FIP, The Netherlands
Panellists: - Darius Uzabakiriho, COO and Co-Founder/ Treasurer, Irebe Biotech Ltd/ Rwanda National Pharmacy Council, Rwanda - Jocelyn Chaibva, Pharmacist Director, Nu Fife Avenue Pharmacy, Harare, Zimbabwe - David Taylor, Emeritus Professor, Pharmaceutical and Public Health Policy, University College London, United Kingdom - Mavere Tukai, Director General, Medical Stores Department (MSD), Tanzania - Jeremy Holmes, Former CEO, RPS, United Kingdom
The academic section concluded with a strategic plan, and advocacy and global influence were identified as critical priorities for the section. Panelists representing key stakeholders worldwide will be invited to address the following questions related to advocacy and change management.
Moderator:
- Barry Bleidt, Adjunct Professor - Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, United States - Jeanine P. Abrons, PharmD, MS, FAPhA, Clinical Associate Professor; Director of International Student Pharmacist Activities; Co-Director UI Mobile Clinic, University of Iowa College of Pharmacy, United States
Panellists:
- Dixon Thomas, Professor & Associate Dean Clinical, Gulf Medical University, United Arab Emirates - Yousif Asiri, Professor of Clinical Pharmacy , King Saud University / University of the Pacific, Saudi Arabia - Suhaib Muflih, Associate Professor, Jordan University of Science and Technology, Jordan - Nisreen Mourad, PharmD, MSc, Chairperson, Pharmaceutical Sciences Department, School of Pharmacy, Lebanese International University, Lebanon
Vaccination is one of the most effective public health interventions to mitigate the burden of disease and saves millions of lives per year. The role of pharmacists as widely documented during the pandemic further reemphasizes the importance of pharmacy-based vaccination in health promotion. The strategic use of vaccination surveillance data can inform and shape public health policies and vaccination approaches. This event will explore the use of surveillance data using international examples of pharmacy-based vaccination services and advocate for extended pharmaceutical services in vaccination. The event will additionally present other global vaccination data-driven projects and their use in policy making.
Moderator: - Ian Bates, Director, Global Pharmaceutical Observatory, International Pharmaceutical Federation (FIP), United Kingdom - Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, International Pharmaceutical Federation (FIP), Spain
Panellists: - Marta Gacic-Dobo, Team Lead, Global Monitoring, WHO, Switzerland
- Katrina Bouzanis, Director, Policy and Advocacy, International Federation on Ageing, Canada
- Farah Aqqad, Data Integration Specialist, International Pharmaceutical Federation (FIP), Jordan
- Sherly Meilianti, FIP Data and Intelligence Specialist, International Pharmaceutical Federation (FIP), United Kingdom
- Lyn Morgan, Head Public Affairs Influenza & Pandemic Preparedness, IFPMA: Coordinator Policy Committee, IVS, International Federation of Pharmaceutical Manufacturers and Associations Company: Sanofi, France
- Nisa Masyitah, FIP Project and Data Support Coordinator, International Pharmaceutical Federation (FIP), Indonesia
Remuneration is vital in the context of vaccination services provided by pharmacists. The adequate compensation of vaccination services recognizes the critical role pharmacists play in vaccine administration, ensuring accessibility and widespread immunization. Third-party remuneration of vaccination services supports the integration of all vaccination pathways and providers in broad vaccination strategies that aim to ensure equity of access to vaccination and high vaccination coverage rates. In addition, remuneration acknowledges the time, expertise, and resources invested in maintaining vaccine storage protocols, staying abreast of immunization guidelines, and participating in ongoing training. This financial recognition fosters a sustainable environment for pharmacies to actively engage in vaccination initiatives, promoting community well-being through increased vaccination rates and effective disease prevention.
Moderator: - Sham Moodley, Pharmacist, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
Panellists: - Zaheer-Ud-Din Babar, Visiting Professor in Pharmacy, University of Huddersfield, UK - Mark Koziol, Chairman, Pharmacists’ Defence Association (PDA), UK - Refiloe Mogale, Executive Director, Pharmaceutical Society of South Africa - Maram Jamal Al Haj Ahmad, Vice Chairwoman, ID Pharma, Jordan
What can the Curriculo PFP Programme for Pharmaceutical Scientists do to enhance my professional development and enable me to effectively manage my career?
Curriculo provides an FIP seal approved professional development program aimed at supporting pharmacists and pharmaceutical scientist. To showcase what the program offers, Curriculo is launching a series of taster sessions aimed at pharmaceutical scientist. The first webinar in that series will be hosted by the New Generation of Pharmaceutical Scientist’s SIG and the Board of Pharmaceutical Science. In the webinar, Curriculo will outline what their program covers, and we will hear from previous pharmaceutical scientists that have enjoyed and learned from the program.
Moderator: - Rebecka Isaksson, Research Fellow, UCL School of Pharmacy, UK
Panellists: - Karen Glen, Director, Curriculo Solutions Ltd, UK based; Delivery world-wide - Sifei HAN, Lab Head, Associate Professor, China Pharmaceutical University (main), Monash University (adjunct), China - Maria Virginia GIOLITO, Postdoctoral researcher, Pole of Pharmacology and Therapeutics, Institut de Recherche Experimentale et Clinique, Université Catholique de Louvain, Belgium - Clement Haeck, Pharmaceutical Formulation Scientist Population Council, France/USA
Adequate medicine disposal is crucial for environmental and public health. Unused or expired medications pose serious risks when disposed of incorrectly, as they can contaminate water sources and harm wildlife. Encouraging responsible disposal helps prevent the emergence of antibiotic-resistant bacteria, increasing the risk of antimicrobial resistance. Public awareness about safe disposal methods, such as drug take-back programs, not only safeguards the environment but also contributes to a safer, healthier community by minimizsing potential hazards associated with improper medication disposal in short- and long-term perspectives.
Moderator: - Chima Amadi, Public health pharmacist 1) Public health Division, Birmingham City Council, United Kingdom 2) Clemac Digital Health, Nigeria.
Facilitator: - Ruben Viegas, FIP Sustainability and Humanitarian Programme Manager, FIP, The Netherlands
Panellists: - Bee Yean LOW, Associate Professor, University of Nottingham Malaysia - Ladan Karim-Nejad, Regulatory Affairs Fellow, Pharmaceutical Industry, USA - Luis Figueiredo
E-labelling, also known as electronic labelling, represents a significant step towards digital transformation in providing medication information electronically rather than through traditional paper information leaflets (PILs). At the 2023 FIP Congress in Brisbane, Australia, an insight board was convened to delve into the value, benefits, and barriers associated with e-labelling, its role in promoting health equity and equitable access to health information as well as the role of pharmacists in facilitating e-labelling adoption. Subsequently, a report summarising key insights and recommendations from the board was produced. FIP is hosting a digital event to build on the results of the report and to further explore e-labelling as a solution for improving accessibility and equity in health information, whilst also addressing challenges associated with the technology and regulatory aspects.
Moderator: - Dalia Bajis, FIP Senior Programme Lead, FIP, The Netherlands
Facilitator: - Nour Eltahla, FIP Equity and Humanitarian Programme Manager, FIP, The Netherlands
Panellists: - Ema Paulino, President, National Pharmacy Association (ANF), Portugal - Brett Simmonds, Chair FIP Regulators Advisory Group, Australia - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
As the pharmacy profession provides services to diverse patient populations, new pharmacy services and approaches that address social determinants of health and the United Nations Sustainable Development Goals need to be designed with principles related to global health. Also, services must reflect the communities' needs by applying principles of global health and ensuring that communities' cultural and linguistic needs are considered to provide care for the whole person, integrating traditional practices, language, and health beliefs.
This session is designed to discuss examples of developing programs and services that achieve these goals, explore mutual benefits between multinational and interprofessional collaborators, and explore non-traditional means to enhance our effectiveness and recognition in service provision by patients and communities. This presentation aims to empower pharmacists worldwide with knowledge and strategies to develop services that reflect these principles.
Moderator: - Jeanine Abrons, Co-Director UI Mobile Clinics, Director, University of Iowa, College of Pharmacy, International Student Pharmacist Experiences, USA
Panellists: - Ashleigh Wallace-Lacey, Consultant, Travel Medica, Dominica - Jane Boyd, Laboratory Instructor, Albany College of Pharmacy and Health Sciences, USA - Carlton Languedoc, Head of Sales, Public Health, and Public Relations, Jollys Pharmacy, Dominica - Deb Dunkhase, Adjunct Instructor, Management and Entrepreneurship, Co-Founder, Open Heartland, University of Iowa, Tippie College of Business and Open Heartland, USA
Tuberculosis (TB) is a preventable and curable disease. However, according to the WHO, in 2022, it affected 10.6 million people worldwide and caused 1.3 million deaths. TB occurs in all countries and in people of all ages. Multi-drug resistant TB (MDR-TB) remains a public health crisis and a threat to health security, with only about two in five people receiving treatment in 2022. In this digital event, experts will explore the role that pharmacists play in the fight against TB, and how this role can be further leveraged. This event marks World TB Day and aims to strengthen pharmacy engagement, foster collaboration and contribute to a TB-free world through collective expertise and commitment.
Moderator: - Manjiri Gharat, Principal, Prin. K.M.Kundnani Pharmacy Polytechnic,India , Vice-President, Indian Pharmaceutical Association, India
Co-moderator: - Cátia Caneiras, Portugal
Panellists: - Hannah Monica Dias, Cross Cutting Lead, Multisectoral engagement and accountability, WHO Flagship Initiative to end TB, Public-Private Mix and TB Elimination, Global Tuberculosis Programme, World Health Organization - Rosalind Miller, Research Consultant TBPPM Learning Network, UK - Tim Rennie, Director of Taught Postgraduate Programmes University of Bath, UK
This event will provide pharmacists with essential knowledge about periodontal disease by exploring the basics of the disease. We will discuss the relationship between oral health and non-communicable diseases, such as diabetes, cardiovascular diseases, and kidney disease, highlighting the need for a holistic approach to wellness. Evidence-based oral hygiene recommendations tailored for effective periodontitis management will also be explored. Join us to celebrate World Oral Health Day and understand the role of pharmacists in periodontal disease and other common oral health conditions.
Moderator: - Luís Lourenço, Professional secretary FIP, Portugal
Panellists: - Philippe Bouchard, Dental Surgeon Université Paris Cité Rothschild hospital, AP-HP France - Zehra Yonel, Clinical Lecturer and Honorary Specialist Registrar in Restorative Dentistry, School of Dentistry, University of Birmingham, United Kingdom - Asma Yahyouche, Assistant Professor in Clinical Pharmacy and Prescribing/ GP non-medical pharmacist prescriber University of Birmingham, United Kingdom
Gender inequities persist in the pharmaceutical and health workforce, hindering the professional growth and opportunities for women. The COVID-19 pandemic has also disproportionately affected women in the workforce, magnifying these inequities which may in turn lead to women leaving the health workforce.
In recognition of International Women’s Day on March 8, 2024, themed ‘Invest in women: Accelerate progress’, FIP will host an event to delve into the challenges faced by women in these sectors, shedding light on gender equity gaps and advocating for inclusive practices. The event will feature a report by Women in Global Health, emphasising the importance of addressing these disparities, exacerbated by the pandemic, for the advancement of gender equity.
Moderator: - Catherine Duggan, FIP Chief Executive Officer, The Netherlands
Facilitator: - Nour ElTahla, FIP Equity and Humanitarian Programme Manager, The Netherlands - Aysu Selçuk, FIP Policy, Practice and Compliance Manager, The Netherlands
Panellists: - Roopa Dhatt, Executive Director, Women in Global Health, United States - Bahijja Raimi-Abraham, Senior Lecturer/Associate Professor in Pharmaceutics, King’s College London, United Kingdom - Vibhuti Arya, Professor and Advisor for Pharmacy Partnerships and Policy, St. John’s Univ/NYC Health Dept, United States - Parisa Aslani, FIP Vice President, FIPWiSE Executive Sponsor, University of Sydney, Australia
In this digital event, we will explore the critical role resilience plays in supporting a healthy workforce and explore strategies that pharmacy technicians can employ to strengthen it. Designed to address the unique challenges faced by early career pharmacy technicians, this event will include discussions on the latest evidence and research related to resilience in the field. Gain insights into fostering resilience amidst evolving demands, discover strategies to support early career professionals, and keep up to date with the latest evidence-based practices. Don't miss out on this unique opportunity to contribute to the resilience of the healthcare workforce while keeping abreast of the latest evidence in the field.
Moderator: - Abigail Tan, Senior Pharmacy Technician KK Women's and Children's Hospital, Singapore
Panellists: - Zubin Austin, Murray Koffler Research Chair Leslie Dan Faculty of Pharmacy, University of Toronto, Canada - Amanda Cavness, PharmD, BCPPS, Clinical Pharmacist Specialist, Hematology/Oncology Children’s Hospital of The King’s Daughters, United States
More than 1 billion people worldwide are obese. The World Health Organization estimates that, by 2025, about 167 million people will be less healthy because they are overweight or obese. In this webinar we will focus on understanding the complexities of obesity, looking at its classification as a disease and a risk factor for chronic diseases such as diabetes, cardiovascular disease and cancer. We will also explore nutritional approaches to obesity prevention and control, and present the latest advances in pharmacological interventions that pharmacists need to be aware of. Attendees will gain valuable knowledge and practical tools from expert speakers. Join us on World Obesity Day and understand the multifaceted management of obesity.
Moderator: - Filipa Alves da Costa, Assistant Professor Faculty of Pharmacy, University of Lisbon, Portugal
Therapeutic biologics products encompass different modalities, and their manufacturing processes may be vastly different. However, there are many similarities that run across the different modalities during the drug product development and manufacturing. In this talk, we will review a roadmap in a phase dependent manner delineating formulation, drug product development and manufacturing considerations in alignment with the different phases of clinical development from pre-clinical through commercialization.
Moderator: - Mathew Cherian PhD, VP of Operations & Development ReVive Biotechnolohy, United States
The event is organized by the HPS to share the Hospital Pharmacy practice and achievements in EMRO. Six different countries will be sharing their experience.
Panellists: - Anas Hamad, Director of Pharmacy Department National Center for Cancer Care & Research, Hamad Medical Corporation, Qatar - Fakhr Al-Ayoubi, Head of the Cardiology Quality Pharmacy Team Department of Cardiac Sciences KFCC, College of Medicine, King Saoud University, Saudi Arabia - Suzan S.Hammoudeh, Pharmacy Administrative Affairs Head King Hussein Cancer Center, Jordan - Salwa Ahsan, Chief of Pharmacy (Shifa) Shifa International Hospitals Ltd. & Pakistan Society of Health-System Pharmacist (PSHP), Pakistan - Ina Adaimy, Head of Pharmacy department Saint Joseph University Hospital, Lebanon - Mohamed Nagy, Pharmacy Director Children's Cancer Hospital Egypt, Egypt
Pharmabridge is a program of the FIP Foundation that aims to facilitate educational and professional development, mentorship/tutoring, exchange opportunities for pharmacists, pharmacy educators, and pharmaceutical scientists. The objective is to strengthen pharmacy services, pharmacy education, and pharmaceutical science in developing and transitional countries. This webinar is an orientation on the pharmabridge program, the previous work of pharmabridge and how pharmacists especially those in developing and translational countries can leverage this program to improve their practice.
Learning objectives
1. To increase awareness of Pharmabridge program amongst FIP members, FIP-ECPG and support organizations. 2. To help members understand how they can participate and benefit from the program. 3. To inform partner organizations and members with vast knowledge and professional experience on how to support the pharmabridge program through being a host/mentor, tutoring, providing educational tools resources and donations.
After the webinar, participants can become either host/mentor or mentee in the program.
Moderator: - Eeva Terasalmi, FIP Foundation, Finland
Panellists: - Harriet Onyedibe, Pharmacist , Nigeria - Rebekah Moles, FIP Foundation Director, Australia
Pharmacy educators in academia often have a wide variety of responsibilities, such as teaching, pharmacy practice, research, and service, which make it difficult to find time to develop scholarship. However, as educators, scholarship is crucial not only for promotion and tenure at universities and institutions, but also for advancing knowledge in their field of expertise as part of professional development and incorporating these innovative concepts in the didactic and clinical setting. This event will have a panel of diverse pharmacy educators sharing their experiences and strategies on how to address these barriers to promote writing productivity.
Moderator: - KarenBeth H. Bohan, Professor, Pharmacy Practice Binghamton University School of Pharmacy and Pharmaceutical Sciences, USA
Co-moderator: - Nicole Cheung, Assistant Professor, Science Education Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, USA
Panellists: - Melody Ryan, Assistant Provost for Global Health and Professor, Pharmacy Practice and Science University of Kentucky, USA - Kristin Janke, Director, Wulling Center for Innovation & Scholarship in Pharmacy Education, Professor, Pharmaceutical Care & Health Systems Associate Dean, Assessment & Quality Coordinator, #RxWritingChallenge University of Minnesota College of Pharmacy, USA - Tina Brock, Director, Collaborative Practice Centre University of Melbourne, Australia - Balamurugan Tangiisuran, Associate Professor School of Pharmaceutical Sciences, Universiti Sains, Malaysia
There has been a recent increase in awareness within the pharmacy profession to practice in an environmentally sustainable manner. This is coupled with the emergence of concern with respect to climate change. However, sustainability is more than environmental consciousness. Sustainable development requires consideration of all three pillars of sustainability: social, economic, and environmental.
Global spending on healthcare is increasing more rapidly than the global economy, now accounting for 10% of global gross domestic product (GDP). The WHO note that this is of particular concern in low- and middle-income countries where health care costs are increasing more rapidly than in high-income countries. As public money funds the majority of healthcare expenditure, this gives rise to ethical concerns with respect to universal access and equality in the provision of health care to populations.
Sustainability has been further described in the Brundtland report as “meet(ing) the needs of the present without compromising the ability of future generations to meet their own needs.” (United Nations, 1987).
This session will provide an opportunity to discuss ethical considerations with respect to sustainable provision of healthcare for current and future generations.
Moderator: - Betty Chaar, Associate Professor The University of Sydney, Australia - Carl Schneider, Associate Professor in Pharmacy Practice The University of Sydney School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
Panellists: - Cicely Roche, Associate Professor in Practice of Pharmacy & Trinity College Dublin Fellow in Education for Sustainable Development, Ireland - Sharon Pfleger,Professor Consultant in Pharmaceutical Public Health NHS Highland, United Kingdom - Sanya Ram, Senior Lecturer Auckland University, New Zealand
This digital event explores the critical role of community pharmacies in advancing cancer care, particularly for patients undergoing oral treatment. As the cancer care landscape evolves towards personalised approaches, the event addresses the urgent need for effective patient support. Experts will explore innovative strategies with a focus on patient-centred approaches. Throughout the event, different pharmacist interventions from different countries will be showcased, providing a broad perspective on global best practices and fostering cross-cultural insights. Attendees can expect valuable discussions on optimising patient outcomes and well-being, fostering collaboration between healthcare providers, and improving the overall quality of cancer care.
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
Panellists: - Melanie Dalby, Clinical Academic Research Lead for pharmacy King’s College Hospital NHS Foundation Trust, UK - Tamara Peiró Zorrilla, Coordinator Pharmaceutical Care Department General Pharmaceutical Council of Spain, Spain - Michael Reff, Founder & Executive Director of NCODA, Inc. National Community Oncology Dispensing Association (NCODA) New York, USA
Join our digital event featuring FIP experts and specialists in Iron Deficiency Anaemia (IDA) for a key discussion on the evolving role of pharmacists in IDA prevention and management. We will launch the "Iron Deficiency Anaemia: Managing Symptoms and Supporting Self-Care" handbook, equipping pharmacists with practical insights. We will explore global data and trends, engage in interactive activities, and gain a deeper understanding of IDA. Learn from community and clinical pharmacists' perspectives and join a panel discussion with experts to address challenges, technological advancements, patient education, and collaborative care models in IDA management.
Moderator: - Sherly Meilianti, FIP Data and Intelligence Specialist, (FIP), The Netherlands
Co-moderator: - Leonila M. Ocambo, Executive Committee Western Pacific Pharmaceutical Forum, Community Pharmacy Section Philippine Pharmacists Association, Philippines
Speakers: - Nisa Masyitah, FIP Project and Data Support Coordinator, (FIP), Indonesia - Grace Adebayo, FIP GPO Intern International Pharmaceutical Federation (FIP), Nigeria - Josep M Guiu-Segura, Director of pharmacy and medicines, Consortium of Health and Social Care of Catalonia, Spain - Rosalynn L. Pangan, Associate Director for Planning & Supplier Relationship, Supply Chain Management Group, St. Luke’s Medical Center, Global City and Quezon City, Philippine Pharmacists Association, Philippines - Susan Tang Siew Chin, Malaysia Pharmacist Society, Malaysia - Jenae Robertz, Clinical Pharmacist Great Lakes Bay Health Centers, Michigan, United States of America, USA - Farah Aqqad, FIP Data Integration Specialist, International Pharmaceutical Federation, Jordan - Sham Moodley, Vice Chair Honorary Research Fellow ICPA Board of Directors School of Health Science UKZN PSSA FPS Exco, South Africa - Linda Tahaineh, Professor of Clinical Pharmacy, Jordan University of Science and Technology, Jordan
Neglected tropical diseases (NTDs) impact over one billion people annually, and disproportionately affect impoverished communities, particularly women and children in tropical areas, leading to 200,000 annual deaths around the world. In addition, global climate change is affecting the distribution patterns of these diseases and cases are emerging in countries where they had never been a cause for concern. Pharmacists can play a pivotal role in raising awareness of NTDs and in their prevention and management. To commemorate World NTDs Day, FIP invites you to join this event and learn how pharmacists may contribute to eradicating NTDs and improving global health.
Moderator
– Shellyza Sajwani, Climate change and pharmacy, global health and oncology pharmacy specialist; FIP Lead for DG 21 (Sustainability in pharmacy), Canada
Panelists
– Chima Amadi, Public health pharmacist, Public health Division, Birmingham City Council, United Kingdom
– Emmanuella Nzeribe, RSTMH Student Ambassador and African Regional Office's Relations Officer of the International Pharmaceutical Students Federation, Nigeria
– Cristina Fernández-Barrantes, PharmD, Hospital San Juan de Dios, Costa Rica
In observance of International Day of Education, the January 24th webinar will mark the launch of the “FIP AIM academic capacity assessment tool”, highlighting the critical role of educational advancement in fostering societal peace and development. This event will introduce a strategic tool by FIP AIM, designed to strengthen academic capacity in pharmacy education, in line with global healthcare and workforce development goals. Experts will discuss strategies to empower educators and improve the impact of their programmes. Key domains from the tool will be addressed, demonstrating its effective application to ensure education meets the evolving needs of the pharmacy profession and contributes to improved health outcomes.
Moderator: - Ozge Ozer, Educational Partnership Manager FIP, The Netherlands
Facilitator: - Genuine Agakhan Desireh, Educational partnerships and project manager FIP, Kenya
Panellists: - Ralph Altiere, Dean, Professor University of Colorado School of Pharmacy, USA - Lilian Azzopardi, Head, Department of Pharmacy University of Malta, Malta - Pierre Moreau, Dean FIP, Kuwait University, Kuwait - Renukha Sellappans, Head of School School of Pharmacy, Taylor’s University, Malaysia - Lisa Hong, Associate Professor and Director of Interprofessional Education Loma Linda University School of Pharmacy, USA - Rajani Shakya, Associate Professor Kathmandu University, Nepal - Mohamed Baraka, Dean Fatima College of Health Sciences, United Arab Emirates - Shaun E. Gleason, Assoc. Prof. and Asst. Dean for Distance Degrees and Programmes University of Colorado Skaggs School of Pharmacy, USA - Abby Kahaleh, PhD, MS, BPharm, MPH, FAACP Tenured Associate Professor for Clinical and Administrative Sciences; Board of Trustees Faculty Roosevelt University, United States - Hanan Refaat, Dean Future University, Egypt
Heart failure is a common condition worldwide. According to the World Health Organization (WHO), it affects an estimated 26 million people globally and is projected to increase in the coming years due to aging populations and increasing rates of risk factors such as obesity, diabetes, and high blood pressure. Join us for an informative webinar that highlights the importance of heart failure management and the crucial role pharmacists play in improving patient outcomes. We’ll discuss the latest research, guidelines, and best practices for pharmacists to enhance their knowledge and skills in heart failure management.
Moderator: - Karolina Cieslak, Associate Director - Risk Management Eli Lilly & Company, USA
Panellists: - Ju-Chieh Wung, Clinical Pharmacy Specialist, Cardiology Taipei Veterans General Hospital, Taiwan - Christine Ko, Cardiology Clinical Pharmacy Massachusetts General Hospital, USA
Pharmacovigilance (PV) is the science of detection, collection, assessment, monitoring and prevention of adverse events due to drugs. With more complex drugs and drug / device combinations in development and use, pharmacovigilance has become progressively become more stringent and challenging. Pharmacovigilance impacts every stakeholder, including CMC, clinical, sales& marketing, regulatory, and manufacturing. Ensuring patient safety is the central theme of PV.
Moderator: - Mathew Cherian PhD, VP of Operations & Development ReVive Biotechnolohy, United States - Kaushik Desai, Advisor Indian Pharma Machinery Manufacturers Association, India
Panellist: - Moin Don, Adjunct Professor of Pharmacy Jamia Hamdard University, India
Since COVID-19 many things have changed about the way we live, work and play. Deployment of technology and use of synchronous and asynchronous modes of communication has been truly phenomenal. Pharmacy and pharmaceutical services must embrace newer ways of working in order to continue to deliver on its mandate on improving lives This digital event provides insights into some of the technologies in use to ensure care and why pharmacy systems across the African continent must be resilient and guard against barriers to embracing positive technological disruptions.
Moderator: - Arinola Joda, Associate Professor of Clinical Pharmacy/Secretary General University of Lagos/African Pharmaceutical Forum, Nigeria
Panellists: - Samuel Akuffo, Global Operations - Africa Fulfillment Lead Zipline International, Ghana - Adeshina Opanubi, Lead Consultant; Project Catalyst Shyne and Chloe Consulting; Pharmalliance, Nigeria - Dudzai Mureyi, Researcher The UNCOVER Group, University of Edinburgh, Zimbabwe - Irene Awuor Olweny, Head, Chairperson Kisumu County Health Products and Technologies Unit and Chairperson of Pharmaceutical Society of Kenya, Nyanza Branch, Kenya
Originally developed in 2008, the FIP Basel Statements set standards for hospital pharmacy practice and the workforce. These 65 statements are grouped into 7 areas and cover all areas of the medicine use process in hospitals, from procurement to monitoring. The statements were last updated in Bangkok in 2014. To ensure the Basel Statements remain relevant and applicable to hospital pharmacists worldwide, HPS again formed a team for updates in 2023. During this webinar, Drs. Stephen Eckel and Michael Stepanovic will discuss the Basel Statement Update Project, review the activities performed in Brisbane, provide an insight into the continued analysis, and highlight next steps and dissemination plans.
Moderator / Speaker: - Stephen Eckel, Assosciate Dean, Global Engagement UNC Eshelman School of Pharmacy, USA
Co-moderator / Speaker: - Michael Stepanovic, Post-doctoral fellow, Health-System Pharmacy Administration UNC Eshelman School of Pharmcacy, USA
This digital event will occur to officially launch the ECPG strategic plan 2023-2030. This strategic plan, born from countless hours of collaboration and consultation, encapsulates ECPG’s commitment to promoting the values of the International Pharmaceutical Federation (FIP). It's a tribute to our relentless pursuit of excellence, our unwavering dedication to lifelong learning, and our fervent belief in the power of connections. Within these pages, you will find not just goals and objectives, but collective aspirations, finely woven with threads of inclusivity, empowerment, and innovation. ECPG aspires to create a thriving community where every early career professional finds their rightful place under the maxim of one FIP.
Moderator: - Emmanuella Nzeribe, Research Assistant, National Institute of Pharmaceutical Research and Development, Abuja, Nigeria
Panellists: - Safiye Çağansel, President, Manager FIP ECPG, Safiye Çağansel Eczanesi/Pharmacy, Cyprus - Paul Sinclair, President FIP, Australia - Luis Lourenço, Professional secretary FIP, Portugal - Waranyu “Kimmy” Lengwiriyakul, President Asian Young Pharmacist Group, Thailand - Lucas Chambel, international affairs department Associação Portuguesa de Jovens Farmacêuticos, Portugal
This Webinar will provide an opportunity for FIP members to learn how they can be involved FIP Foundation program and give input to the future of the FIP Foundation for Education and Research. Join small group discussions to learn about the Foundation’s Research grants, the Pharmabridge/Connections and Collaborations exchange program, and the Foundation’s Leadership Development scholarships for travel to World Congress and participate in the Leadership Development Workshop. You will be able to provide insights into future Foundation programming activities and identify areas for your involvement with Foundation Programs.
Moderator:
Abdikarim Mohamed Abdi, Associate Professor of Clinical Pharmacy Department of Clinical Pharmacy, Yeditepe University, Turkey Chair: - Jennifer Marriott, Adjunct Associate Professor Monash University, Australia
Panellists:
Jenelle Sobotka, Professor | Director of Online Certificate and Masters Programs in Pharmacy Leadership University of Cincinnati James L Winkle College of Pharmacy, United States of America - Andy Gray, Senior Lecturer University of Kwa-Zulu Natal, South Africa - Rebecca Moles, Associate Professor University of Sydney, Australia - Kevin Ben Laurence, FIP Foundation Board Member - Funmbi Okoya, Nigeria/United States of America
The academic section concluded with a strategic plan, and advocacy and global influence were identified as critical priorities for the section. Panelists representing key stakeholders worldwide will be invited to address the following questions related to advocacy and change management.
Moderator: - Onyeka Obidiegwu, Assistant Secretary Pharmaceutical Society of Nigeria, Anambra State Chapter, Nigeria
Panellists: - Cyril O. Usifoh FPSN, FPCPharm, FNAPharm, Professor and President Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Edo State, Nigeria/Pharmaceutical Society of Nigeria, Nigeria - Gisele Etame, Associate Professor and Head, Department of Pharmacy, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon - Serigne Omar Sarr, Professor and Chair, Scientific Committee Cheikh Anta DIOP University, Dakar, Senegal/Senegalese National Pharmacists Council, Senegal - Michael Mungoma, Dean School of Pharmacy, Mount Kenya University, Kenya - Andy Gray, Senior Lecturer University of KwaZulu-Natal, South Africa
Preventing new HIV infections is one of the most important steps towards curbing the HIV epidemic. Pharmacists are ideally placed to support prevention strategies that can reduce the risk of transmission, including advice on safer sex practices, supporting the use of pre- or post-exposure prophylaxis (PrEP/PEP) and supporting harm reduction strategies for intravenous drug users. Managing and optimising treatments in people living with HIV is another important way in which pharmacists can contribute. This event aims to explore options on how to assess and support patients, establish adherence strategies, manage side effects, provide counselling on lifestyle factors, and make appropriate referrals. Further, this event aims to provide skills to optimise HIV therapy, identify and resolve medication-related problems, collaborate with the care team, and empower patients to improve health outcomes.
Moderator: - Sham Moodley, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA) - South Africa
Panellist: - Ali Ahmed, Assistant Prof. Pharmacy Practice Riphah Institute of Pharmaceutical Sciences; Riphah International University, Islamabad, Pakistan - Natalie Schellack, Head of the Department of Pharmacology University of Pretoria, South Africa - Náila Neves, Associate Editor Ministry of Health, Brazil
In this webinar a speaker from the B Federal Institute for Drugs and Medical Devices and from AstraZeneca each will discuss aspects of ICH Q13 related to continuous manufacturing and real time release testing with a special focus on dissolution testing. Specifically, Dr. Dumarey will start the webinar by presenting a case study of how to approach real-time release testing for an oral solid dose formulation. In the second half of the webinar, Dr. Limberg will discuss the assessment of prediction models for quality attributes”.
Moderator: - Andreas Abend, Senior Principal Scientist MSD - USA
Panellists: - Melanie Dumarey, Associate Director at AstraZeneca - Sweden - Jobst Limberg, Head of Section Scientific Quality in European Procedures, Federal Institute for Drugs and Medical Devices - Germany
A convoluted network of diverse worldwide regulatory demands can hinder patients from obtaining generic medications. During this presentation, we will present global initiatives and participation in different regulatory domains, such as ICH, IPRP, GBHI, among others. The FDA OGD global affairs program will share the latest information regarding the Generic Drug Cluster and parallel Scientific Advice (PSA). We will discuss the benefits of a global harmonization that may enable quicker access to high quality, safe and effective generic drugs for patients.
Moderator: - Mathew Cherian PhD, VP of Operations & Development ReVive Biotechnolohy, United States
FIP has developed a humanitarian programme that aims to identify all areas FIP can provide to support pharmacists and pharmacy teams in crises. Very often, pharmacists provide essential roles and services by supporting the distribution of medicines to patients and providing advice on stock management.
At FIP, we wish to support the profession in countries during a crisis and create awareness of pharmacists’ roles in disasters and emergencies, using their communities as support frameworks to ensure the profession’s preparedness. This event aims to showcase different emergency and disaster situations, showcasing the needs for the different countries and regions and pointing out how pharmacists can be involved.
Moderator: - Rúben Viegas, Practice Development and Transformation Projects Coordinator FIP, The Netherlands
Facilitator: - Nour ElTahla, Projects Coordinator – Equity, sustainability policy and development FIP, The Netherlands
Panellists: - Andraž Počič, MPharm, head of community pharmacy JZ Koroška Lekarna, Lekarniška podružnica Mislinja, Slovenia - Hwaida Elsadig, Head of pharmacy practice department University of Medical Sciences and Technology Khartoum/Sudan, Sudan - Catherine Duggan, Chief Executive Officer FIP, The Netherlands - Prosper Hiag, Vice President FIP, Cameroon - Salami Nouredine, Pharmacien SIGMAPHARM, Morrocco
Resistant fungi are a growing public health threat. Fungal resistance poses a great challenge in the treatment of dermatophyte infections. To treat dermatophyte infections antifungal medications are prescribed which are usually given without confirmatory mycological testing. Moreover, they are overprescribed due to widespread use and availability of inexpensive topical antifungal preparations or corticosteroid–antifungal–antibacterial combinations.
Pharmacists can play a crucial role in appropriate antifungal prescribing through antifungal stewardship. They can educate patients, increase awareness and be effective stewards of antifungal prescriptions.
This webinar will focus on the growing issue of drug resistant fungal infections and highlight the role of pharmacists in this issue.
Moderator: - Manjiri Gharat, FIP AMR Commission Chair FIP, India
Panellists: - Dallas Smith, Epidemiologist Mycotic Diseases Branch, Centers for Disease Control and Prevention (CDC), United States - Valeria Gigante, Technical Officer at AMR Division WHO, Switzerland - Darija Kuruc Poje, Vice President European Association of Hospital Pharmacists, Croatia - Anna Khanina, Antifungal Stewardship Project Officer National Centre for Infections in Cancer (NCIC), Peter MacCallum Cancer Centre, Australia
The World Health Organization has emphasised the importance of antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) education. The first objective of the Global Action Plan on AMR is to improve awareness and understanding of AMR through effective communication, education, and training. To address AMR, all clinicians and health-care workers must become stewards of antimicrobials by prescribing them appropriately and educating their patients and colleagues on the proper use of this increasingly scarce medical resource.
However, there is limited evidence regarding the educational needs of the pharmaceutical workforce at a global level. Both HCPs and students express a desire to enhance their knowledge and competency through targeted and effective education and training on AMR. Therefore, FIP developed an online survey to identify the educational needs of pharmaceutical students, practitioners and educators. This webinar will focus on the results of this FIP AMR education survey.
Moderator: - Catia Caneiras, Professor and Coordinator, Microbiology Laboratory of Environmental Health University of Lisbon, Portugal
Panellists: - Rula Darwish, Dean School of Pharmacy, The University of Jordan, Jordan - Maarten Lambert, PhD Candidate University of Groningen, The Netherlands - Hamisi Msagama, Master Student in Global Health Pharmaceutical Society of Tanzania, Brighton and Sussex Medical School, Tanzania - Souheib Kirat, Chairperson of Internal Relations IPSF, Algeria - Alison Etukakpan, PhD student Monash University, Australia
Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework allows, a wide range of point-of-care tests (POCT) can be carried out in community pharmacies. POCT can be incorporated into disease management programmes to monitor the effects of treatment in people living with non-communicable diseases. In addition, in acute situations, pharmacy professionals can use POCT to support clinical decision-making and provide rapid, safe pharmaceutical care. These tests provide valuable data to inform health-related decisions and reduce avoidable visits to primary care physicians or emergency departments. At this event, FIP will launch a global intelligence report on pharmacy-based point-of-care testing.
Moderator: - Sherif Guorgui, President of the FIP Community Pharmacy Section, Canada
Panellist: - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, FIP, The Netherlands - Mfonobong Ekpoh, FIP Intern, Nigeria - Paul Sinclair, President FIP, Australia - Luís Lourenço, Professional secretary FIP, Portugal - Sadaf Faisal, Director, Professional Affairs, Canadian Pharmacists Association, Canada - Ema Paulino, President, Portuguese National Association of Pharmacies (ANF), Portugal - Mariet Eksteen, Professional Development and Support Pharmaceutical Society of South Africa, South Africa - Elen Jones, Director for Wales Royal Pharmaceutical Society, UK
Pharmacists can provide education and services related to key men’s health issues like erectile dysfunction and prostate cancer. This event will overview treatment options for erectile dysfunction, adequate medication use, including non-prescription medicines, and counselling points for these patients. Further, examples of specific campaigns in these areas can help attendees gain insights and skills to better support men in our communities for conditions highlighted by this global campaign.
Moderator: - Rúben Viegas, Practice Development and Transformation Projects Coordinator, FIP ,The Netherlands
Panellists: - Nour Eltahla, FIP Projects coordinator for Equity, sustainability policy and development, FIP, Netherlands - Regina Ahmed, Guidance Manager, Royal Pharmaceutical Society, UK - Pablo Caballero Portero, Scientific Dissemination Technician General Pharmaceutical Council of Spain, Spain - Raj Vaidya, Community Pharmacist, Hindu Pharmacy, Panaji – Goa, India
Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease that requires comprehensive care. Pharmacists have a role to play in the prevention, care and management of COPD. This event aims to highlight the key role of the pharmacist in COPD by providing insights into medication optimisation, inhaler technique and patient counselling. Participants will also learn about the COPD Right Care programme, a global social movement initiated by the International Primary Care Respiratory Group (IPCRG) to improve care for people with COPD, and also the Speak Up for COPD campaign, which aims to raise awareness and understanding of COPD among health and policy makers by amplifying the voices of patients, the COPD community and the public.
Moderator: - Ema Paulino, President National Pharmacy Association (ANF), Portugal
Panellist: - Tonya Winders, President & acting CEO of the Global Allergy & Airways Patient Platform (GAAPP); Chair of Speak Up for COPD, USA - Siân Williams, Chief Executive Officer, International Primary Care Respiratory Group (IPCRG), Registered in Scotland, working internationally - Darush Attar-Zadeh, Clinical Fellow Respiratory Pharmacist North West London Integrated Care Board, RightBreathe, United Kingdom (England) - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, The Netherlands
FIP is organizing a series of three webinars centred on critical aspects of vaccination. These webinars aim to provide insights into three key topics to advance pharmacy-based vaccination services: 1. The first event is dedicated to addressing vaccine confidence and aims to explore the factors that influence public trust in vaccines and discuss strategies to bolster vaccine acceptance. 2. The second event focuses on preparing for vaccination campaigns during the winter season. This includes discussions on adapting vaccination strategies for seasonal challenges and ensuring the availability of vaccines during this crucial period. 3. The third event focuses on at-risk or vulnerable groups and examines the importance of reaching and safeguarding these populations and explores ways in which pharmacies can play a crucial role in their vaccination.
Moderator: - Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain
Panellist: - Alexandre Chadi, Pharmacist, Montreal University, Canada - Anna Sangster, Director, Policy, Advocacy and Innovation, International Federation on Ageing, Canada - Jorge Schlottke, Pharmacist, Confederacion Farmacèutica Argentina (COFA), Argentina - Leonila Ocampo, President, Asia Pacific Institute for Medication Management, Philippine
One of the key objectives of this webinar series is to harness the insights gained from the panel discussions to inform the development of global guidelines for pharmacy practices related to vaccination. These guidelines will serve as a valuable resource for the international pharmacy community, contributing to more effective and inclusive vaccination efforts worldwide.
Moderator: - Dr Luna Bizri, Founder and manager of community pharmacy; Clinical Assistant professor; Adjunct faculty member, Lunapharm pharmacy; Lebanese International University; Lebanese American University, Lebanon
Panellists: - Prof Lisa Nissen, Director – Health Workforce Optimisation, Centre for the Business and Economics of Health, University of Queensland, Australia - Dr Eric J. Yager, Chair, Department of Allied Health Sciences; Albany College of Pharmacy and Health Sciences, USA - Mr Ilan J. Kreiser, Pharmacist - International Liaison Officer, Pharmaceutical Association of Israel, Israel - Miss Anna van Renen, Research and Policy Officer, International Longevity Centre, UK - Ms Leticia Caligaris, Pharmacist, Ministery of Defense, Uruguay
The World Health Organization estimated that more than one in 10 medicines in low- and middle-income countries was substandard or falsified (SF). This means that these countries spend well over USD 30 billion annually on SF pharmaceutical products. The FIP is seriously concerned about the ever-increasing risk to public health represented by SF pharmaceutical products, particularly in countries where legislation governing the manufacture and distribution of medical products, or the enforcement of legislation, is non-existent or ineffective.
Therefore, FIP Regulatory Advisory Group developed a regulatory self-assessment tool which is for the detection, quarantine and removal of SF medical products from the pharmaceutical supply chain in a country and to prevent the SF medical products from being used by the patient.
This webinar will focus on the issue of SF medical products and provide recommendations on how the new tool can be used globally to prevent SF medical products.
Moderator/Co-moderator: - Brett Simmonds, Chair, FIP Regulatory Advisory Group, Australia - Ronald Guse, Healthcare Consultant, National Association of Boards of Pharmacy, Canada
Speakers: - Dr John Hertig, Associate Professor and Department Chair, Butler University College of Pharmacy and Health Sciences, USA - Babatunde Jayeola, Technical Officer (Health Products), WHO, Congo - Zuzana Kusynová, FIP Lead for policy, practice and compliance, The Netherlands - Dr Carmen Catizone, Regulatory Expert, CLM Pharmacy Advisors, USA - Leonor Soares, Pharmacist, Professional Development & International Affairs, Portuguese Pharmaceutical Society, Portugal
Tightly controlled particle size distribution is highly important for pharmaceutical drug development. Powder particle size distribution is a valuable indicator of quality and performance as it affects drug efficacy, safety and manufacturability.. The flowability and ease of handling of the API (Active Pharmaceutical Ingredient) and excipients (fillers and lubricants) are key requirements for the drug formulation. Dissolution rates, and drug content uniformity are the most important parameters for drug effectiveness, quality, and most importantly, bioavailability.
FIP is organizing a series of three webinars centred on critical aspects of vaccination. These webinars aim to provide insights into three key topics to advance pharmacy-based vaccination services:
The first event is dedicated to addressing vaccine confidence and aims to explore the factors that influence public trust in vaccines and discuss strategies to bolster vaccine acceptance.
The second event focuses on preparing for vaccination campaigns during the winter season. This includes discussions on adapting vaccination strategies for seasonal challenges and ensuring the availability of vaccines during this crucial period.
The third event focuses on at-risk or vulnerable groups and examines the importance of reaching and safeguarding these populations and explores ways in which pharmacies can play a crucial role in their vaccination.
One of the key objectives of this webinar series is to harness the insights gained from the panel discussions to inform the development of global guidelines for pharmacy practices related to vaccination. These guidelines will serve as a valuable resource for the international pharmacy community, contributing to more effective and inclusive vaccination efforts worldwide.
Moderator: - Leonila Ocampo, President Asia Pacific Institute for Medication Management, Philippines
Panellists: - Mary S. Hayney, Professor University of Wisconsin-Madison School of Pharmacy, United States - Melody L Berg, Editorial Director, Patient Medication Information American Society of Health Systems Pharmacists (ASHP), United States - Ross McKinnon, Professor College of Medicine and Public Health, Flinders University, Australia
On the 25th October, FIP celebrates five years since the signing of the Astana Declaration on primary health care on behalf of the profession. FIP will mark this special day with a digital event. During the event, progress and challenges on SDGs, key issues from WHA and FIP response will be discussed together with distinguished speakers. FIP will identify trends, gaps, challenges, and opportunities in the field of pharmacy and its relation to the UN Sustainable Development Goals, universal health coverage and, of course, primary health care.
Moderator: - Catherine Duggan, CEO FIP, The Netherlands
Panellists: - Mark Koziol, Chairman Pharmacists' Defence Association (PDA), United Kingdom - Ian Bates, Director FIP Global Pharmaceutical Observatory, United Kingdom - Lars Ake Söderlund, Sweden - Faraz Khalid
This is the 4th and final episode in the FIP series ‘Vaccination: Benefits beyond specific disease prevention’ which aimed to highlight the extensive advantages of vaccination beyond merely guarding against specific pathogens in older adults.
Parts 1 and 2 focused on the evidence base of indirect benefits of vaccination in areas such as cardiovascular health, diabetes and arthritis in older adults and prolonged immune responses that contribute to sustained health. They also underscored the indispensable role of pharmacists in promoting healthy aging through vaccination.
Este webinar se impartirá en inglés con traducción simultánea al español
Este webinar será apresentado em inglês com tradução simultânea para português
Ce webinaire se déroulera en anglais avec traduction simultanée en français.
このウェビナーは英語で行われ、日本語への同時通訳がつきます。
Moderator: - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Netherlands
Panellists: - Dalia Bajis, FIP Lead for Provision and Partnerships FIP, The Netherlands - Eric J. Yager, Associate Professor, Microbiology; Chair, Department of Allied Health Sciences; Director, Pre-Pharmacy Programme; Albany College of Pharmacy and Health Sciences, USA - Nicola Veronese, Senior Researcher, University of Palermo, Italy
Pharmaceutical education in the South-East Asia (SEA) region is undergoing a dynamic transformation, driven by the evolving healthcare landscape, technological advancements, and the need for highly skilled professionals. To support pharmaceutical education reform in SEA, FIP through the UNITWIN Network on Global Pharmacy Education Development, in collaboration with UNESCO and University College London (UCL), is establishing The FIP-UNESCO UNITWIN Centre for Excellence in South-East Asia.
Recognising the unique needs and systems across countries and regions, this Centre seeks to leverage the expertise gained from the pioneer FIP UNESCO UNITWIN Centre for Excellence in Africa. This aligns with the UNESCO agreement for 2023–2027, emphasising the need for an integrated approach to research, teaching, training, community engagement, and communication. The aim of the FIP-UNESCO UNITWIN Centre for Excellence in South-East Asia is to advance pharmaceutical education in South-East Asia by fostering academic institutions collaboration, networking, and educational development.
Moderator: - Dalia Bajis, FIP Lead for Provision and Partnerships FIP - The Netherlands - Alison Ubong Etukakpan, FIP Educational partnerships and projects manager FIP - The Netherlands
Panellists: - Catherine Duggan, FIP CEO FIP - The Netherlands - Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences - USA - Rajani Shakya, Associate Professor Department of Pharmacy, School of Science, Kathmandu University - Nepal - Rao V. S. V. Vadlamudi, Immediate Past President Indian Pharmaceutical Association - India - Sherly Meilianti, FIP Data and Intelligence Specialist (FIP) - Netherlands - Editha Renesteen, Head of Internal Quality Assurance System, Faculty of Military Pharmacy, The Republic of Indonesia Defense University - Indonesia - Andi Hermansyah, Academia Faculty of Pharmacy Universitas Airlangga - Indonesia
Millions of people across the globe live with pain on a daily basis, including from osteoarthritis, rheumatoid arthritis, other forms of musculoskeletal pain and other types of pain. Pharmacists are uniquely positioned to support patients in achieving appropriate pain management and control, by providing advice on pharmacological, non-pharmacological and behavioural measures. By enhancing their knowledge, pharmacists can meaningfully contribute to the interdisciplinary care of pain patients. This event will explore evidence-based approaches that pharmacists can recommend for improving the quality of life of those living with pain.
Moderator: - Leonila Ocampo, President Asia Pacific Institute for Medication Management - Philippines
Panellists: - Jack Collins, Lecturer The University of Sydney - Australia - Bhuvan KC, Lecturer in pharmacy, Discipline of Pharmacy School of Clinical Sciences, Faculty of Health, Queensland University of Technology - Australia - Andrew McLachlan, Head of School and Dean Sydney Pharmacy School, The University of Sydney - Australia
13.00 - 14.30 IMPLEMENTATION SCIENCE: Panelists in this session will describe implementation of innovative pharmacy technician roles and provide real-world examples of successful practice models. The goal of this session is to inspire learners and provide practical suggestions for future advanced technician role implementation in the workplace.
Moderator: - Kimberly McKeirnan, Associate Professor, Department of Pharmacotherapy Director, Center for Pharmacy Practice Research Washington State University Health Sciences Spokane - United States - Michael Mungoma, Dean, School of Pharmacy Mount Kenya University - Kenya
Panellists: - Ken Hohmeier, Director of Community Affairs Professor, College of Pharmacy The University of Tennesse Health Science Center - United States - Pauline Roberts, Systems Thinking Practitioner - United Kingdom
14.30 - 15.45 TEAM TECHS AND PHARMACISTS: SUCCESS STORIES AND PARTNERSHIPS: Pharmacy technicians are critical members of the health care team. This session will highlight successful partnerships between pharmacy technicians, pharmacists, and other members of the care team.
Moderator: - Alison Hemsworth - United Kingdom
Panellists: - Tara Clayson-Fisher, Statewide Pharmacy Technician Manager Statewide Hospital Pharmacy, Tasmanian Health Service - Australia - Michelle Beirne, Senior Pharmacist Children’s Health Ireland - Ireland
15.45 - 16.00 CLOSING REMARKS - Susan James, Ontario College of Pharmacists, Canada, as well as Chair, Pharmacy Technician Advisory Committee - Ian Bates, Director, FIP Global Observatory
13.00 - 13.15 Opening Remarks by Dr Catherine Duggan, FIP CEO
13.15 - 14.30 RACIAL EQUALITY AND PHARMACY IN THE UK: This session will explore equality, diversity and inclusion, through the lens of race, in UK pharmacy practice. How is this experienced and what is being done to address inequity?
Moderator: - Peter Karegwa, National Chairman Kenya National Union of Pharmaceutical Technologists - Kenya - Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board - United States
Panellists: - Parampreet Bahia, Programme Manager: Pharmacy Integration Programmes Workforce, Training and Education Directorate NHS England – South East / Pharmacy Technicians of Colour - United Kingdom - Samantha Quaye, Head of School (Pharmacy) Workforce, Training and Education Directorate NHS England – London / Pharmacy Technicians of Colour - United Kingdom
14.30 - 16.00 COMPETENCY FRAMEWORK AND GLOSSARY PROJECT UPDATE: The development of a competency framework for pharmacy technicians will set a new standard for the workforce to consider, support and monitor the pharmacy support workforce. The aim of the project is to facilitate and enable the sharing of relevant knowledge, skills and professional development tools for all pharmacy support workforce, across countries and regions.
Moderator: - Dana Lyons, Manager, Provincial Operations Pharmacy Services Alberta Health Services - Canada - Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board - United States
Panellists: - Kat Hall, Associate Professor of Clinical Education. Pharmacy Technicians Advisory Committee Member and Head of School, South East Pharmacy Team - NHS England - Teri-Lynne Fogarty, Lecturer/ Coordinator of Pharmacy technician programme Nelson Mandela University - South Africa
Common ailment schemes (CAS) (aka minor ailment schemes) are programmes where patients can receive advice, care and, when needed, treatment for an agreed range of common, self-limiting health problems, generally without the need for appointment. They are equally important for triaging patients that do require being seen by a medical doctor or nurse. Such schemes greatly contribute to providing accessible, agile and quality care to patients, and to reducing pressure on general practice and emergency departments, thus making health systems more efficient. FIP conducted a global study on common ailments schemes, including a literature review, a survey of its member organisations, a compilation of case studies and an insight board meeting. The outcomes have been put together into a global intelligence report that will be presented and discussed at this event.
Moderator: - Virginia Olmos, FIP vice president - Uruguay
Panellists: - Pedro Amariles, Professor and researcher on Pharmaceutical Care and Clinical Pharmacy Universidad de Antioquia - Colombia PharmaceuticalCare and Clinical Pharmacy Universidad de Antioquia - Colombia - Stefano Omboni, Director Italian Institute of Telemedicine - Italy - John 'Ikenna' Ogwuegbu , Translation Research ORISE Fellow Centers for Disease Control and Prevention/Oak Ridge Institute for Science and Education (ORISE) - USA
Medication management is particularly important for people living with cardiovascular diseases (CVD) due to the increased likelihood of co-morbidities. This often leads to the need for multiple pharmacological therapies, resulting in polypharmacy. Close medication management between pharmacists and CVD patients is essential to ensure effective achievement of treatment goals, ensure adherence and reduce the incidence of unpleasant or fatal side effects, thereby reducing the burden of CVD. This digital event will address the importance of proper medication management and adherence in the successful management of CVD, the factors associated with non-adherence to CVD medications, and the economic impact of pharmacist interventions on CVD medication adherence.
Moderator: - Virginia Olmos, FIP vice president - Uruguay
Panellists: - Pedro Amariles, Professor and researcher on Pharmaceutical Care and Clinical Pharmacy Universidad de Antioquia - Colombia PharmaceuticalCare and Clinical Pharmacy Universidad de Antioquia - Colombia - Stefano Omboni, Director Italian Institute of Telemedicine - Italy - John 'Ikenna' Ogwuegbu , Translation Research ORISE Fellow Centers for Disease Control and Prevention/Oak Ridge Institute for Science and Education (ORISE) - USA
The academic section concluded with a strategic plan, and advocacy and global influence were identified as critical priorities for the section. Panelists representing key stakeholders in Asia (as part of a worldwide series) will be invited to address the following questions related to advocacy and change management.
Moderator: - Toyin Tofade, President Albany College of Pharmacy and Health Sciences - United States
Panellists: - Yolanda Robles, President - Professor; BS Pharm, MPharm, PhD Federation of Asian Pharmaceutical Association - Philippines
- Ken-ichi Inui, President - Asian Association of Schools of Pharmacy – Professor Emer, Kyoto Pharmaceutical University - Japan
- TV Narayana, President - Owner Indian Pharmaceutical Association - SBD College of Pharmacy - India - Amrahi Buang, President Malaysian Pharmacists Society - Malaysia
As mental health problems become more prevalent, this event will address the role that pharmacists can play in integrated interprofessional care, through early screening, effective referral and support of people with mental health conditions. Attendees will gain insight into the latest screening tools that enable pharmacists to identify individuals at risk and refer them to appropriate resources. In addition, the event will explore the pharmacist's role in providing appropriate support and counseling to patients and working with healthcare teams to promote holistic mental wellness. Through this event, FIP hopes to empower pharmacists to transform mental health care.
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation - Sweden
Panellists: - Claire O'Reilly, Associate Professor, Sydney Pharmacy School The University of Sydney - Australia - Hayley Gorton, Senior Lecturer In Pharmacy Practice University of Huddersfield - UK - Sheilla; Ferreira, PhD Sheilla Ferreira Department of Pharmacy, Federal University of Ceará, Brazil - Brazil
Migraine is a neurological disorder with intense headaches and various symptoms, which affects the quality of life of millions of people. Medication overuse headache (MOH) is a debilitating condition caused by excessive use of pain relievers, often to manage chronic headaches. Pharmacists play a crucial role in the management of both conditions by advising patients about proper medication usage, suggesting non-pharmacological interventions and lifestyle changes, and collaborating with other healthcare professionals to ensure patients receive appropriate care. This event will explore different options for the management of migraine and MOH and provide guidance on how pharmacists may support patients.
Moderator: - Tara Hehir, SAPS President Social and Administrative Pharmacy Section - Australia
Panellists: - Jacinta Johnson, Senior Lecturer in Pharmacy University of South Australia - Australia - Pernilla Bjerkeli, Associate Professor in Public Health and Pharmacist University of Skövde / School of Health Sciences - Sweden
Non-communicable diseases (NCDs) continue to rise and represent a major global health challenge. This digital event addresses the importance of proper medication management and adherence in the successful management of long-term NCDs. It will discuss medication management practices and adherence, factors influencing non-adherence in patients with lifestyle-related NCDs, and interventions to promote adherence in low- and middle-income countries (LMICs). Pharmacists play a critical role in optimising medication treatments, educating patients and implementing interventions to improve adherence, thereby contributing to better health outcomes for NCD patients worldwide.
Moderator: - Timothy F Chen, Professor of Medication Management, Head of Pharmacy Practice and Health Services Research, Research Academic Director – Health Services Research - The University of Sydney
Panellists: - Job F.M. van Boven, Associate Professor University Medical Center Groningen (UMCG)/Medication Adherence Expertise Center of the Netherlands (MAECON) - The Netherlands - Rie Nakajima, Lecturer School of Pharmacy, Nihon University - Japan - Chaisiri Angkurawaranon
Building on the Part 2 of the series, Part 3 will focus on the burden of diseases and the risks and costs of not widening access to vaccination. FIP resources will be revisited as well as the process of setting up vaccination at a pharmacy: pre-vaccination, vaccination, post-vaccination and in-depth case studies. The event will take the format of a brief presentations followed by a panel discussion in which experts will join in to share their knowledge and expertise.
Moderator: - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP) - Netherlands
Facilitator: - Nour Eltahla, FIP Projects coordinator for Equity, sustainability policy and development FIP - Netherlands
Panellists: - Esther McNamara, Senior Health Policy Lead International Longevity Center UK - United Kingdom - Jane Barratt, Secretary General International Federation on Aging - Canada - Sachiko Ozawa, Associate Professor, Division of Practice Advancement and Clinical Education UNC Eshelman School of Pharmacy - United States - Peter Guthrey, Senior Pharmacist-Strategic Policy Pharmaceutical Society of Australia - Australia
Community pharmacy spatial requirements and design are a crucial intersection of accessibility, functionality and the enablement of a range of professional services in the field of pharmacy. This topic brings together pharmacists, architects, designers, and experts in the healthcare industry to delve into the spatial considerations that can impact pharmacy practice, patient interactions, and architectural aspects, and contribute to the optimal functioning and customer experience at community pharmacies.
Moderator: - Gonçalo Sousa Pinto, Lead for Practice Development and Transformation
Panellists: - Raimond Pinto, Interior Designer Rai Pinto Studio, www.raipinto.com - Spain / USA - Ranjita Dhital, Lecturer in Interdisciplinary Health Studies University College London - UK - Joseph Cook, Creative Fellow University College London - United Kingdom - Laura Martín Gutiérrez, Lead for National Professional Sections General Pharmaceutical Council of Spain - Spain - Aliki Peletidi, Pharmacy Programme Coordinator, Assistant Professor of Pharmacy Practice & Academic Director for Training and Service Provision Department of Health Sciences, University of Nicosia/Federation of the Cooperative Pharmacies of Greece - Cyprus/Greece
The relationship between acute pain and mental health significantly influences an individual's overall well-being. Untreated acute pain can disrupt daily functioning, potentially leading to subsequent mental health issues. Similarly, mental health conditions can sometimes manifest as acute pain. Pharmacists hold a key position in this context. This webinar will spotlight their crucial role in integrated acute pain management, emphasizing the link between acute pain and mental well-being, and promoting a holistic approach to care.
Moderator: - Dalia Bajis, FIP Lead for Provision and Partnerships FIP - The Netherlands
Co-moderator: - Ozge Ozer, FIP Education and Professional Development Manager FIP - The Netherlands
Panellists: - Aline Hajj, Associate Professor Laval University - Canada - Beth Fowler, Specialist Clinical Pharmacist - United Kingdom - Alicia Peña Bizama, Chartered Psychologist - United Kingdom
COVID-19 has forever changed the world of work and how things are done across the globe. The pandemic was a brutal exposé on global health systems and emergency preparedness with Pharmacy playing a crucial role in supporting the populace through tough times. This digital event X-rays the experiences of Pharmacists that have re-invented their roles in various areas of practice amidst crisis across the African continent.
Moderator: - Arinola Joda, Associate Professor of Clinical Pharmac University of Lagos - Nigeria
Panellists: - Jocelyn Chaibva, CEO Nu Fife Avenue Pharmacy - Zimbabwe - Sola Solarin, Managing Partner Savante Consulting Ltd. - Nigeria - Mujahidhussein G Valji, Chief Pharmacist Aga Khan Health Services - Tanzania - Mariam El Boakye-Gyasi, Associate Professor Faculty of Pharmacy and Pharmaceutical Sciences Kwame Nkruma University of Science and Technology, Kumasi - Ghana - Elijah Mohammed, Former Registrar Pharmacy Council of Nigeria - Nigeria
The semisolid topical dosage forms include creams, ointments, and gels. They are special dosage forms with particular compositions, structures, transformations at the site of administration and mechanisms of release. In vitro release test (IVRT) is a simple, reliable and reproducible tool utilized for the assessment of the performance of these complex formulations. The applications of IVRT gradually evolved from screening of the impact of scale up post approval changes (variations) to comparative evaluations of multisource drug products. The presentation will focus on the particularities and relevance of IVRT, the role of critical assessment of qualitative / quantitative composition for appropriate interpretation, the current applications and possible extension.
Moderator: - Horst-Dieter Friedel, Former Director, retired Worked for Bayer AG, Germany
Panellists: - Flavian Stefan Radulescu, Assoc.Prof. University of Medicine and Pharmacy Carol Davila Bucharest - Romania - Xiao Yu Xie, Head of laboratory Eurofins PHAST Development GmbH & Co. KG - Germany
Global collaboration of international health authorities is encouraged by WHO to ensure the safety, quality, and efficacy of locally registered medicinal products. Strong regulatory systems for approving the marketing of medicinal products are a critical element of well-functioning health systems and important contributors to improving access and achieving universal health coverage. Regulatory reliance is an effective way of regulating medical products through using global resources & financial investment more efficiently. The implementation of Good regulatory Reliance practices (GRelP) on other regulators’ work promotes regulatory cooperation, convergence and transparency through networking and work-sharing.
Moderator: - Mathew Cherian, Consultant - USA
Co-Moderator: - Nikolina Biskic, Global Regulatory Affairs Manager - Croatia
We all know that the primary goal of vaccination is the prevention of pathogen-specific infection. But what about the indirect benefits of vaccines which drive longer-term immune responses that promote long-term health? This webinar – Part 2 - will share contributions, activities, tools that pharmacists lead and utilise to promote healthy aging in the practice setting. The webinar will highlight the varied but crucial role of pharmacists in vaccination, particularly for older adults, and supporting patients' quality of life.
Moderator: - Dalia Bajis, FIP Lead for Provision and Partnerships - The Netherlands
Facilitator: - Ozge Ozer, FIP Education and Professional Development Manager - The Netherlands
Panellists: - Jane Barratt, Secretary General International Federation on Ageing - Canada - Suzete Costa, Executive Director & Senior Research Director Institute for Evidence-Based Health (ISBE) - Portugal - Peter Guthrey, Senior Pharmacist- Strategic Policy Pharmaceutical Society of Australia - Australia
According to WHO, individuals spend less than 1h a year with a health worker versus over 8700h a year in self-care. Self-care interventions promote individuals’ active participation in their own healthcare. To support them on this journey, pharmacists are equipped with knowledge and skills to better their self-determination, self-efficacy, autonomy, and engagement in health.
This digital event is designed as a collection of three CPB Bites to equip early career pharmacists with essential self-care knowledge in the context of reflux management, irritable bowel syndrome, and respiratory symptoms (including sore throat). Issues around gender biases in patient interactions and during treatment will be highlighted.
Moderator: - Sham Moodley, Community Pharmacist Vice Chair Independent Community Pharmacy Assoc NEC on Pharmaceutical Society of SA - South Africa
Co-moderator: - Gonzalo Miquel Adsuar-Meseguer, Community Pharmacist in Rojales, Alicante, FIP ECPG, Spanish Society of Clinical, Familiar and Pharmacy (SEFAC) - Spain
Panellists: - Veronica Kihugi, Pharmacist Anaya Pharmaceuticals - Kenya - Anja St. Clair Jones, Consultant Pharmacist Gastroenterology University Hospitals Sussex NHS Foundation Trust - United Kingdom - Leonila Ocampo, President Asia Pacific Institute for Medication Management (APIMM) - Philippines
Facilitator: - Alison Etukakpan, Educational partnerships and projects manager - FIP - Genuine A. Desireh, Pharmacist FIP - Kenya
We all know that the primary goal of vaccination is the prevention of pathogen-specific infection. But what about the indirect benefits of vaccines which drive longer-term immune responses that promote long-term health? This webinar – Part 1 - will delve into technical and evidence-based insights on positive downstream effects of vaccines in older adults including that on cardiovascular events and diseases, diabetes or arthritis.
Moderator: - Dalia Bajis, FIP Lead for Provision and Partnerships - The Netherlands
Facilitator: - Ozge Ozer, FIP Education and Professional Development Manager - The Netherlands
Panellists: - Mine Durusu Tanriover, Professor of Internal Medicine Hacettepe University - Turkiye - Eric J. Yager, Associate Professor, Microbiology Chair, Department of Allied Health Sciences Director, Pre-Pharmacy Programme Albany College of Pharmacy and Health Sciences - USA
Following the pandemic, how to continue to lead the profession globally and support our members during those uncertain times became a core priority for FIP in 2023. As we move on from responding directly to COVID-19 to responding to the aftermath and to readying ourselves for future pandemics and health emergencies, FIP sought to derive key lessons, recommendations and considerations for the future in another report, “Pandemic Preparedness, Response and Recovery: Lessons Learnt for Global Pharmacy” which will be launched at the digital event on August 16.
The event moderators are: - Sherly Meilianti – FIP Data and Intelligence Specialist - Farah Aqqad – FIP Regional, Enngagement Support and Development Manager - Nour Eltahla – FIP Projects coordinator for equity, sustainability policy and development, The Netherlands
The event speakers are: - Lina Bader – FIP Lead for equity, sustainability policy and development, The Netherlands - Rao Vadlamudi - Immediate Past President, Indian Pharmaceutical Association (IPA); Professional Secretary, SEARPharm Forum, India - Jackie Maimin, Chief Executive Officer, Independent Community Pharmacy Association (ICPA); Council member, Pharmaceutical Society of South Africa, South Africa - Rony Zeenny, Director, Department of Pharmacy, American University of Beirut Medical Centre; INSPECT-LB, Lebanon - Clare Fitzell, Head of Strategic Policy, Irish Pharmacy Union, Ireland - Leonor Soares, International Affairs, Portuguese Pharmaceutical Society, Portugal - Nobuo Yamamoto, President, Japan Pharmaceutical Association, Japan - Maria Mendes, Area Manager, Public Health Interventions and Pharmacy Services, National Association of Pharmacies, Portugal - Sofía Segura, University of Costa Rica and College of Pharmacists of Costa Rica, Costa Rica - Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists, Malta
Pharmacists support appropriate medication selection and provision of medicines management in the healthcare of athletes and pharmacy operations of sporting events. Increasingly recognised within the world of sports as a valuable expertise, the practice is known as “sports pharmacy”. This webinar will revisit the findings of the FIP report on “Sports pharmacy practice and education” and showcase good practices of sports pharmacists from around the world.
Moderator: - Sham Moodley, Pharmacist Independent Community Pharmacy Assoc (ICPA) South Africa-Vice Chair Pharmaceutical Society South Africa (Exco) - South Africa
Panellists: - Ashley Anderson, Clinical sports pharmacist International Sports Pharmacists Network - United States - Claire May, Senior Lecturer in Medicines Use, lead for Interprofessional Education and Professionalism University of Brighton - United Kingdom - David Mottram, Emeritus Professor of Pharmacy Liverpool John Moores University - United Kingdom - Mark Stuart, Operations development senior manager International Testing Agency - Switzerland - Robert Nickell, Pharmacist and CEO Pharmco Inc, Enovachem Pharmaceuticals, Nubratori RX Inc. - United States - Mohy El-Din EL-Gaafary, Sports Pharmacist & Anti-doping consultant IOC accredited sports pharmacist - Egypt - Somer Helvaci, IOC certified Sports pharmacist, Lecturer of sports pharmacy - Turkey
FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.
The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.
Moderator: - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP) - Netherlands
Facilitator: - Nour Eltahla, FIP Projects coordinator for Equity, sustainability policy and development FIP - Netherlands
Panellists: - Fei Sim, National President Pharmaceutical Society of Australia - Australia - Daphné Holt, Chair Coalition for Life-course Immunisation - France - Sarah Sorum, Executive Vice President & CEO Pharmacy Society of Wisconsin, an ASHP state-affiliate - United States - Catherine Duggan, FIP CEO FIP - The Netherlands
This event holds significant importance as it aims to discuss effective strategies for empowering pharmacy teams in their self-care practices. We will explore various aspects, including leveraging technology, showcasing successful community pharmacy initiatives, and emphasizing the importance of patient engagement.
By bringing together experts and stakeholders, this event will foster knowledge exchange, shed light on global insights, and provide practical approaches to enhance self-care within the pharmacy profession.
This event on Procurement and Supply Chain Management (PSM) aims to address the crucial importance of PSM in the pharmaceutical industry and its impact on global health outcomes. By focusing on the challenges faced by healtcare practitioners working in Supply Chain Management, the event will provide valuable insights and strategies to optimise processes, enhance efficiency, and ensure the availability of safe and effective healthcare products. Additionally, the event will highlight the FIP seal awarded online programme on Global Health Procurement and Supply Chain Management, equipping participants with comprehensive knowledge of PSM, including government policies, donors, manufacturers, and procurement agents.
Moderator: - Ozge Ozr, FIP Education and Professional Development Manager FIP - The Netherlands
Panellists: - Andy Barraclough, Director-Education and Capacity Building Empower School of Health - Thailand - Mudzimu, Procurement and Supplies Management Manager UNDP-GFATM - Zimbabwe - Ralph Stephane Guilbaud, Pharmacist in Supply Chain, Doctors Without Borders Belgium - Haiti - Dalia Bajis, FIP Lead for Provision and Partnerships FIP - The Netherlands
To meet the medical need of efficient RNA delivery beyond the liver, my lab rationally designs inhalable and biocompatible nanocarriers for efficient siRNA delivery to the lung. Delivery is the major hurdle thwarting the therapeutic potential of RNA medicines. While all siRNA drugs on the market target the liver, the lung offers a variety of currently undruggable targets which could be treated with RNA therapeutics. Hence, nebulizable and biocompatible nanocarriers for pulmonary administration of RNA nanoparticles could finally enable delivery beyond the liver.
Moderator: - Mathew Cherian PhD, Consultant Self Employed - The United States Co-moderator: - Nikolina Biskic, Global Regulatory Affairs Manager, Croatia
Panellists: - Olivia Merkel, Professor Chair Drug Delivery, Ludwig Maximillian University (LMU), Munich - Germany
To meet the medical need of efficient RNA delivery beyond the liver, my lab rationally designs inhalable and biocompatible nanocarriers for efficient siRNA delivery to the lung. Delivery is the major hurdle thwarting the therapeutic potential of RNA medicines. While all siRNA drugs on the market target the liver, the lung offers a variety of currently undruggable targets which could be treated with RNA therapeutics. Hence, nebulizable and biocompatible nanocarriers for pulmonary administration of RNA nanoparticles could finally enable delivery beyond the liver.
Moderator: - Abigail Tan, Senior Pharmacy Technician KK Women's and Children's Hospital - Singapore
Panellists: - Kimberly McKeirnan, Associate Professor, Department of Pharmacotherapy Director, Center for Pharmacy Practice Research Washington State University Health Sciences Spokane - USA - Rebecca Bastable, Pharmacy Technician Lead Workforce, Training and Education Directorate NHS England – South East - UK
This webinar will update members on the ECPG Career Development Toolkit and introduce the new structure and variety of content for the Curriculo PFP Program Moderator: - Amanda Cavness, Clinical Pharmacy Specialist Children's Hospital of The King's Daughters - United States
Co-Moderator: - Godsgift Iwendii, Pharmacy Council of Nigeria - Nigeria
Panellists: - Karen Glen, Director Curriculo Solutions - UK - David Morrison, Director Curriculo Solutions - United Kingdom
Mental health is a critical aspect of overall health and well-being. Mental health disorders are common affecting one in four people worldwide. However, mental health patient care services are often inaccessible, leading to negative outcomes such as disability and poor physical health. Pharmacists play a vital role in providing mental health patient care services, as they are often the first contact for the patients asking for help. Developing competency in delivery of mental health services is thus essential for pharmacy students and practitioners. To obtain a high level of knowledge and skills, but also attitudes and values required for these roles, a variety of teaching and learning methods can be used. As indicated in FIP-GCFE, teaching methods should be aligned with participants' needs and the context of learning. This webinar aims to provide an overview of pharmacists' roles in not just promoting mental health and well-being, but to highlight strategies to really deliver mental health patient care services among practitioners and students, and showcase experiences of capacity building programs in the mental health care.
Co-moderator: - Arinola E. Joda, Associate Professor of Clinical Pharmacy Faculty of Pharmacy, University of Lagos - Nigeria
Panellists: - Alena Tatarević, Community Pharmacist Pharmacy Bobanović Vujnović Pula - Croatia - Abdikarim Mohamed Abdi, Associate Professor of Clinical Pharmacy Department of Clinical Pharmacy, Yeditepe University - Turkey - Sarah Y. Khamis, Assistant professor in clinical pharmacy Jerash University, Pharmacy Faculty - Jordan - Odhiambo David, Curator African Pharmaceutical Network (APN) - Kenya - Anisha Sandhu, Assistant Lecturer School of Pharmacy, Monash University - Malaysia
Emphasis is often placed on healthcare challenges facing providers and pharmacists that care for the adult and elderly patient populations – however, children are cared for in many of the same patient care settings: hospitals, ambulatory clinics, and community pharmacies. As compared to adults, children may be at greater risk of medication errors and potential adverse drug events due to individualized weight-based dosing, differences in compounded formulations and concentrations, inability of children to communicate adverse effects, and confusion between units of measure (e.g. milligrams versus milliliters). This session will provide “need to know” information about how to care for a paediatric patient throughout the care continuum (inpatient considerations, transitions between inpatient and outpatient care, outpatient considerations, and transitions from paediatric to adult care) as well as more advanced information regarding innovative approaches and technology implementation in paediatric pharmacy.
Moderator: - Juliane Mayette, PharmD, BCPS Clinical Staff Pharmacist Carondelet St. Joseph’s Hospital - United States
Panellists: - Lauren Kormelink, PharmD, BCACP, Cystic Fibrosis Clinical Pharmacist University of Kentucky HealthCare - United States of America - Jorge Alberto Robledo, Biochemist, Pharmacist and PhD in Health Sciences, Director del Programa Interinstitucional de Prevención y Educación en Salud (PIPES) Bioquímico y Farmacéutico - Doctor en Ciencias de la Salud - Argentina - Sherif Kamal, RPh, MSc, DHCM, Pharmacy Program Director Health Sciences Academy Children’s Cancer Hospital Egypt - Egypt - Dr Régis Vaillancourt, OMM, CD, B.Pharm, Pharm D, FCSHP, FFIP, FOPQ Director of Pharmacy/ Directeur de la Pharmacie Children’s Hospital of Eastern Ontario - Canada
Chronic kidney disease (CKD) is a prevalent and severe condition that progresses silently in most patients. As such, many patients are not diagnosed until the late stages of CKD, resulting in a greater risk of poor outcomes, such as end-stage renal disease requiring dialysis or transplant. Community pharmacists and their teams are ideally placed to raise CKD awareness, identify those at risk and be the driving force behind earlier detection and referral to primary care partners for screening, diagnosis and intervention. At this event, the “Chronic kidney disease - Toolkit Guide” to support pharmacists in providing a range of CKD pharmacy services will be presented.
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation - Sweden
Panellists: - Connie Marshall, Director of Expert Content IPG Health - Canada - Alfonso Pereira Céspedes, Adjunct professor Faculty of Pharmacy, University of Costa Rica, and University of Granada Spain - Costa Rica - Ronald Castelino, Associate Professor in Pharmacy University of Sydney - Australia
This 4th of 4 Digital Events on mentorship will follow the third event that focused on the responsibilities and behaviours of the organization and its leaders in facilitating effective mentorship, oversight of a successful mentoring programme, and imbuing a culture of mentorship. This Digital Event features organizational leaders of successful wide-scale mentoring programmes and includes FIP Executive Director, Catherine Duggan, to share her perspectives on mentoring and how might mentoring platforms take further shape in the Federation.
Moderator: - Dr. Efi Mantzourani, Reader in Pharmaceutical Sciences - Wales
Co-Moderator: - Shane Desselle, Associate Dean for Research and Professional Affairs Touro University California College of Pharmacy - USA
Panellists: - Brittany Torres, Associate Pharmacotherapy Touro University California College of Pharmacy - USA - Helen Chang, Head of Professional Development Royal Pharmaceutical Society - England - Catherine Duggan, Executive Director International Federation of Pharmacy (FIP) - The Netherlands
This webinar will update members on the ECPG Career Development Toolkit and introduce the new structure and variety of content for the Curriculo PFP Programme.
Moderator: - Amanda Cavness, Clinical Pharmacy Specialist Children’s Hospital of The King’s Daughters - United States
Co-Moderator: - Godsgift Iwendii, Pharmacy Council of Nigeria - Nigeria
Tobacco use is a global health problem with 1.13 billion smokers and 8 million deaths annually, including 1.2 million from second-hand smoke. It is a burden on individuals, communities and economies, causing various diseases and preventable deaths. Tobacco is a major risk factor for non-communicable diseases such as chronic respiratory and cardiovascular diseases, cancer and diabetes. At this event, FIP will launch a new handbook to support pharmacists and their organisations in providing a range of tobacco cessation services. This will be accompanied by a reference guide identifying the knowledge and skills pharmacists need to provide such services.
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation - Sweden
Panellists: - Dongbo Fu, Medical Officer for Tobacco Cessation World Health Organization - Switzerland - Tan Ching Siang, Dean, School of Pharmacy KPJ Healthcare University College - Malaysia - Darush Attar-Zadeh, Clinical Fellow Respiratory Pharmacist North West London Integrated Care Board, RightBreathe - United Kingdom (England) - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP - The Netherlands - Dalia Bajis, Lead for provision and partnerships FIP - The Netherlands
Empowering patient self-care improves health outcomes and reduces the burden of diseases. Improving health and self-care literacy is key to empowering pharmacy-based self-care. This is especially important when it comes to the management of minor ailments through pharmacy. Consisting of a series of five events focusing on common health issues, this new FIP digital programme aims to examine how pharmacists can be enabled to improve health and self-care literacy. Approaches for each of the five areas of minor ailments will be discussed including embedding health and self-care literacy into education and training, developing self-diagnosis and self-medication protocols, widening access to patient information, and improving referral strategies.
The FIP Global Competency Framework (GbCF) was first developed in 2012 (Version 1) and it contained a structured assembly of behavioural competencies that can contribute towards supporting foundation level practitioner development. In September 2020, revisions to the GbCF were completed and the updated version labelled as GbCF Version 2 (GbCFv2). This Event will present GbCFv2 and case studies from different countries on its implementation.
Co-Moderator: - Lina Bader, FIP Lead for Equity, Sustainability Policy and Development - The Netherlands - Dalia Bajis , FIP Lead for Provision and Partnerships FIP - The Netherlands
Panellists: - Asmaa Al-Haqan, Clinical Lecturer Kuwait University - Kuwait - Sherry Nasralla, Lecturer University of Bahrain - Kingdom of Bahrain - Huda Jawad, Assistant Professor University of Bahrai - Kingdom of Bahrain - Ayodeji Matuluko, FIP Early Career Pharmaceutical Group - United Kingdom - Aline HAJJ, Associate Professor Laval University (Canada) & Saint-Joseph University (Lebanon) - Canada/Lebanon - Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham - UK - Jayanthi Srinivas Kotian, Lecturer University Of Bahrain - Kingdom of Bahrain - Franciscus Kristianto, Lecturer University of Surabaya, Indonesia/ Indonesian Pharmacists Association (IPA) - Indonesia - Yosef Wijoyo, Lecturer Sanata Dharma University - Indonesia - Shepard Nqobile Mhlaba, Assistant Director DATIS - Zimbabwe - Ian Bates, Chair of pharmacy education University College London - UK
Digital health has transformed clinical practice in many ways, and pharmacists need to be ready to use, create, and benefit from the new technologies. The 2021 FIP report on digital health in pharmacy education showed the importance of designing courses, materials, and practical experiences to train a pharmacy workforce with digital skills. At this event, we will reflect on the progress made to date, launch the revised digital health in pharmacy course, and how this initiative builds on FIP competency frameworks and reports.
Co-Moderators: - Jaime Acosta, Community pharmacist Farmacia Acosta - Spain - Dalia Baijs, FIP Lead for Provision and Partnerships - Bahrein
Panellists: Naoko Arakawa, Assistant Professor in International Pharmacy, University of Nottingham, UK Aukje Mantel-Teeuwisse, Professor of Pharmacy and Global Health, Utrecht University, the Netherlands Whitley Yi, Adjunct Lecturer, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Mohamed Baraka, Associate professor of Clinical Pharmacy Al Ain University, UAE Natasa Jovanovic Ljeskovic, Dean Faculty of Pharmacy, Faculty of Pharmacy Novi Sad, Serbia Barry A. Bleidt, Barry and Judy Silverman College of Pharmacy Nova Southeastern University, USA Genuine A. Desireh, Pharmacist, FIP, Kenya
The Global Humanitarian Competency Framework (GbHCF) is a holistic developmental framework designed to be used for pharmacists working in the humanitarian arena internationally. The developmental framework has a clear link with the FIP Global Competency Framework (GbCF) embedding the same four clusters of competencies that are required for effective performance when working in a humanitarian arena. With a global perspective in mind, the framework ensures that an “adopt and adapt” approach for implementation can be consistently applied at global, regional, national and organisational levels.
Moderator: - Rúben Viegas, Practice Development and Transformation Projects Coordinator FIP - The Netherlands - Marwan Akel, Projects Manager Workforce development evidence & impact Journal Editor – Pharmacy Education Journal (PEJ) FIP - The Netherlands
Facilitator: - Nour ElTahla, Projects Coordinator – Equity, sustainability policy and development FIP - The Netherlands
Panellists: - Ali Burak Salman, Membership Marketing Coordinator FIP - The Netherlands - Rony Zeenny, Director, Department of Pharmacy American University of Beirut Medical Center INSPECT-LB - Lebanon - Tasnim Khan, Policy Officer The Pharmacists’ Defence Association - United Kingdom - Catherine Duggan, Chief Executive Officer FIP - The Netherlands
Empowering patient self-care improves health outcomes and reduces the burden of diseases. Improving health and self-care literacy is key to empowering pharmacy-based self-care. This is especially important when it comes to the management of minor ailments through pharmacy. Consisting of a series of five events focusing on common health issues, this new FIP digital programme aims to examine how pharmacists can be enabled to improve health and self-care literacy. Approaches for each of the five areas of minor ailments will be discussed including embedding health and self-care literacy into education and training, developing self-diagnosis and self-medication protocols, widening access to patient information, and improving referral strategies.
This 3rd of 4 Digital Events on mentorship will follow the second event that examined relationships and communication among peers to facilitate successful collaboration. This Event will focus on the responsibilities and behaviours of the organization in promoting successful mentorship. Buy-in from administrators/leaders, recognizing good mentoring, incorporating training and establishing a culture of mentorship, and investing resources will result in not only initial success of a mentoring programme, but also its long-term viability. The program will feature research outlining successful practices a well as speakers with leadership responsibility for long-standing, effective mentoring programs at both organizational and even national levels.
Moderator: - Efi Mantzourani, Reader in Pharmaceutical Sciences - Wales
Panellists: - Shane Desselle, Associate Dean of Research and Professor Touro University California College of Pharmacy - United States - Anandi Law, Professor and Associate Dean Western University - United States - Sanna Passi, Finnish Pharmacists Association - Finland
Empowering patient self-care improves health outcomes and reduces the burden of diseases. Improving health and self-care literacy is key to empowering pharmacy-based self-care. This is especially important when it comes to the management of minor ailments through pharmacy. Consisting of a series of five events focusing on common health issues, this new FIP digital programme aims to examine how pharmacists can be enabled to improve health and self-care literacy. Approaches for each of the five areas of minor ailments will be discussed including embedding health and self-care literacy into education and training, developing self-diagnosis and self-medication protocols, widening access to patient information, and improving referral strategies.
This webinar will provide all necessary information for the FIP Foundation and ECPG Grant for Professional innovation and and guide applicants on how to make the application stronger and more competitive by improving their research proposal.
Moderator: - Amanda Cavness, Clinical Pharmacy Specialist Children’s Hospital of The King’s Daughters - USA
Panellists: - Usman Abubakar, Assistant Professor Qatar University - Qatar - Jack Collins - Australia
This 2nd of 4 Digital Events on mentorship will follow the introductory event on mentoring and focus specifically on the use of motivating language as well as draw upon social provisions theory to evoke more effective communication between mentors, mentees, and all colleagues. Research has demonstrated how communication using these strategies helps to engender organizational and profession commitment, as well as mitigate burnout in pharmacy. They are also useful strategies when mentoring and communicating with persons of varied backgrounds to promote gender and racial equity and increase comfort levels of mentors and mentees who are varied in their background.
Moderator: -Shane Deselle, Associate Dean for Research and Professional Affairs Touro University California College of Pharmacy-USA
Panellists: -Brooke Clubbs, Coordinator, MA in Higher Education Southeast Missouri State University, Department of Leadership, Middle & Secondary Education-UA -Efi Mantzourani, Reader in Pharma;cy Practice University of Cardiff School of Pharmacy-Wales -Imbi Drame, Amine Global LLC-USA -Heiko Spallek, University of Sydney School of Dentistry-Australia
Stress is defined as any type of change that causes physical, emotional or psychological tension, and it has been dubbed as “the health epidemic of the 21st century” by the World Health Organization. Stress is the body's response to any situation that requires attention or action, and everybody experiences some level of stress. However, high levels of stress may lead to various physical, mental, and emotional symptoms such as muscle tension, headaches, fatigue, sleep disorders, irritability, increased heart rate, and difficulty in breathing. Chronic stress is also a risk factor for the development or exacerbations of non-communicable diseases. Pharmacists have an important role in helping people prevent and manage stress though pharmacological and non-pharmacological approaches.
Moderator: - Filipa Alves da Costa, Assistant Professor Faculty of Pharmacy, University of Lisbon - Portugal
Panellists: - Carole Spiers, Chair International Stress Management Association - UK - Hahn, Martina, Clinical pharmacist University hospital Frankfurt and Department of mental health, varisano hospital Frankfurt Hoechst - Germany - Ricardo Cintra, Clinical Phycologist Farmácia Moreira Barata, Lda - Portugal
Empowering patient self-care improves health outcomes and reduces the burden of diseases. Improving health and self-care literacy is key to empowering pharmacy-based self-care. This is especially important when it comes to the management of minor ailments through pharmacy. Consisting of a series of five events focusing on common health issues, this new FIP digital programme aims to examine how pharmacists can be enabled to improve health and self-care literacy. Approaches for each of the five areas of minor ailments will be discussed including embedding health and self-care literacy into education and training, developing self-diagnosis and self-medication protocols, widening access to patient information, and improving referral strategies.
Moderator: - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP) - Netherlands
Co-moderator: - Nour Eltahla, FIP Projects coordinator for Equity, sustainability policy and development FIP - Netherlands
Panellists: - Muriel Schneider, Program director Global Self-Care Federation - Global but based in Switzerland - Jonathan Penm, Senior Lecturer The University of Sydney - Australia - Iqbal Fahs, Clinical Assistant Professor Lebanese International University - Lebanon
Generic drugs play an important role in helping to address rising health care costs and in promoting access to medicines. Development and availability of generic drugs is a challenge in the United States and globally. In addition, the requirements and scientific approaches to developing and assessing generic drugs can vary from country to country. To help address all of these issues, FDA established a multi-country forum, the Generic Drug Cluster, to achieve a common understanding of each member agency’s generic drug regulatory requirements and to help increase scientific alignment.
Moderator: - Mathew Cherian PhD Consultant Self employed - The United States
Participants: - Sarah Ibrahim, Associate Director CDER, US FDA - The United States
Sleep is a basic human need and it is essential for optimal health and well-being. However, lifestyle and environmental factors are increasingly causing sleep disturbances or sleep disorders. The negative effects of sleep deprivation include physical effects (e.g., sleepiness and fatigue), decline in cognitive function (e.g., diminishment of mental concentration and performance, increasing the risk of accidents and injuries), and mental health complications (e.g., increasing feelings of irritability, anxiety, sadness, and anger, and difficulty to manage stress). Sleep deprivation also increases the risk of chronic diseases. Pharmacists can play a role in managing and supporting people in dealing with sleep disorders through pharmacological and non-pharmacological approaches .
Moderator: - Jaime Acosta-Gómez, Community pharmacist Farmacia Acosta - Spain
Panellist: - Erna Sif Arnardóttir, Associate Professor Reykjavik University - Iceland - Bingqian Zhu, Research Associate Professor, Associate Dean for Research Shanghai Jiao Tong University School of Nursing - China - Zaswiza Mohamad Noor, Associate Professor, Academic Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak - Malaysia - Julie Ann Dopheide,Professor of Clinical Pharmacy, Psychiatry and the Behavioral Sciences University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences - United States of America
In recognition of different regional needs, this event summarizes a new approach for FIP to advance regional priorities that are aligned with FIP’s global objectives. Presentations will highlight the relevance of a Biopharmaceutical Classification System (BCS)-based biowaiver regulatory strategy and outline the regionally-driven approach to implement harmonized biowaiver legislation among Latin American countries. FIP’s role as a facilitator in raising awareness among relevant stakeholder can be adapted to other priorities of different regions that are aligned with FIP’s global vision of a world where everyone benefits from access to safe, effective, quality and affordable medicines.
Moderator: - Giovanni M. Pauletti, Scientific Secretary, International Pharmaceutical Federation (FIP) - USA
Panellist: - Steve Estêvão Cordeiro, Technical Officer at the World Health Organization World Health Organization - Switzerland - Talita Ferreira, Coordinator Latin America Biowaiver Project ANVISA - Brazilian Health Regulatory Agency - Brazil - Alexis Aceituno, Head SD Sanitary Registry of Bioequivalent Pharmaceutical Products ANAMED ISPch – Public Health Institute of Chile, National Drug Agency - Chile - Eduardo Agostinho Freitas Fernandes, Specialist in health regulation and surveillance ANVISA - Brazilian Health Regulatory Agency - Brazil
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, healthcare professionals are in contact with multiple patients daily and are therefore at increased risk of contracting and further spreading vaccine-preventable diseases.
Moderator: - Luís Lourenço, FIP Professional Secretary FIP - Portugal
Panellist: - Ryan Forrey, Global Clinical Solutions Director BD - U.S.A. - Jerry Zee, Uniformed Service (Military) Pharmacist U.S. Public Health Service Commissioned Corps - U.S.A. - Mansi Doshi, Medicines Optimisation Pharmacist and Adjunct Professor, Medicines Optimisation Clinic; PIPR, Parul University (Vadodara); MET, Mumbai University (Mumbai) - India - Safiye Çağansel, Owner / Pharmacist in Charge, Safiye Çağansel Eczanesi/Pharmacy - Cyprus - Sherif Guorgu-President FIP Community Canada - Filipa Alves da Costa, Assistant professor University of Lisbon - Portugal - Sola Solarin, President FIP Industrial Pharmacy Section - Nigeria - Susan James, Representatieve FIP Pharmacy Technicians Advisory Committee - Canada - Rúben Viegas, Practice Development and Transformation Projects Coordinator FIP - The Netherlands
Empowering patient self-care improves health outcomes and reduces the burden of diseases. Improving health and self-care literacy is key to empowering pharmacy-based self-care. This is especially important when it comes to the management of minor ailments through pharmacy. Consisting of a series of five events focusing on common health issues, this new FIP digital programme aims to examine how pharmacists can be enabled to improve health and self-care literacy. Approaches for each of the five areas of minor ailments will be discussed including embedding health and self-care literacy into education and training, developing self-diagnosis and self-medication protocols, widening access to patient information, and improving referral strategies.
“Whole life mentoring” is the highest form of personal development, and encompasses advanced communication and relationship-building strategies. Mentoring programmes must account for organizational culture and resources that can impact individuals and the entire workforce, while successful dyadic and/or group mentoring partners must avert potential pitfalls, engage in nurturing communication that builds capacity, enhance competency, promote well-being, and bolster teamwork. This digital event addresses the creation and maintenance of successful, thriving mentoring relationships from both the organization and individual levels, with attention paid toward cultivating leadership throughout education and practice, thus preparing all persons for continuous professional development.
1. Compare and contrast “whole life mentoring” versus other types of mentoring, coaching, and advising, and describe how this approach aims to further develop the pharmacy workforce. 2. Discuss behaviours, communication strategies, best practices, and ideal attitudes of both mentors and mentees involved in either formal or informal mentoring. 3. Discuss similarities and differences in mentoring persons in various sectors of the pharmacy workforce, including researchers, educators, pharmacists, and support personnel.
Moderator: - Victoria Garcia Cardenas, Senior Lecturer in Pharmacy University of Technology Sydney - Australia
Panellists: - Shane Desselle, Associate Dean of Research and Professional Affairs, and Professor, Touro University California - U.S.A. - Efi Mantzourani, Reader in Pharmaceutical Sciences, Cardiff University - Wales - Fernanda Stumpf Tonin, Researcher Assistant, Polytechnic Institute of Lisbon - Portugal
This digital event will describe how professional and regulatory organizations are supporting the pharmacy technician workforce throughout the world. Presenters will also discuss recent initiatives of the FIP Pharmacy Technicians Advisory Committee.
Learning Objectives: ● Identify ways that professional and regulatory bodies support the pharmacy technician workforce ● Recognize the role of advocacy in supporting the pharmacy technician workforce ● Describe recent projects of the Pharmacy Technicians Advisory Committee
Moderator: - Catherine Schuster, Coordinator of Pharmacy Technician Programs Accreditation Canadian Council of Accreditation of Pharmacy Programs - Canada
Panellist: - Dana Lyons, Technical Practice Manager Alberta Health Services - Canada - Abigail Tan, Senior Pharmacy Technician KK Women's and Children's Hospital - Singapore - Ryan Burke, Director of Professional Affairs Pharmacy Technician Certification Board - United States
How digital health is changing care delivery for pharmacists and improving public health
Description
The FIP Technology Forum brings together experts from within FIP membership to exchange views on current activities, problem areas, best practices, and more, in technology. It also serves as a networking platform for finding new contacts among fellow pharmacists and allows members to work together on joint projects that bring added value and are aligned with FIP’s Strategic Plan. In this session, participants will learn more about the activities led by FIP Technology Forum as well as be exposed to an array of topics related to digital services in pharmacy, the challenges and benefits of digitisation in pharmacy and the impact on pharmacy education and training.
What is around the corner for digital pharmacy?
Learning objectives: • To get to know the FIP Technology Forum • Get insight to the FIP resources on digital health • To learn about the digital development of pharmacy practice in different settings post Covid-19 • Create interest for attending the FIP World Congress of Pharmacy in Brisbane
Chair: - Lars-Åke Söderlund, Executive Advisor Apoteket AB, Sweden - Sweden - Jaime Acosta-Gómez, Community pharmacist Farmacia Acosta - Spain
Panellists: - Paul Fahey, Director Glenough Consulting Limited - Ireland - Rob Moss, Immediate past president FIP - The Netherlands - Claudia Rijcken, Founder / CEO Pharmi - The Netherlands - Nataša Jovanović Lješković, Dean of Faculty of Pharmacy Faculty of Pharmacy Novi Sad - Serbia - Whitley Yi, Pharmacy Specialist and Delivery Lead, Adjunct Lecturer University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences - United States
FIPWiSE (Women in Science and Education) is a programme that was launched by the International Pharmaceutical Federation (FIP) on 11 February 2020 on the United Nations’ International Day of Women and Girls in Science. Three years since its launch, several initiatives and transformation tools were introduced including FIPWiSE Toolkit for Positive Practice Environments for Women in Science and Education, FIPWiSE Rising Stars List, Women Leadership Lab, Fearless Podcast Series and Mentorship Programme
This special event is hosted so that, together, we can celebrate the 3rd year anniversary of FIPWiSE. We will be revisiting the key outcomes delivered, reflecting on their successes, impacts and lessons, and discussing a future for FIPWiSE with the widest reach and social value. We want to reflect how FIPWiSE supports women to in pharmacy achieve their fullest potential, and to attract female students and young professionals into these fields.
Learning objectives:
Celebrate the United Nations’ International Day of Women and Girls in Science.
Understand the aim and scope of the FIPWiSE programme and its key initiatives.
Discuss how the initiative can further support women in pharmaceutical science and education into the future.
Participants: - Catherine Duggan, FIP CEO, The Netherland - Claire Thompson, FIPWiSE Chair, CEO Agility Life Sciences, UK - Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, FIP, The Netherlands - Zuzana Kusynova, FIP Lead for Policy, Practice and Compliance, FIP, The Netherlands - Aysu Selcuk, FIP Educational and Primary Health Care Policies Specialist, FIP - The Netherlands - Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, FIP, The Netherlands - Alison Etukakpan, FIP Educational Partnership Specialist, FIPt, The Netherlands - Lilian Azzopardi, Head, Department of Pharmacy University of Malta, Malta - Charlotte Rossing, Director of Research and Development, The Danish College of Pharmacy Practice, Denmark - Marilyn Morris, Distinguished Professor and Chair of the Department of Pharmaceutical Sciences University at Buffalo, US - Dalal Hammoudi Halat, Common Year Coordinator - QU Health, Qatar University, Qatar
Pharmacy professionals are fully committed to an interprofessional and person-centred approach to healthcare. Where the regulatory framework permits, a broad range of point-of-care (POC) tests can be performed at community pharmacies or clinical biology laboratories. POC tests can provide valuable information to support health-related decision making and reduce unnecessary presentations to general practitioners or emergency departments. POC tests may also be provided as part of a disease state management service to monitor the outcomes of treatment in people with chronic non-communicable diseases. In addition, pharmacy professionals can use POC tests to intervene and provide safe and quick pharmaceutical care in acute situations.
Attendees will learn about:
1. The role of pharmacy professionals in point-of-care testing; 2. The importance of providing point-of-care testing services in the screening and management of chronic non-communicable diseases and acute situations; 3. Challenges and opportunities for pharmacists in addressing point-of-care testing services.
Moderator: - Daragh Connolly, Chair of the FIP Board of Pharmaceutical Practice, Ireland
Panellists: - Sherif Guorgui, President, FIP Community Pharmacy Section, Canada - Julien Fonsart, Head of the Clinical Biology laboratory, Saint-Louis Lariboisiere University Hospitals, Greater Paris University Hospitals (APHP), France - Teresa Torres. General Director of GO FAR ANF, Portugal - Efi Mantzourani, Reader in Pharmacy Practice / Research and Evaluation Lead in Choose Pharmacy, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University / Primary Care, Digital Health and Care Wales, NHS Wales, UK
This webinar is the third of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will cover: • Current health economics stance on precision medicine applications • What we know and what we don’t know about precision medicine cost-utility • How costs may evolve with emerging technologies or trends • Priorities for future HTA research in this area
At the end of this session, participants will be aware of: • The impact of precision medicine advancements on health technology assessment • The economic arguments for and against precision medicine • International coordination in health technology assessment policies for precision medicine
Moderator: - Donnacha Fitzgerald, Predoctoral Fellow, The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital - Germany
Panellists: - Stephanie Huang, Professor Department of Experimental and Clinical Pharmacology, University of Minnesota, USA - IÑAKI GUTIERREZ-IBARLUZEA, Board Director and Former President Health Technology Assessment International (HTAi), Spain
FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.
The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.
Panellists: - Sarah Sorum, Executive Vice President & CEO, Pharmacy Society of Wisconsin, an ASHP state-affiliate, United States - Marisol Flores Campos, Pharmacovigilance Officer, Punto Seguro, Costa Rica - Pedro Costa e Silva, Manager - Health Services Business Unit, Associação Nacional das Farmácias (ANF), Portugal - Omaima Arab, Scientific evaluation expert, Saudi Food and Drug Authority, Saudi Arabia
This webinar will focus on how to develop innovative pharmacy education curricula to better respond to global public health needs. It will also discuss the importance of covering all pharmacy fields and specialties in the pharmacy program, and how to integrate digital health in the global pharmacy education to continuously enhance the quality of education and competencies of the pharmaceutical workforce, as having competent pharmaceutical workforce is critical to providing quality health care services
1. Highlight the importance of quality of education for pharmaceutical workforce to provide high quality health services 2. Understand the innovative pharmacy education curricula 3. Providing effective strategies for comprehensive pharmacy education and training 4. Examining global tools and approaches to integrate e-learning and digital health to enhance the quality of pharmacy education and competencies of health
Moderators: - Hanane Kebaili, President of the Algerian Early Career Pharmacists Group , Fédération Algérienne de Pharmacie, Algeria - Abby A. kahaleh, PhD, MS, BPharm, MPH, FAACP, Board of Trustees Faculty & Tenured Faculty of Clinical and Administrative Sciences, RUCSHP, USA
Panellists: - Abeer Al-Ghananeem, Professor of Pharmaceutics and Biopharmaceutics, Associate Dean for Research College of Pharmacy and Health Sciences, Sullivan University, Louisville, Kentucky, USA - Anisha Sandhu, FIP AcPS Communication & Collaboration Working Group Member, FIP Technology Forum Committee Member; Assistant Lecturer, Monash University Malaysia School of Pharmacy, Malaysia - Martin Henman, Associate Professor in the Practice of Pharmacy, The School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland - Carl Schneider, Associate Professor in Pharmacy Practice, The University of Sydney School of Pharmacy, Faculty of Medicine and Health, Australia
Research has shown that women may receive less intensive, less effective and lower quality treatment due to stereotyped responses attributed to women, such as dramatising, overemphasising their experiences of pain, being more willing to report pain, inaccurately reporting pain or being less tolerant to pain than men. It results in the underestimation and undertreatment of women’s pain worldwide. This is often referred to as the “gender pain gap”.
Regarding the gender pain gap, self-awareness and training are not issues owned only by pharmacists; they should be shared with all healthcare professionals and the public.
Pharmacists can be supported to address the gender pain gap through education and partnerships. Good understanding of the variety of pain symptoms can support unbiased pain management. Pharmacists also have a responsibility to educate the public on where and how to seek help for pain management, thus further addressing the gender pain gap.
The event aims to
Define the gender pain gap
Increase awareness about gender pain gap
Describe how pharmacists can be supported to address the issue
Describe the knowledge and training for pharmacists to close the gender pain gap
Learning objectives:
Understand the gender inequalities in pain research
Increase their awareness of gender gap in treatment offers for pain management
Describe knowledge and training status on unconscious bias towards women in pain management
Define knowledge, attitudes and practices that pharmacists have, to close the gender pain gap
Describe how pharmacists can be supported with e.g. training, tools to address gender inequalities in pain management, bring close the gender pain gap, achieve behavioural change towards women
Chair: - Parisa Aslani, Professor, The University of Sydney School of Pharmacy, Australia
Facilitator: - Aysu Selcuk, FIP Education and Primary Health Care Policies Specialist, The Netherlands
Panellists: - Catherine Duggan, FIP CEO, The Netherlands - Jonathan Penm, Senior lecturer, The University of Sydney School of Pharmacy, Australia - Jack Collins, Postdoctoral Research Associate, The University of Sydney, Australia - Leticia Caligaris, Community pharmacist lead, Executive committee member, member of Pharmacist Association of Uruguay - Miranda Sertic, Associate Professor, Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia - Roger Knaggs, Associate Professor in Clinical Pharmacy Practice, University of Nottingham, UK
Pharmacists have an important role in supporting the management of minor ailments in the community and promoting informed and responsible self-care. Gastroesophageal reflux is a common reason for consultations to community pharmacists, and symptoms associated with reflux can often be managed through non-prescription medicines. Pharmacists can assess and provide advice on both the pharmacological and non-pharmacological options that patients might follow, check for possible interactions with medication that patients might be taking, and provide education for improved self-care.
Attendees will learn about:
1. The resources FIP developed on reflux management 2. Understand the main therapeutic options to support relief of reflux-like symptoms 3. Explore pharmacists’ perspectives of reflux management
Moderator: - Luís Lourenço, FIP Professional Secretary FIP, Portugal
Panellists: - Rúben Viegas, Practice Development and Transformation, Projects Coordinator FIP, The Netherlands - Kai Zhen Yap, Lecturer, National University of Singapore, Department of Pharmacy, Singapore - Ana Zovko, Member of the ExCo of CPS of the FIP, Owner and director , Pharmacy institution Afarm, Bosnia and Herzegovina - Pali Hungin, Emeritus professor, Institute of Health and Society, Faculty of Medical Sciences, Newcastle University, UK - Peter Kahrilas, Professor of medicine,, Northwestern University, Feinberg School of Medicine, USA
The COVID-19 pandemic highlighted the requirement for current and future pharmacy education to be improved to strengthen the pharmacy profession and improve resilience. With the demand and options at higher education increasing, enrolment strategies have become more critical to pharmacy institutions.
FIP AIM has developed a handbook to support academic pharmacy leaders to update enrolment management strategies in schools of pharmacy. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help global health leaders to implement new enrolment methods.
• Develop strategies to recruit more and better students into pharmacy schools using traditional and social media • Advocate for the profession, its scope of practice, and its importance in the healthcare system • Reflect on a global integrated approach to foster student interest and improve admissions
Moderator: - Pierre Moreau, Dean FIP, Kuwait University, Kuwait
Panellists: - Lilian Azzopardi, FIP AIM Chair-elect & AIM Advisory Committee member, Head, Department of Pharmacy University of Malta-Malta - Brian Hemstreet, Associate Dean for Student Affairs University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences-USA - Frank Moriarty, Pharmacist and senior research fellow RCSI School of Pharmacy and Biomolecular Sciences-Ireland - Gea Abigail U. Ecoy, Assistant Professor and Chair University of San Carlos-Philippines - Hanan Refaat, Dean Future University-Egypt - Marlon Prince, FIP AIM member, Director of Admissions at Howard University College of Pharmacy-USA - Mohd Zulkefeli Mat Jusoh, FIP AIM member, Dean International Medical University-Malaysia - Rajani Shakya, Head of Department of Pharmacy Kathmandu University-Nepal - Wendy Cox,Assoc. Dean, Admissions and Accreditation, University of North Carolina at Chapel Hill Eshelman School of Pharmacy-USA
FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.
Regulations of pharmacy practice is a critical determinant of pharmacists’ authority to administer and/or prescribe vaccines. FIP data shows that regulations on pharmacy-based vaccination vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies describing how pharmacy-based vaccination, including prescribing, is regulated in their countries.
Panellists: - Hanne Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association, Norway - Fei Sim, National President Pharmaceutical Society of Australia, Australia - Luna Bizri, Founder and manager of community pharmacy; Clinical Assistant professor; Adjunct faculty member Lunapharm pharmacy; Lebanese International University; Lebanese American University, Lebanon - Joyce Mariama Kallon, Team Lead for the supply Chain and logistics vaccine unit Immunisation unit, Sierra Leone
Telepharmacy has gained increasing importance in the delivery of pharmaceutical care, largely due to the COVID-19 pandemic which has placed enormous pressures on healthcare systems globally. There are some innovative models of telepharmacy services aimed at optimizing and improving access to pharmaceutical care, resulting in improved patient safety and outcomes. However, despite these benefits, major barriers for implementation of telepharmacy remain such as patient confidentiality and privacy of health information.
Attendees will learn about:
1. The global role of telehealth in supporting primary health care services 2. The current trends in telepharmacy around the globe 3. Examples of good practice in telepharmacy
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
Panellists: - Rúben Viegas, Practice Development and Transformation Projects Coordinator, The Netherlands - Sarah Dineen-Griffin, FIP CPS ExCo member, Australia - Jaime Acosta, Community pharmacist Farmacia Acosta, Spain - Josep M. Guiu-Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain - Derrick Muneene, Unit Head, Digital Health Capacity Building and Collaboration, WHO, Switzerland
Biorelevant in vitro performance testing of orally administered dosage forms has become an important tool for the assessment of drug product in vivo behavior. An in vitro performance test which mimics the intraluminal performance of an oral dosage form is termed biorelevant. Biorelevant tests have been utilized to decrease the number of in vivo studies required during the drug development process and to mitigate the risk related to in vivo bioequivalence studies.
Prediction of intraluminal performance of an orally administered dosage form and the active pharmaceutical ingredient with biorelevant in vitro performance testing requires appropriate simulation of luminal conditions. Key luminal parameters to be simulated may vary with the process to be simulated, the structure of the active pharmaceutical ingredient and the type of dosage form. A variety of biorelevant media have been proposed, making it now possible to simulate most regions in the gastrointestinal tract in both prandial states. The levels of biorelevance and accompanying decision tree may serve as a useful tool during formulation development, in order to ensure high quality, predictive performance results without unnecessary complexity of media.
• Participants will be introduced in biorelevant dissolution testing • Participants will be informed on dissolution media that simulates the physicochemical characteristics of the contents of the gastrointestinal lumen • Participants will be informed on the in vitro methodologies that have been shown to be useful in simulating the intraluminal environment
Chair: - Horst-Dieter Friedel, FIP Chair Regulatory Sciences and Quality, Director Former at Bayer AG, Germany
Moderator: - Christos Reppas, Professor in Pharmaceutics National and Kapodistrian University of Athens, Greece
Guests: - Maria Vertzoni, Associate Professor in Pharmaceutical Technology and Biopharmaceutics National and Kapodistrian University of Athens, Greece
One year after the launch of the FIP global call to action on advancing pharmaceutical education, FIP will report on each region’s progress against the call to action, building on the results of the FIP-UNITWIN inter-regional impact workshops held in November 2022. The event will also host the launch of the FIP Education transformation toolkit, which will be a collection of FIP’s relevant publications and digital events to implement the FIP global call to action on advancing pharmaceutical education.
Objectives: 1. Present progress since 2021 on priority FIP Development Goals of the regions in the context of pharmaceutical education 2. Present progress on FIP-UNITWIN regional roadmaps 2021 and the impact on FIP global call to action on pharmaceutical education 3. Discuss the way forward for the delivery of each regions’ roadmaps with establishment of regional FIP-UNITWIN centres for excellence programme in the months ahead 4. Launch the FIP Education transformation toolkit
Moderators: - Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences- USA - Lilian Azzopardi, FIP AIM Chair-elect , University of Malta -Malta
Panellists: - Toyin Tofade, President Albany College of Pharmacy and Health Sciences, USA - Silvana Nair Leite, Professor Federal University of Santa Catarina, Brazil - Arinola Joda, Assistant Secretary & Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria - Rajani Shakya, Ass.Prof. Department of Pharmacy, Kathmandu University, Nepal - Mohamad Rahal, Dean School of Pharmacy, Lebanese International University, Lebanon - Paul Gallagher, Prof.Department of Pharmacy, National University of Singapore, Singapure - Nilhan Uzman, FIP Lead for Education & Primary Health Policies, Turkey - Alison Etukakpan, Educational Partnership Specialist International Pharmaceutical Federation, Nigeria
Pharmacists as athlete support personnel have rooted themselves as key players in medical teams serving athletes. Sports pharmacy evolved from a niche practice during the establishment of WADA two decades ago, gaining traction with the publication of the FIP guidelines “The Role of the Pharmacist in the Fight against Doping in Sport” in 2014. Today, we recognise sports pharmacy as a specialty practice, fundamental to the antidoping movement and athlete health. Pharmacists provide accurate sports drug information, avoid inadvertent doping, and coordinate pharmacy services at sporting events. We present two successful models in education and proper training of pharmacists to work with athletes.
Attendees will learn about:
1. Exploring the specialty of sports pharmacy based on expert consensus 2. Discussing a foundation for sports pharmacy curricula 3. Describing a successful example of sports pharmacy practice
Moderator: - Daragh Connolly, Chair Board of Pharmaceutical Practice, Ireland
Panellists: - Ashley Anderson, Clinical Sports Pharmacy Specialist / Antidoping Pharmacist International Sports Pharmacists Network, USA - David Mottram, Emeritus Professor- Liverpool John Moores University, UK - Mark Stuart, Pharmacist to the International Olympic Committee Medical Commission International Olympic Committee, UK - Claire May, Academic University of Brighton, UK - Somer Helvaci, Lecturer IOC accredited sports pharmacist, Turkey - Shigeo Yamamura, Specially-Appointed Professor Josai International University, Japan
Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.
By the end of the session participants will: - Understand the specific vaccination needs of several special-risk population groups - Become familiar with FIP’s resources on vaccination for special-risk groups - Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups
Panellists: - Jean-Luc Eiselé, CEO World Heart Federation, Switzerland - Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally) - Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine - Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom - Jane Barratt, Secretary-General International Federation on Ageing, Canada - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK
Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.
By the end of the session participants will: - Understand the specific vaccination needs of several special-risk population groups - Become familiar with FIP’s resources on vaccination for special-risk groups - Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups
Panellists: - Jean-Luc Eiselé, CEO World Heart Federation, Switzerland - Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally) - Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine - Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom - Jane Barratt, Secretary-General International Federation on Ageing, Canada - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK
Remuneration of pharmacy vaccinations is one of the key policy enablers of pharmacy-based vaccinations, and thus life-course immunisation. FIP data shows that remuneration models vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies sharing their remuneration models and journeys for the benefit of policy-enablement everywhere.
This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.
Moderator: - Sari Westermarck, Community pharmacist FIP Community Pharmacy Section, Finland
Panellists: - Eleftherios Marinos, General Secretary-Federation of Pharmacists’ Cooperatives of Greece, Greece - Ahmad Al-Rusasi, General manager/Lecturer Alnoor Drug Store, Jordan - Sham Moodley, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa - Susan O’Dwyer, Head of Governance and Pharmacy Service, Irish Pharmacy Union, Ireland - Luís Lourenço, President of the South and Autonomous Regions Branch of the Portuguese Pharmaceutical Society, Portuguese Pharmaceutical Society, Portugal
The COVID-19 pandemic is one of the greatest public health emergencies of our time. The development of new diagnostics, treatments and vaccinations has arguably required greater innovation and collaboration across research, pharmaceutical industry and healthcare sectors than ever before. This event reflects on innovations and collaborations during the COVID-19 pandemic. Consideration will be given to applying what has been learnt to future pandemics.
Aim To reflect on innovations and collaborations in pharmaceutical science that have made an impact against COVID-19. To consider how to apply this learning to our response to future pandemics.
Learning objectives:
• Explain how pharmaceutical scientists innovated and collaborated in the fight against COVID-19. • List challenges and opportunities for the development of diagnostics, treatments and vaccinations during the COVID-19 pandemic; • Discuss approaches for fast-tracking diagnostics, treatments and vaccinations in future pandemics without compromising patient safety. • Reflect on what has been learned from innovative and collaborative approaches during the COVID-19 pandemic that can be used for future pandemics.
Moderator: - Chris John, FIP Lead for Data and Intelligence, UK
Panellists: - Louise Druedahl, Researcher University of Copenhagen, Denmark - N Udupa, Research Director Shri Dharmasthala Manjunatheshwara University, India - Yvonne Perrie, Professor of Drug Delivery University of Strathclyde, UK
This event will discuss pharmacists’ roles in infectious & tropical disease prevention, and management by improving pharmacists’ knowledge in these diseases as well as showcasing practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications across Africa in the context of infectious and tropical diseases. Pharmacists are uniquely positioned to provide a wide array of services to prevent, and manage infectious and tropical diseases. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of infectious & tropical disease.
Learning objectives 1. Improve knowledge of pharmacists in the scope of infectious & tropical diseases as well as anti-infectives within the African region; 2. Showcase practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications in the context of infectious & tropical diseases as well as anti-infectives within the African region; 3. Identify the needs and priorities of pharmacists in the prevention and management of infectious & tropical diseases within the African region.
Moderator: - Jocelyn Chaibva, Vice president African Pharmaceutical Forum, Zimbabwe
Facilitators: - Nilhan Uzman, FIP Lead for Education and Primary Health Policies, Turkey - Alison Etukakpan, FIP Educational Partnership Specialist, Nigeria
Guests: - Mirfin Mpundu, Director ReAct Africa, Kenya - Natalie Schellack, Head of the Department of Pharmacology, University of Pretoria, South Africa - Arinola Joda, Associate Professor University of Lagos, Nigeria
This event will discuss pharmacists’ roles in infectious & tropical disease prevention, and management by improving pharmacists’ knowledge in these diseases as well as showcasing practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications across Africa in the context of infectious and tropical diseases. Pharmacists are uniquely positioned to provide a wide array of services to prevent, and manage infectious and tropical diseases. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of infectious & tropical disease.
Learning objectives 1. Improve knowledge of pharmacists in the scope of infectious & tropical diseases as well as anti-infectives within the African region; 2. Showcase practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications in the context of infectious & tropical diseases as well as anti-infectives within the African region; 3. Identify the needs and priorities of pharmacists in the prevention and management of infectious & tropical diseases within the African region.
Moderator: - Jocelyn Chaibva, Vice president African Pharmaceutical Forum, Zimbabwe
Facilitators: - Nilhan Uzman, FIP Lead for Education and Primary Health Policies, Turkey - Alison Etukakpan, FIP Educational Partnership Specialist, Nigeria
Guests: - Mirfin Mpundu, Director ReAct Africa, Kenya - Natalie Schellack, Head of the Department of Pharmacology, University of Pretoria, South Africa - Arinola Joda, Associate Professor University of Lagos, Nigeria
The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.
By the end of the session participants should be able to: • Understand the roles pharmacists can play in HIV prevention, screening and management • Recognise some resources and tools that pharmacists can use in this area • Find and use the FIP toolkit on HIV prevention, screening and management
Moderator: - Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
Panellists: - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Ali Ahmed, Ph.D. Final Year Student (Clinical Pharmacy) Monash University Malaysia, Malaysia - Alicia Krüger, Clinical pharmacist Brazilian federal council of pharmacy, Brazil - Elise HARO-BRUNET, Employed pharmacist CESPHARM (prevention committee) / French Chamber of pharmacists, France - Romeo Ongpoy Jr, Dean Emilio Aguinaldo College - Cavite Campus, Philippines - Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, USA - Hamish Bowden, Senior Clinical Pharmacist (HIV & Sexual Health) The Albion Centre NSW Health, Australia
Long covid, also known as post COVID-19 condition, is estimated to affect 10-20% of people who develop COVID-19. While the majority go on to fully recover, this group of people suffer a variety of physical, physiological and cognitive symptoms for many weeks, months and sometimes longer. The condition can be debilitating and recovery requires a holistic and personalised care approach, including pharmaceutical care.
This event by FIP aims to explore in more depth what long covid is, what the key characteristics and symptoms are and how these symptoms can be managed in the pharmacy. The panellists include a public health expert on long-covid-19, a clinical pharmacist who is recovering from long covid, a physiotherapist and more.
Learning objectives: 1. Describe the key characteristics and symptoms of long COVID-19 2. Understand the latest research and evidence concerning treatment and care 3. Discuss ways long covid symptoms can be managed in the pharmacy 4. Identify the importance of pharmacists' understanding of the condition and care needs
Moderator: - Leonila Ocampo, FIP Community Pharmacy Section, Asia Pacific Institute for Medication Management Philippine Pharmacists Association, Philippines
Panellists: - Darren Brown, Clinical Academic Physiotherapist, Chelsea and Westminster Hospital NHS Foundation Trust; Long COVID Physio, United Kingdom - Rani Khatib, Consultant Cardiology Pharmacist and Associate Professor University of Leeds, United Kingdom - Lucette Cysique, Associate Professor The University of New South Wales, Australia
Webinar video • 24 November 2022, 14:00 - 15:30 CET
Supporting pharmacy leaders and educators for implementing competency-based education in pharmacy and pharmaceutical sciences education: Launch of the FIP CBE implementation handbook
Competent pharmaceutical workforce is vital to ensure healthy lives and promote well-being. This is aligned with the FIP Development Goals. Competency-base education (CBE) model became a core of healthcare professions education and training globally.
Some challenges are encountered relating to the implementation of CBE model to initial pharmacy and pharmaceutical education and training (IPET). Hence, FIPEd team has developed the handbook to support pharmacy leaders and educators for their journey of CBE implementation in their education programme. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help them implement CBE.
Learning objectives: • Understand the importance of CBE in pharmacy and pharmaceutical education • Describe the structure of FIPEd CBE Implementation Handbook • Identify how the Handbook can support oneself for their CBE implementation journey
Panellists: - Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK - Jessica McMullen, Pharmacist and PhD Student University of Nottingham, UK - Andries Koster, Associate Professor of Pharmacology Dept. Pharmaceutical Sciences, Utrecht University, The Netherlands - Pierre Moreau, Professor of pharmacology and therapeutics College of pharmacy Kuwait University, Kuwait - Shaun Gleason, Global Lead for Academic Capacity, FIP Workforce Development Hub, Assistant Dean for Distance Degrees and Programs; Associate Professor of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy, USA
Our final event will celebrate the success of the AMS in Action Webinar series as we reflect on the great work being done globally to tackle AMR.
We will showcase our competition winners who will share their innovative ideas and tools to help support AMS and prevent the spread of AMR.
Join us in our Call to Action! Make a pledge with Antibiotic Guardian about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to: • Provide education and development • Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans. • Inform the 2023 Commitment to Action and Health Ministers Summit.
Learning objectives: With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:
Outline regional educational and development headline needs in AMR and AMS,
Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
Input on how they can contribute to the FIP AMR 2023 plans.
Chair: - Manjiri Gharat, FIP Vice President & Chair of the FIP Commission on AMR, India
Guest: - Victoria Rutter, Executive Director, CPA, UK
Facilitators: - Dalia Bajis, FIP Lead for Provision and Partnerships, Bahrain - Chin-Yen Yeo, Senior AMS Pharmacist, Concord Repatriation General Hospital, Australia - Fiona Doukas, Senior Project Officer, ACSQHC, Australia
Panellists: - Usman Ebubakar, Senior Lecturer, Universiti Sains Malaysia, Malaysia - Michelle Gijzelaar, National Clinical Pharmacy Manager, Life Healthcare, South Africa - Onyeka Chinwuba Obidiegwu, Lecturer, Nnamdi Azikiwe University, Awka, Nigeria - Roop Gupta, Vice President, IPA, India - Syamhanin Adnan, Leader, AMS Focus Group for Pharmacist, MPS, Malaysia - Fitria Nur Hidayah, Clinical Pharmacist, Cipto Mangunkusumo Hospital, Indonesia
With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to: • Provide education and development • Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans. • Inform the 2023 Commitment to Action and Health Ministers Summit.
Learning objectives: With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:
Outline regional educational and development headline needs in AMR and AMS,
Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
Input on how they can contribute to the FIP AMR 2023 plans.
Chair: - Daragh Connolly, FIP BPP Chair, Ireland
Guest: - Victoria Rutter, Executive Director, CPA, UK
Facilitators: - Aysu Selcuk, FIP Education and PHC Policies Specialist, Turkey - Cátia Caneiras, Professor, University of Lisbon, Portugal - Khalid Eljaaly, Associate Professor, King Abdulaziz University, Saudi Arabia
Panellists: - Alison Etukakpan, FIP Educational Partnership Specialist, Nigeria - Katarina M. Kostadinovic, Chairman, Assembly of Pharmaceutical Chamber of Montenegro, Montenegro - Olfat Fakih, Instructor, Al Razi University, Yemen - Saed Nuh, Chairman of Medicines Regulatory Authority, Ministry of Health Development, Somalia - Cristina Fernández, Hospital Pharmacist, San Juan de Dios Hospital, Costa Rica - José Pablo Díaz Madriz, AMS Director, Clínica Bíblica Hospital, Costa Rica - Brigid K. Groves, Senior Director, Practice&Professional Affairs, APA, USA - Curtis D. Collins, Pharmacy Specialist, Infectious Diseases Trinity Health Ann Arbor, USA
As busy health care professionals we are always looking for tools and resources to make our jobs more efficient and effective. This session will look at some tools and resources that are used in practice across the globe to support AMS initiatives, inspiring you to think about what you could develop or apply in your own practice to help support the more appropriate use of antimicrobials with both patients and colleagues.
Learning objectives: ● Discuss innovative tools for sharing information ● Learn about the development and deployment of an innovative and fun teaching tool ● Describe how you can use different platforms to engage healthcare professionals and communities
Moderator: - Meghna Joshi-von Heyden, Strategic Lead: Partnerships and Advocacy Commonwealth Pharmacists Association, Switzerland - Maxencia Nabiryo, Project Manager Commonwealth Pharmacists Association, Uganda - Israel Sefah, Lecturer and Specialist Pharmacist, Department of Pharmacy Practice in the School of Pharmacy of the University of Health and Allied Sciences, Ghana - Akello Zainab, Lead pharmacist and AMS Technical Lead Gulu Regional Referral Hospital, Uganda - Andrew Balamba, Pharmacist University Teaching Hospital, Zambia - Jessica Fraser, Programmes Coordinator Tropical Health & Education Trust, UK - Ugyen Tashi, Chief Program Officer Essential Medicines and Technology Division (EMTD), Ministry of Health, Bhutan - Bridget Kebirungi, Project Manager Commonwealth Pharmacists Association, Uganda
Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.
Este webinar tiene los objetivos:
• Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos. • Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS. Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina. Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.
Moderadora: - Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica International Pharmaceutical Federation (FIP), Brazil
Panelista: - Diego Alejandro Gutierrez Triana, Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) Director de medicamentos y productos biológicos, Colombia
The US public benefits from reduced costs and improved access to treatment enabled by availability of generics drug products. Patients offer a unique perspective when advocating for accessibility to high-quality and affordable generics. As critical stakeholders, it is important that the FDA Office of Generic Drugs (OGD) captures patient perspectives, needs, and priorities to help better inform patients. This session will explore the role of patients in generic drug development, OGD’s patient engagement sessions to date and the opportunities that can be used to improve patient engagement.
Learning objectives:
The FDA’s perspectives on patient’s role in drug development
How Office of Generic Drugs (OGD) is working on patient engagement
Moderator: - Mathew Cherian, FIP IPS ExCo Member for Webinars, Consultant, USA
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with diabetes have particular vaccination needs that will be highlighted at this event.
By the end of the session participants should be able to: - Understand the most important vaccines for people living with diabetes - Recognise the role of pharmacists in promoting vaccination to people living with diabetes - Discuss strategies for pharmacists to support people living with diabetes with their vaccination needs.
Moderator: - Astrid Czock, CEO QualiCCare, Switzerland
Panelists: - Marco Goeijenbier, Medical doctor internal medicine and intensive care, Spaarne Gasthuis Haarlem/Hoofddorp & Erasmus Medical Center Rotterdam, The Netherlands - Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist, University of Huddersfield and Sheffield Teaching Hospitals NHSFT, United Kingdom - Iryna Vlasenko, Vice president International Diabetes Federation, Ukraine - Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy, Puerto Rico
Pharmacists are well placed as members of the multidisciplinary team but are also key and accessible healthcare professionals for members of the public. Webinar 4 will explore and consider how pharmacists can support AMS in community practice around the globe.
Learning objectives: - Define how pharmacists working in the community can support AMS and IPC initiatives as part of the wider multidisciplinary team; - Explain how different forms of education and awareness raising can support the AMR agenda in the community setting; - Discuss learning opportunities for reducing the risks of AMR that can be harnessed from experiences in treating and managing other infectious diseases such as TB, malaria and HIV; - Describe how you can inspire and engage members of the community in a call to action on AMR; - Demonstrate how AMR can impact patients at an individual, community and global level; and - Apply behaviour change techniques to improve AMS initiatives in community practice.
Moderators
- Claire Brandish, Senior Antimicrobial Resistance Technical Advisor, The Commonwealth Pharmacist Association - Dalia Bajis, Lead for Provision and Partnerships, International Pharmaceutical Federation
Speakers
- Amy Chan, Clinical Academic Pharmacist, University of Auckland - Tadeo Tumusiime, National Programs Coordinator, Makerere University School of Public Health - Erick Venant, Founder- Roll Back Antimicrobial Initiative & Lead Coordinator-BSAC’s-Stop Superbugs, Roll Back Antimicrobial Initiative - Manjiri Gharat, Principal of K M Kundnani Pharmacy Polytechnic, VP of Indian Pharmaceutical Association and VP of FIP, K M Kundnani Pharmacy Polytechnic, FIP and IPA - David Musoke, Senior Lecturer, Makerere University School of Public Health - Ella Balasa, Patient Advocate and Consultant
As we approach a post-pandemic world, the global supply chain has been greatly influenced by various factors. Many different drug and product shortages have been exacerbated in recent years due to supply chain issues. Through this webinar, we want to give a better overview of understanding the current global supply chain, current threats to the supply chain such as drug shortages, natural disasters, counterfeit medicines, and how to create a resilient supply chain as we move forward in society. We also want to emphasize the value of a pharmacist in this area and the difference they can make.
Learning Objectives: 1. Describe the current global pharmacy supply chain 2. Compare the contrast the different threats to the pharmacy supply chain such as drug shortages, natural disasters, and counterfeit medicines 3. Understand how these threats can interrupt the supply chain from each panel member’s perspective/countries 4. Outline how to create a resilient supply chain and future endeavours taking place to protect the supply chain (i.e., automation and technology)
Moderator: - Rob Moss, PharmD, Immediate past president, FIP Hospital Pharmacy Section, FIP, European Association of Hospital Pharmacists, The Netherlands
Panellists: - Yuh Lih Chang, PhD, RPh Director, Department of Pharmacy, Taipei Veterans General Hospital; Principal Investigator, National Drug Shortage management Project; Associate Professor, National Yang-Ming Chiao-Tung University, Taiwan Veterans General Hospital, National Yang-Ming Chiao-Tung University, Taiwan - Dr. Sohail Fitieh, Ph.D, MS PLA, RPh, Pharmacy & Supply Chain Consultant, United Arab of Emirates - Michael Ganio, Pharm.D., M.S., BCPS, FASHP, Senior Director, Pharmacy Practice and Quality, American Society for Health-System Pharmacists, USA
What methods and data can be captured to elucidate how antimicrobials are used in different healthcare settings? How do we know if antimicrobials are being used appropriately and whether there is scope to make improvements? Webinar 3 will consider point prevalence data to understand antimicrobial use, how the data can be utilised to implement change and how to embed that change to create sustainable action.
Learning objectives:
Define the Global Point Prevalence Survey tool and discuss the benefits of using this for data capture;
Appraise different tools for antimicrobial use data capture and understand the pros and cons of each;
Explain challenges to data capture and how to work around these;
Examine how local data can be used to drive positive changes and support AMS initiatives; and
Recognise how continuous quality improvement methodology can be used to help with Point Prevalence Survey data collection and to bring about sustainable behaviour changes as a result.
The FIP Development Goal 3 (Quality Assurance) Leads have developed a pharmacy education quality assurance tool. It can be used as a self-assessment tool, and for data collection to better understand quality assurance of pharmacy education programmes in different countries around the world.
The questions relate to the pharmacy degrees for initial entry to practice and/or licensure of pharmacists, reflected in three core sections: 1. Accreditation processes and accrediting bodies 2. Standards for quality assurance 3. Views on the value, relevance and outcomes of accreditation in the country
Learning Objectives: 1. To provide the rationale for conducting the FIP Quality Assurance in Pharmacy Education survey 2. To describe the three core sections in the QA tool 3. To provide information on completing the survey and potential benefits
Moderator: - Abby A. Kahaleh, PhD, MS, BPharm, MPH, FAACP Tenured Faculty & Board of Trustees Faculty Roosevelt University College of Science, Health, & Pharmacy, USA
Panellists: - Abeer M. AlGhananeem, DG3 Global Lead at FIP Workforce Development Hub, Associate Dean and Professor Sullivan University College of Pharmacy and Health Sciences, USA - Banan Mukhalalati, Global lead for FIP Development Goal 3: quality assurance Assistant Professor Qatar University, Qatar
How nutrition impacts heart health is the focus of this event, the last and final one in the 'Food for thought: Pharmacists' role in healthy nutrition.' The webinar aims to examine the interlinks between nutrition and heart health, its role in the prevention and management of cardiovascular diseases, how pharmacy-based nutrition services can support patients with heart conditions.
The event aims to:
Understand how nutrition impacts heart health
Describe the importance of pharmaceutical care for heart health with a focus on supplements
Highlight the important role of pharmacists in improving heart health and preventing cardiac disease.
Moderator: - Jaime Acosta, FIP-CPS Professional Secretary, Community pharmacist Farmacia Acosta, Spain
Panellists: - Philip Calder, President, Federation of European Nutrition Societies, Head of the School of Human Development and Health at the University of Southampton, UK - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, Portugal - Esraa Altawil, Consultant Clinical Pharmacist King Saud University Medical City, Saudi Arabia
The FIP Global Competency Framework for Educators & Trainers in Pharmacy (FIP-GCFE) is a new tool to support advancement and competence development for our colleagues around the world, serving in any sector of pharmaceutical education. It was initiated by the Academic Pharmacy Section of FIP and created in collaboration across FIP, involving our leads, experts, volunteers across the Federation. This works is authored by experienced authors, global leaders in pharmaceutical education who are active in academic, practice and science fields of the pharmacy profession. The commitment to gather their knowledge, experience, values, and efforts, inspiring our colleagues to advance in the field of education, resulted in comprehensive and evidence-based framework.
Participants will be able to: • Understand how to empower our individual and institutional members, focused on those involved in creating, delivering and assuring quality of pharmaceutical education. • Learn about the valuable source of information and guide for educators and trainers in pharmacy at individual, organizational, national, and global levels. • Understand how to use the Framework for their own personal and professional development. • Start the application, research, and validation of the Framework • Conduct the self-assessment of competencies according to the Framework
Moderators: - Astrid Czock, FIP WDH Global Lead; CEO QualiCCare, Switzerland - Marwan Akel, Projects Manager–Workforce development, evidence & impact Journal Editor – PEJ, Lebanon
Panellists: - Arijana Mestrovic, FIP AcPS Vice President, FIP WDH Global lead for Competency Development; Director, Professional services Pharma Expert, Croatia - Mike Rouse, Director, International Services Accreditation Council for Pharmacy Education. USA - Martin Charles Henman, FIP AcPS ExCO member Adjunct Assoc. Prof. Trinity College Dublin, Ireland - Ian Bates, Chair of pharmacy education-University College London, UK - Catherine Duggan, FIP CEO, Netherlands
Pharmacists have key roles in hospital multidisciplinary teams. Webinar 2 will explore how pharmacists can play a lead role in these teams and drive AMS initiatives in their place of work. How can we implement small day-to-day changes that lead to better patient outcomes? Learn more about the importance of collaboration in hospitals between healthcare professionals and how pharmacists fit into this collaborative work.
Learning objectives:
- Explain the importance of governance structures for successful AMS programmes; - Learn how to set up medicines and therapeutics subcommittees and infection prevention control subcommittees; and - Recognise the impact of AMR on patients when treatment fails.
Guests: - Freddy Eric Kitutu, Senior Lecturer Makerere University, Uganda - Mary Millard, USA - Elaine Cloutman-Green, Consultant Clinical Scientist, Deputy Director of Infection Prevention and Control and Lead Healthcare Scientist, Great Ormond Street Hospital for Children, NHS Foundation Trust, UK - Abraham Weeks, Senior Technical Specialist, Organization of Eastern Caribbean States Pharmaceutical Pooled Procurement Unit Organization of Eastern Caribbean States Commission (OECS Commission), St Lucia - Andrea Kwa Lay Hoon, Assistant Director (Research)/Specialist Pharmacist (Infectious Diseases)/Director of Infectious Diseases Pharmacotherapy Residency. Associate Professor Singapore General Hospital & Duke-NUS Medical School, Department of Emerging Infectious Diseases/NUS Pharmacy, Singapore
This special event is held during a week which marks two significant dates for global health. We will have passed the 1000 days since 30 January 2020 when the World Health Organization declared the COVID-19 outbreak at the time as a Public Health Emergency. The same week will also mark the 4th anniversary since the world, including FIP, came together in Astana in 2018 to endorse the new Declaration of Astana emphasizing the critical role of primary health care. Join us on this special launch event on pandemic preparedness to learn about global pharmacy’s response to COVID-19 and discuss the important of resilient pharmacy and health systems.
Learning objectives: 1. Understand how FIP supported (and continues to support) its members during the pandemic 2. Describe how pharmacy leadership bodies responded to the pandemic across the world 3. Discuss country best practices and lessons for future pandemic preparedness 4. Learn about FIP’s map of primary health care, focusing on strengthening health systems and recovery
Moderator:
- Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, Saudi Arabia
Panellists: - Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (PSSA), South Africa - Hala Sacre, CEO, INSPECT-LB, Lebanon - Clare Fitzel, Head of Professional Services, Irish Pharmacy Union, Ireland - Teresa Almeida, Member of the board of directors, Associação Nacional das Farmácias, Portugal - Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists, Malta - Leonor Soares, Leonor Soares, International Affairs, Portuguese Pharmaceutical Society, Portugal - Nobuo Yamamoto, President, Japan Pharmaceutical Association, Japan - Atsushi Toyomi, Executive Director, Japan Pharmaceutical Association, Japan - Sofía Segura, Professor, University of Costa Rica and College of Pharmacists of Costa Rica, Costa Rica - Roop Gupta, Chairman, Hospital Pharmacy Division and Vice President, India - Jack Shen Lim, Treasurer, Malaysian Pharmacists Association, Malaysia - Daragh Connolly, FIP Chair of BPP, Ireland
FIP staff: - Catherine Duggan, FIP Chief Executive Officer, UK/Netherlands - Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, Saudi Arabia - Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan - Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia - Nilhan Uzman, FIP lead for education and primary health care policies, The Netherlands
The World Health Organization estimate that 17.9 million people die from cardiovascular diseases each year, representing 32% of all global deaths. Pharmacists have a role to play in the prevention, care and management of cardiovascular diseases and their complications. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of cardiovascular diseases-related services. This handbook — which will be launched at this event — also identifies the knowledge and skills that pharmacists require for the provision of such services, thus offering guidance to academic institutions and CPD providers. This handbook is part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Learning objectives:
Explore the role of pharmacists in the prevention, care and management of cardiovascular diseases and their complications;
Identify the challenges and opportunities for pharmacists in addressing cardiovascular diseases;
Identify the relevant knowledge and skills required for the delivery of cardiovascular diseases-related services.
Moderator: - Paul Sinclair, Chair Board of Pharmaceutical Practice FIP, Australia
Panellists: - Jean-Luc Eiselé, CEO World Heart Federation, Geneva, Switzerland - Pedro Amariles, Full professor and researcher on Pharmaceutical Care and Clinical Pharmacy Universidad de Antioquia, Colombia - Francesca Wirth, Senior Lecturer Department of Pharmacy, University of Malta, Malta - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, Portugal - Dalia Bajis, FIP Lead for Provision and Partnerships, Australia
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region across the globe, selected some of the FIP Development Goals which are the priorities of their region. Western Pacific region: DG 1 (Academic capacity), DG 2 (Early career training strategy), DG 4 (Advanced and specialist development), DG 7 (Advancing integrated services), DG 12 (Pharmacy intelligence), DG 19 (Patient safety), and DG 20 (Digital health).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
Western Pacific Panel Discussion on DG priorities and data requirements:
There are 4 DGs that are the foundation of other DGs, specifically for Western Pacific but can also apply globally: 1) DG 1 (Academic capacity), 2) DG 5 (Competency development), 3) DG 9 (Continuing professional development strategies), 4) DG 6 (Leadership development).
DG 12 (Pharmacy intelligence) is very important because much research is being undertaken but attention is needed on how to use the collected data, how it could be applied and operationalized.
DG 18 (Access to medicines, devices, and services) is also a priority, because there is still a challenge to achieve equity and equality in terms of accessing their medicines devices and services.
In terms of DG 1 (Academic capacity), Australia has 47 accredited pharmacy programs offered by 20 providers and 125 pharmacists per 100.000 people. However, about 40% workforce are less than 35 years old and there is an increased proportion on this population who do not intend to practice beyond the next 10 years. There is a need to find out why young people are leaving the profession and whether we have been investing sufficiently to support the young graduates to advance further in their career. The government needs to work together with professional bodies and academic institution to invest more in pharmacy education and training to meet the demands of current and future health care needs.
The development in early career strategy such as residency training programs by Society of Hospital Pharmacy in Australia (SHPA), early career pharmacists (ECP) forum and communities of specialty interests (CSIS) are aligned with the DG 2 (Early career training strategy).
It is much better to have longitudinal data and track things rather than a snapshot. There are some readily available data such as the number of students coming in and go out successfully that might reflect academic capacity. There is a need for a common set of assessment that can be used across the region.
For DG 7 (Advancing integrated services), we need to look at what policies and strategies are needed for strengthening and transforming pharmacy workforce education and systematic training on trainers and educators.
There are some DGs that can be quantified numerically for the monitoring process such as in DG 9 (Continuing professional development strategies) we can count the attendance in continuing professional development events as a ratio to the total membership of the profession.
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Eastern Mediterranean region: DG 2 (Early career training strategy), DG 5 (Competency development), DG 9 (Continuing professional development strategies), DG 13 (Policy development), and DG 19 (Patient safety).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
East Mediterranean Region Panel Discussion on DG priorities and data requirements:
In Qatar, there is a gap in DG 2 (Early career training strategy) i.e. there is a need for training for the early career pharmacists. This also aligns with the competency framework, which is needed for both early graduated pharmacists and advanced pharmacists.
Qatar have done well so far on DG 1 (Academic capacity) and DG 3 (Quality assurance). In terms of quality assurance, College of Pharmacy at Qatar University have gone through accreditation at Canadian Council for Accreditation of Pharmacy Programs (CCAP).
The top priority is to develop a practice framework for pharmacist practitioners whether they are in early or advanced career.
Data needed are the number of pharmacists in the country within different sectors, and whether they are following professional development program or certifying system for continuing their education. Currently Qatar also has a committee which is focusing on professional development not only for pharmacists but also for all health care profession in general. Qatar can also learn to create the framework from FIP and neighbouring countries such as Saudi Arabia.
There is a gap between science, education and workforce which need to be connected in EMR. The competency of pharmacists at work is important. More efforts relating to pharmacy education are needed such as accreditation for the educational level, continuous education, certification, and competency framework as a standard. The variation in pharmacy education globally also needs to be unified.
To advocate for a broader and more harmonized implementation of Biopharmaceutical Classification System (BCS)-based biowaivers in Latin American countries, the FIP is supporting regional leaders in raising awareness of this science-based regulatory pathway designed to accelerate market approval of safe and effective generic pharmaceuticals. The second part of this series of webinars designed specifically for the Latin American region highlights examples of BCS-based biowaiver regulatory approval pathways currently being implemented in select Latin American countries. Experts will address the legislative basis for biowaiver regulations and discuss harmonization opportunities within the region.
This webinar has the objectives:
• Differentiate between in vivo bioequivalence and BCS-based biowaiver regulatory strategies for generic drug approval. • Understand the public health implications of the BCS-based biowaiver regulatory pathway. • Outline opportunities and challenges for the implementation of a harmonized biowaiver regulatory approval process within the Latin American region. • Outline solubility, permeability, and dissolution contributions for BCS-based biowaiver applications.
Moderator: Talita Ferreira, Coordinator Latin America Biowaiver Project International Pharmaceutical Federation (FIP), Brazil
Panelist: Eduardo Agostinho Freitas Fernandes, Specialist in health regulation and surveillance ANVISA - Brazilian Health Regulatory Agency, Brazil
Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.
Este webinar tiene los objetivos:
• Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos. • Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS. • Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina. • Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.
Moderadora: - Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica International Pharmaceutical Federation (FIP), Brazil
Panelista: - Andrés Figueroa Campos, Gerente SD Registro Sanitario de Productos Farmacéuticos Bioequivalentesy, ANAMED ISPch – Agencia Nacional de Vigilancia Sanitaria de Chile
In 2019, the FIP Advisory Committee for the Pharmacy Technician and Support Workforce Strategic Platform was established and took on the responsibility to host future Symposia. Since 2020, the Pharmacy Technicians’ Symposium has been hosted and delivered as a digital event to promote widespread access to this learning forum. The committee is once again pleased to host, on October 18th and 19th,, the 2022 Pharmacy Technicians’ Symposium. This digital event will offer 2 half day sessions showcasing global roles and practice models among the pharmacy technician workforce, built on a theme of resiliency and contribution by working with other members of the pharmaceutical workforce toward recovery of the healthcare system. More here.
Pharmacists have a key role in leading antimicrobial stewardship initiatives to help tackle antimicrobial resistance. In Webinar 1, you will learn more about the magnitude of this recognised global health threat, its impact on real life, and how our profession can overcome challenges and make the most of opportunities to work collaboratively and shine in this space.
Learning objectives:
Identify the problem of AMR globally and some of the initiatives in place to tackle this;
Describe the importance of multidisciplinary teams and the role pharmacists play within them in the context of AMS;
Become familiar with how pharmacists from different geographical regions are helping to address AMR; and
Recognise the impact of AMR on patients when treatment fails.
In 2019, the FIP Advisory Committee for the Pharmacy Technician and Support Workforce Strategic Platform was established and took on the responsibility to host future Symposia. Since 2020, the Pharmacy Technicians’ Symposium has been hosted and delivered as a digital event to promote widespread access to this learning forum. The committee is once again pleased to host, on October 18th and 19th,, the 2022 Pharmacy Technicians’ Symposium. This digital event will offer 2 half day sessions showcasing global roles and practice models among the pharmacy technician workforce, built on a theme of resiliency and contribution by working with other members of the pharmaceutical workforce toward recovery of the healthcare system. More here.
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Southeast Asia region: DG 12 (Pharmacy intelligence), DG 15 (People-centred care), and DG 19 (Patient safety).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualization) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
Southeast Asian Region Panel Discussion on DG priorities and data requirements:
The 21 DGs are aligned with the health system transformation in Indonesia, especially for DG 4 (Advanced and specialist development), DG 12 (Pharmacy intelligence and DG 20 (Digital health). DG 4 (Advanced and specialist development) is the most aligned DG in relation with transformation agenda on health human resources in Indonesia.
In Sri Lanka, the priority goals are DG 1 (Academic capacity), DG 2 (Early career training strategy), DG 5 (Competency development), and DG 9 (Continuing professional development strategies). DG 1 is important because Sri Lanka has different pathways of creating pharmacists with most of the other countries, there are 3 programs with different qualification.
Sri Lanka needs is to collect the data of pharmacists working in different sectors, because all pharmacists are having the same certificate and this not mention the area of practice.
Currently, Sri Lanka does not have a well-organized education and training program to support early career pharmacists, or a development framework to support career development and no continuing professional development program for pharmacists.
All 21 DGs resonate with the needs in India. The priority areas are DG 12 (Pharmacy Intelligence), DG 15 (People-centred care) and DG 19 (Patient safety). Pharmacy council of India is maintaining the data about number of pharmacists and number of colleges which needs to be updated regularly and available to the policy makers as well as the people.
India is currently developing the data regarding available pharmacists and their area of work.
Indonesia needs the data of pharmacists that provide services across nation, their competencies profile and progress on the career. Indonesian Pharmacists Association already created the information system to provide the data on number of pharmacists, however, the data is still lacking the competencies profile and the progress on their career pathway for advanced practice perspective.
Despite a temporary drop in the incidence of seasonal influenza during the pandemic, it will continue to represent a heavy burden for healthcare systems and societies overall. In a post-pandemic scenario, it will be crucial to protect and further advance the progress that had been achieved globally in terms of flu vaccination rates. This event will discuss why flu vaccination remains a priority, and how co-administration of flu and COVID-19 vaccines can provide a convenient and effective solution for driving vaccination uptake for both diseases. The event will also explore how pharmacists can contribute to flu vaccination strategies.
By the end of the session participants should be able to: • Understand the importance of flu vaccination, especially for vulnerable population groups, like the elderly • Recognize the need for improving vaccination coverage rates for both the flu and COVID-19. • Discuss pharmacists’ contribution to flu vaccination strategies.
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
Panelists: - Joshua A. Mott, Technical Advisor for Influenza and Pandemic Preparedness, WHO, Department of Epidemic and Pandemic Preparedness and Prevention, Switzerland - Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France - Maria Mendes, Area Manager at the Centre for Medicines Information and Health Interventions (CEDIME) at the National Association of Pharmacies, Portugal National Association of Pharmacies, Portugal
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Africa region: DG 1 (Academic capacity), DG 3 (Quality assurance), DG 9 (Continuing professional development strategies), and DG 18 (Access to medicines, devices, and services).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
African Region Panel Discussion on DG priorities and data requirements:
All FIP DGs are relevant. The first and the main priority from FIP DGs is the DG 1 (Academic capacity). Academic capacity is the first step for developing the profession. There is a need to collect the data on education such as the number of people in academia, university lecturers, and hours of courses. The second one is the strong regulation for quality assurance of the medicines.
In Ghana, there is a need to improve access to quality medicines (DG 18). DG 18 (Access to medicines, devices, and services) is the main priority in the continent.
Three most prioritized goals are: 1) DG 4 (Advanced and specialist development), to enforce the law established in 2012; 2) DG 5 (Competency development) to standardize the competency of pharmacy graduates; 3) DG 20 (Digital health) to control substandard and falsified medicines.
The Pharmacy Council of Ghana is also developing the e-pharmacy policy and subsequently have developed national electronic pharmacy platform.
For DG 4 (Advanced and specialist development), there’s a need to get the baseline data in terms of available capacities and specialists. After having the baseline data as well as the needs assessment results, pharmacies can be trained based on their interests and we can track the implementation after the training.
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. European region: DG 1 (Academic capacity), DG 4 (Advanced and specialist development), DG 7 (Advancing integrated services), DG 13 (Policy development), DG 15 (People centred care), DG 19 (Patient safety), DG 20 (Digital health), and DG 21 (Sustainability in pharmacy).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualization) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
European Region Panel Discussion on DG priorities and data requirements
FIP DGs are aligned with national priorities, which also to achieve the United Nation’s health related Sustainable DGs. Nowadays there is an organizational shift which reduces the boundaries and encourage integrated care according to the patient needs, this is also one of the reasons why FIP DGs are really aligned to the national priorities.
In the UK, DG 2 (Early career training strategy), DG 7 (Advancing integrated services) and DG 21 (Sustainability in pharmacy) resonates with the national needs.
In Portugal, DG 5 (Competency development), DG 7 (Advancing integrated services) and DG 13 (Policy development) are the DGs that mostly aligned with three national priorities, which are to: 1) increase access to patient information, 2) guarantee successful implementation of pharmaceutical career in national health system, and 3) promote implementation and reimbursement of new pharmaceutical services.
In Northern Cyprus, DG 9 (Continuing professional development strategies), DG 13 (Policy development), DG 19 (Patient safety), and DG 4 (Advanced and specialist development) are the DGs that are mostly resonates with the national priorities.
Data needed to track the progress are: 1) quantitative and qualitative data of pharmacists’ placement in undergraduate curriculum, 2) competencies measurement and the real impact of pharmacists from holding a specific competency and 3) qualitative data regarding continuous professional development and specialists (i.e., sport pharmacists).
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Americas region: DG 1 (Academic capacity), DG 3 (Quality assurance), DG 13 (Policy development), and DG 15 (People-centred care).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
Americas Region Panel Discussion on DG priorities and data requirements
Progress was highlighted with DG 18 (Access to medicines, devices, and services), DG 19 (Patient safety) and DG 20 (Digital health). For DG 20, there are electronic health records and apps about Coronavirus information. Current needs are not only to generate new data but also to make more data available to public. However, this is limited by the regulatory agency.
It is difficult to assess only specific DG priority because each of the DGs is often connected to another. For example, DG 15 (People centred care) is linked to DG 8 (Working with others), DG 7 (Advancing integrated services) and DG 11 (Impact and outcomes).
In the Americas, there is often a lack of data related to the multi-employment of pharmacists. There is also lack of professionals presents in community pharmacy.
There is a need for data related to pharmacies participation in immunization and occupation and renumeration related to gender.
To implement strategic plans, we need the data before and after the implementation
The COVID19 pandemic has highlighted that we need better antiviral therapies, especially for respiratory viral diseases. We have developed inhalation therapies consisting of siRNA nanoparticles which inhibit the viral genome of coronaviruses. The advantage over vaccination is the therapeutic index for virus variants and new coronaviruses. Other so far undruggable targets are transcription factors which are often drivers of tumorigenesis. Accordingly, examples for pulmonary delivery of therapeutic RNA in asthma, targeting GATA-3, and in lung cancer, targeting mutated KRAS, will be discussed.
Learning objectives: *siRNA nanoparticles for inhalation delivery *Application to un- druggable targets like transcription factors
Co-moderator: Kaushik Desai, Associate ExCo Member, Industrial Pharmacy Section, Secretary General International Pharmaceutical Excipients’ Council of India-India
Panelist: Olivia Merkel, Professor of Drug Delivery Ludwig Maxmillian University (LMU) Munich, Germany
This webinar is the second of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will cover: - Ongoing technological developments, including: o Multi-omics o Single-cell sequencing o High-resolution imaging o Combinatorial drug screens o Biostatistics, machine learning and open software repositories - Examples of clinical translation of the above technologies in a research context - Thoughts on future directions of the field, and unaddressed gaps.
At the end of this session, participants will: 1. Have an awareness of some of the key technological advances driving the evolution of precision medicine. 2. Be familiar with some examples of its potential implementation 3. Be aware of current limitations and remaining challenges to be addressed
Co-Chairs: -Donnacha Fitzgerald, FIP Technology Forum member, Predoctoral Fellow The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital, Germany -R. Stephanie Huang, Professor Department of Experimental and Clinical Pharmacology, University of Minnesota, USA
Panellists: -Wolfgang Huber, Co-Director, Molecular Medicine Partnership Unit Group Leader ad Senior Scientist The European Molecular Biology Laboratory (EMBL), Germany -Christoph Merten, Associate Professor Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland
Cancer is the second leading cause of death globally, according to the World Health Organization. Prevention and early screening are crucial elements of interprofessional strategies to reduce the burden, morbidity and mortality associated with cancer, as are medication management for optimal outcomes, and patient support. Pharmacists have a key role to play in all these areas. At this digital event, FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of cancer-related services. In addition, the handbook will be accompanied by the knowledge and skills (K&S) reference guide in cancer which identifies the K&S that pharmacists require for the provision of such services, thus offering guidance to pharmacists, academic institutions and CPD providers. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Attendees will learn about:
1. The role of pharmacists in the prevention, screening, care and management of cancer; 2. Challenges and opportunities for pharmacists in implementing cancer-related services; 3. The knowledge and skills pharmacists need to acquire to support their role in the delivery of cancer-related services.
Moderator:
-Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, Portugal
Panelists: -Evelyn Handel, ISOPP President (2022-2024) International Society of Oncology Pharmacy Practitioners (ISOPP), USA -Folakemi T. Odedina, Professor of Oncology Mayo Clinic Cancer Center, USA -Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre, Canada -Dalia Bajis, Lead for provision and partnerships FIP, Australia
Vaccination is one of the most effective measures to prevent disease transmission and help people remain healthy and retain functional ability as they grow older. Adopting a life-course approach to vaccination and providing convenient and accessible vaccination pathways for older adults is essential to achieve high vaccination coverage rates in this particular population group. Pharmacists increasingly offer reliable information and vaccination services around the world. Among the different special-risk population groups, older adults have specific vaccination needs that will be discussed in this event.
By the end of the session participants should be able to: 1. Understand the most important vaccines for older adults 2. Recognise the role of pharmacists in promoting vaccination to the elderly 3. Discuss strategies for the promotion of a life-course approach to vaccination
Moderator: - Lina Bader, Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Saudi Arabia
Panelists: - Jean-Pierre MICHEL, Honorary Professor of Medicine University of Geneva, Switzerland - David Sinclair, Chief Executive ILC. UK - Jane Barratt, Secretary General International Federation on Ageing, Canada - Ruggli Martine, President pharmaSuisse, Switzerland
Strengthening our patients' immune systems has never been more important, and healthy nutrition is one critical factor. This event focuses on how nutrition impacts immunity and its importance in supporting a strong and responsive immune system. It is the second event in the 2022 FIP series 'Food for thought: Pharmacists' role in healthy nutrition'.
Moderator: Jaime Acosta, Community Pharmacist Farmacia Acosta- Spain
Panelists: -Philip Calder, President, Federation of European Nutrition Societies Head of the School of Human Development and Health at the University of Southampton, United Kingdom -Joanna Harnett, Senior Lecturer Sydney Pharmacy School, Australia -Basma Abdulsamad, Clinical Pharmacist – MSc. Immunology and Allergy – Harvard Associate Alumni Medical Research Institute, Alexandria Egypt, Egypt
Asthma and chronic obstructive pulmonary disease are common chronic respiratory diseases (CRD) that affect millions of people worldwide. Pharmacists have a role to play in the prevention, care and management of CRD. FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of CRD-related services. This will be accompanied by a reference guide which identifies the knowledge and skills that pharmacists require for the provision of such services. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Attendees will learn about: 1. The role of pharmacists in the prevention, screening, care and management of chronic respiratory diseases and their complications; 2. Challenges and opportunities for pharmacists in addressing chronic respiratory diseases-related services; 3. The knowledge and skills pharmacists need for the delivery of chronic respiratory diseases services.
Moderator: - Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation, Portugal
Panelists: - Ema Paulino, President Portuguese National Pharmacy Association, Portugal - Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, Portugal - Dalia Bajis, FIP Lead for provision and partnerships, Australia - Richard Sammy, Pharmacist Changu Pharmacy Ltd, Kenya
Webinar video • 12 September 2022, 10:00 - 11:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the Western Pacific region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in the Western Pacific.
Webinar video • 9 September 2022, 13:00 - 14:30 CEST
Achieve equitable, inclusive and quality pharmaceutical education for all: Launch of the FIP toolkit for addressing inequities in pharmaceutical education
Inequity has been identified as one of the most serious issues in education worldwide, with multiple causes and consequences. Recent evidence and findings from FIP research indicate that inequities in pharmaceutical education need to be addressed, and this FIP toolkit for addressing inequities in pharmaceutical education intends to motivate, assess, and inform forward thinking changes targeted at transforming pharmaceutical education through addressing inequities globally, across all regions and locally.
At the end of this session, participants will: 1. Learn about the vital inequity themes that impact pharmaceutical education; 2. Understand the importance of having equitable pharmaceutical education; 3. Discuss with the toolkit authors and high-level speakers how to take action towards enabling equitable pharmaceutical education nationally, regionally and globally
Moderator: - Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
Guests: -Catherine Duggan, FIP CEO, The Netherlands
Panelists: - Nilhan Uzman, FIP Lead for education and primary health care policies, The Netherlands - Alison Ubong Etukakpan, FIP Educational Partnership Specialist, Nigeria - Karima Bennara, Chairperson of pharmacy education, International Pharmaceutical Students Federation, Algeria - Khalid Garba Mohammed, Post doctoral Fellow, Pharmaceutical Engineering Group, School of Pharmacy, Queens University Belfast, UK - Oliver Grundmann, Clinical Professor The College of Pharmacy, University of Florida, USA - Neelaveni Padayachee, Senior lecturer and Researcher Department of Pharmacy and Pharmacology, Pharmacy Practice Division, The University of Witwatersrand, South Africa - Aysu Selcuk, FIP Education and Primary Health Care Policies Specialist, Turkey - Dalal Hammoudi, Associate Dean for Assessment Lebanese International University, School of Pharmacy, Lebanon
Webinar video • 8 September 2022, 16:00 - 17:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the Americas region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.
FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.
This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in the Americas.
Moderator: - Magaly Rodrigu, Vice president Pharmaceutical Forum of the Americas, USA
Panelists: - Patricia Klahn Acuña, Clinical Pharmacist- Hospital Carlos Van Buren, Chile - Ilisa Bernstein, Interim Executive Vice President and CEO American Pharmacists Association, USA - Natalia Sancho-Vargas, Colegio de Farmacéuticos de Costa Rica, Costa Rica - Leticia Caligaris, Uruguay - Catalina Cano Abásolo, Head of the Department of Pharmaceutical Policies and Regulations, Health Providers and Complementary Medicines. Division of Healthy Public Policies and Promotion Assistant Secretary of Public Health, Ministry of Health, Chile - Timothy Aungst, Associate Professor. Freelance Writer and Consultant The Digital Apothecary, USA
Changes in climate constitute a reality that, according to recent projections, is going to worsen in the coming years.1 Increasing air pollution and climate change have an impact on respiratory health and mortality where climate change represents a massive direct threat to respiratory health by promoting or aggravating respiratory diseases or indirectly by increasing exposure to risk factors for respiratory diseases.
Overall Aim: To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them to provide better patient advice and self-care.
Learning objectives:
- Identify the changes in climate as well as the interrelationship between climate change and air pollution - Understand the impact of climate change and air pollution on health particularly respiratory health - Understand how climate change and air pollution affect people living in low- and middle-income countries - Know the intervention, treatment and management strategies including self-care measures to minimize the impact on respiratory health - Recognize the role pharmacists must play to support better health care delivery and patient care
Moderator: - Gonçalo Sousa Pinto, Lead for practice development and transformation, FIP Spain
Panelsists: - Kian Fan Chung, Professor of Respiratory Medicine, National Heart & Lung Institute, Imperial College London, United Kingdom - Sundeep Salvi, Founder and Director The Chest Research Foundation, India - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Saudi Arabia - Ravijyot Saggu, Lead clinical pharmacist and CPhO clinical fellow ’21/’22, NHS England, UK
Influenza and COVID-19 can have an important impact in health, productivity and quality of life, especially for vulnerable populations. Likewise, both diseases have vaccines that are available and support a lower risk of transmission of the disease.
Pharmacists can play a major role in reminding people to get vaccinated, building vaccine confidence and supporting their decision making, dispensing vaccines and, in some countries, administering those vaccines. The coadministration of these vaccines can lead to an efficient and convenient way of improving vaccine uptake against both diseases. Community pharmacies’s accessibility and credibility put them in an ideal situation to provide this important service, thus making a valuable contribution to disease prevention.
This digital event will discuss the importance of promoting the coadministration of COVID-19 and flu vaccines as well as strategies for pharmacies’ involvement.
By the end of the session participants should be able to:
Understand the benefits of vaccine coadministration
Recognize the need for vaccination coverage in both flu and COVID-19
Present the FIP Guideline on this topic
Moderator:
- Daragh Connolly, President, Community Pharmacy Section, Ireland
Panellist:
- Mitchel Rothholz, Immunization Consultant, Three-C Consulting, USA - Lisa Nissen, Professor (Program Director) – Health Workforce Optimisation, Centre for Business and Economics of Health, (Faculty of Business), Australia - Sham Moodley, Pharmacist, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa - Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal
Webinar video • 5 September 2022, 10:00 - 11:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the South East Asian region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.
FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.
This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in South East Asia.
Moderator: -Tanniru V Narayana, President SEARPharm Forum, India
Panelists: -Rao Vadlamudi, Professional Secretary/Immediate past president SEARPharm Forum/ the Indian Pharmaceutical Association, India -Hilwan Yuda Teruna, Vice President Indonesian Pharmacist Association, Indonesia -Kelum Jayasuriya, Group Manager Pharmacy Operations Asiri Group of Hospitals, Sri Lanka -Chinta Abayawardana, Past President, Pharmaceutical Society of Sri Lanka, Sri Lanka
Webinar video • 2 September 2022, 13:00 - 14:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the European region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in Europe
This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.
Learning objectives: 1. Improve knowledge of pharmacists on the risks of influenza 2. Exploring pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate within the African region; 3. Showcase country cases from pharmacists across the continent on influenza vaccination, digital vaccination solutions and patient communication on vaccines.
Moderator: - ArinolaJoda, Assistant Secretary and Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria
Guests: - Cheryl Cohen, Professor & Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases and School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, South Africa - Gonçalo Sousa Pinto, Lead for practice development and transformation, FIP, Portugal - Redouane Soualmi, Chairperson of external relations Algerian Pharmaceutical Federation - Fédération Algérienne de Pharmacie, Algeria - Merilynn Steenkamp, General Manager Sanofi Vaccines, South Africa - Wael Ali, General Secretary, EMRPharm Forum , President Egyptian organization of pharmacy, Egypt
Facilitators: - Nilhan Uzman, Lead for Education and Primary Health Policies, FIP, Turkey - Alison Etukakpan, Educational Partnership Specialist, FIP, Nigeria
This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.
Learning objectives: 1. Improve knowledge of pharmacists on the risks of influenza 2. Exploring pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate within the African region; 3. Showcase country cases from pharmacists across the continent on influenza vaccination, digital vaccination solutions and patient communication on vaccines.
Moderator: - Arinola Joda, Assistant Secretary and Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria
Guests: - Cheryl Cohen, Professor & Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases and School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, South Africa - Gonçalo Sousa Pinto, Lead for practice development and transformation, FIP, Portugal - Redouane Soualmi, Chairperson of external relations Algerian Pharmaceutical Federation - Fédération Algérienne de Pharmacie, Algeria - Merilynn Steenkamp, General Manager Sanofi Vaccines, South Africa - Wael Ali, General Secretary, EMRPharm Forum , President Egyptian organization of pharmacy, Egypt
Facilitators: - Nilhan Uzman, Lead for Education and Primary Health Policies, FIP, Turkey - Alison Etukakpan, Educational Partnership Specialist, FIP, Nigeria
This will be a 2-part workshop to introduce the FIP YPG Career Development toolkit. Part 1 will review the toolkit, the available resources, and discuss how it will benefit the user. Attendees will then be instructed to work through the toolkit over the next few weeks.
Part 2 of the workshop will be an engaging session where participants are asked to return with their completed toolkits to discuss what they learned with other attendees, review their toolkits in breakout rooms, and have the opportunity to ask questions.
Facilitar el acceso a los medicamentos: Bioequivalencia - Metodologías In Vitro para la Demostración de Equivalencia Terapéutica
Sesión V: Bioequivalencia - Estudios de Permeabilidad: principios, metodologías y análisis de datos
Sesión en Español
Este webinar tiene como objetivo presentar los conceptos:
• Rutas de absorción oral de fármacos • Transportadores intestinales • Estudios de permeabilidad in vitro • Impacto de excipientes sobre la absorción oral de fármacos • Aplicaciones de los estudios de permeabilidad
Moderadora: -Talita Ferreira, FIP Coordinadora de Proyectos de bioexención en Latinoamérica, Brasil
Panelista: -Pablo González, CEO Innovation and Biopharmaceutical Evaluation Center-Chile
Pharmacy needs to build sustained data and analytics capabilities that support evidence-based decision making and advocacy interventions that inform policy development. Improving capacity in data and intelligence across FIP and its member organisations, is essential to advance pharmacy world-wide. This event explores challenges and opportunities that maximise the use of data to generate evidence of impact across safe and effective use of medicines, pharmacy practice and the pharmacy workforce..
Aim To describe approaches for delivering the required data and intelligence to generate evidence of impact for the profession and current and future policy: enablers and barriers that will support this through practical approaches.
Learning objectives:
1) Explain how health information systems can be strengthened; 2) Describe approaches to evidence generation; 3) List current enablers/opportunities and barriers for using pharmacy data and intelligence to their full potential; 4) Discuss how the pharmacy profession makes better use of data and intelligence.
Moderator: - Christopher John, FIP Lead for Data and Intelligence FIP, UK
Panellists: - Sallie Pearson, Professor of Health Systems Research UNSW Sydney, Australia - Astrid Czock, FIP Global Lead for DG8: Working with others, CEO Qauliccare, Switzerland - Saja A. Alnahar, Assistant Professor Yarmouk University, Jordan - Hong Anh Chu, Technical Officer, WHO, Switzerland
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.
Learning objectives: By the end of the session participants should be able to: • Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated • Understand the main recommended vaccines for people living with cardiovascular diseases • Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group
Moderator: - Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia
Panellists: - Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina - Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland - John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.
Learning objectives: By the end of the session participants should be able to: • Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated • Understand the main recommended vaccines for people living with cardiovascular diseases • Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group
Moderator: - Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia
Panellists: - Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina - Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland - John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA
Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.
By the end of the session participants should be able to: • Understand dysbiosis and gut wellness • Identify tips to manage abdominal pain • Understand the role of diet in immunologic modulation • Understand the use of probiotics for gut wellness
Moderator: - Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India
Panelists: - Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia - Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal - Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey - Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey
Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.
By the end of the session participants should be able to: • Understand dysbiosis and gut wellness • Identify tips to manage abdominal pain • Understand the role of diet in immunologic modulation • Understand the use of probiotics for gut wellness
Moderator: - Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India
Panelists: - Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia - Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal - Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey - Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey
Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.
By the end of the session participants should be able to: • Understand dysbiosis and gut wellness • Identify tips to manage abdominal pain • Understand the role of diet in immunologic modulation • Understand the use of probiotics for gut wellness
Moderator: - Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India
Panelists: - Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia - Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal - Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey - Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey
This event will showcase how nations have coordinated pharmacy support for person-centred care in the fight against COVID-19 with a focus on strategy, policy and practice. Barriers and enablers to pharmacy’s involvement in the pandemic will be discussed as well as insights for countries wanting to advocate for pharmacy’s greater contribution in health systems. The future role of pharmacy in pandemics will be highlighted.
Aim To describe current and future pharmacy practice in delivering person-centred care during the fight against COVID-19 and possible future pandemics.
Learning objectives:
1. List policy and professional enablers and barriers for developing pharmacy practice during the COVID-19 pandemic; 2. Give examples of pharmacy services used in the fight against COVID-19; 3. Describe approaches for advocating for pharmacy support in pandemics; 4. Predict the role of the pharmacist and their teams in future pandemics.
Moderators: -Nadia Bukari, FIP Global Lead/Associate Professor, University College London FIP/UCL, UK -Abby Kahaleh, PhD, MS, BPharm, MPH, FAACP, FIP Global Lead on Quality Assurance for Pharmacy Education, Tenured Associate Professor for Clinical and Administrative Sciences; Board of Trustees Faculty, Roosevelt University, USA
Panelsits: -Suzete Costa, PharmD, MPH, PhD Executive Director & Senior Research Director Institute for Evidence-Based Health (ISBE), Portugal -Michael Ganio, Senior Director, Pharmacy Practice and Quality ASHP, USA -Shepard Mhlaba, FIP Global Lead, FIP Workforce Development Hub, WDG2: Early career training strategy, Drug Information Pharmacist/Research Assistant, Drug and Toxicology Information Services (DATIS), Harare, Zimbabwe
Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder that affects people of all ages. Pharmacists can play an important role in symptom management, referral to other healthcare professionals and provision of advice to improve quality of life. This event will provide an overview of the main roles pharmacists can have in supporting people living with IBS, from a community pharmacy perspective.
By the end of the session participants should be able to: • Discuss the role of community pharmacists around IBS • Understand the difference in symptoms between abdominal cramping pain and IBS • Identify red flag symptoms for referral of IBS patients
Consumers throughout the world are increasingly looking to the internet to purchase their drugs. The worldwide pandemic has caused many consumers, who had not done so previously, to look to the internet for healthcare, healthcare information and medicinal products. However, at any given time, 95% of the roughly 35,000 online drug sellers worldwide operate illegally, in violation of laws and placing consumers at risk. Drugs purchased through an illegal drug seller on the internet may contain no drug, subtherapeutic levels of a drug, a completely different drug, or toxic chemicals. These websites will appear to be “pharmacies” or other “medical centres” providing credible health care, drug information and safe and approved medications, but are not and present risk to the unknowing consumer.
Regulators throughout the world are monitoring the level of nefarious drug sellers and “medical clinics” on the internet. Regulatory solutions to combat and remove the presence of these harmful vendors and sites have not been widely implemented. Public awareness is an important step, but also raising the awareness among healthcare providers, law makers and social media platforms.
Learning Objectives: -To identify the level of illegal online drug sellers and bogus medical clinics on the internet and impact on the unsuspecting public -To identify the barriers to overcome and better protect the public. To identify programs and initiatives currently in place to combat misinformation, poor virtual care and falsified medication to enhance the safety and protect the internet consumer -To encourage and support standards for virtual care.
Moderator: -Ronald Guse, Chair FIP Regulators Forum - Canada Panelists: -Mike Isles,Director Alliance for Safe Online Pharmacy-EU-UK -Justin Macy,Digital Health Senior Manager National Association of Boards of Pharmacy-USA -Libby Baney,Senior Advisor to ASOP Global; Partner, Faegre Drinker LLP, Alliance for Safe on Pharmacy Global-USA
Overall Aim: To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them provide better patient advice and self-care.
Learning objectives: • Identify the sources of indoor air pollution and its increasing threat to health • Understand the short- and long-term impact of indoor air pollution particularly on children • Understand clinical, pharmacological, and non-pharmacological treatments including self-care measures to minimize the impact of air pollution on respiratory health • Illustrate how advocacy can impact behavior change to support adoption of better self-care practices aimed at reducing health impact of air pollution.
Moderator: - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia
Facilitator: - Nour Eltahla, FIP Projects Coordinator for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Ar
